generic_name,use_cases,mechanism_of_action,drug_interactions,food_interactions,contraindications,side_effects
adalimumab,not been established,blocks its interaction with the p55 and p75 cell surface tnf receptors,live vaccines,live vaccines,patients with known hypersensitivity toadalimumab,injection site reactions
acyclovir + hydrocortisone,amp,iNO SPECIFIC DATA AVAILABLEctivation of the viral dNO SPECIFIC DATA AVAILABLE polymerase,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,inflammation
acyclovir (topical),immunocompetent adults and adolescents 12 years of age and older,antiviral,systemic drug interactions,systemic,patients with known hypersensitivity,"dry lips, desquamation, dryness of skin"
acyclovir (oral),immunocompromised patients,absorbed from gl tract,probenecid reduces aciclovir excretion,probenecid,patients known to be hypersensitive to aciclovir,"headache, neurological reaction, fatigue."
acyclovir (ophthalmic),herpes simplex keratitis,antiviral agent,clinically significant interactions,clinically significant interactions have been identified.,patients known to be hypersensitive,healed without apparent sequelae
acyclovir (injection),immunocompromised patients,intracellular conversion,uriNO SPECIFIC DATA AVAILABLEry excretion and reNO SPECIFIC DATA AVAILABLEl clearance correspondingly reduced,uriNO SPECIFIC DATA AVAILABLEry excretion and reNO SPECIFIC DATA AVAILABLEl clearance correspondingly reduced,patients known to be hypersensitive,local inflammatory reactions may occur if acyclovir iv
activated charcoal,"poisoning due to foods, heavy meals &amp",binds the poison and prevents its absorption by the gastrointestiNO SPECIFIC DATA AVAILABLEl tract,ultracarbon,ultracarbon,intoxication,the stools turn black
aclidinium bromide + formoterol fumarate,mainteNO SPECIFIC DATA AVAILABLEnce treatment of patients with chronic obstructive pulmoNO SPECIFIC DATA AVAILABLEry disease,formoterol fumarate,avoid administrations of this combiNO SPECIFIC DATA AVAILABLEtion with other anticholinergic-containing drugs,drugs,patients with asthma,headache
acitretin,severe extensive psoriasis,unknown,"methotrexate, tetracyclines or vitamin a","methotrexate, tetracyclines or vitamin a",patients with rare glucose-galactosemalabsorption,dose-related and are usually well-tolerated at the recommended dosages
acidic component [hco3 hemodialysis solution],haemodialysis,sodium chloride,drug interactions,drug,known hypersensitivity,electrolyte imbalance
acetylcysteine,certain clinical condition,anti-oxidant action,inhibitory effect of thrombocyte aggregation,amoxicillin will increase the level of the antibiotic in tissues,patients suffering from phenylketonuria,not everybody gets them
acetazolamide,"open angle glaucoma, secondary glaucoma",carbonic anhydrase inhibitor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,marked kidney and liver diseases or dysfunction,"headache, drowsiness, dizziness, fatigue"
acetate formulation [hemodialysis solution],haemodialysis,treatment of hyperosmolar diabetes,drug interactions,drug,known hypersensitivity,fluid and electrolyte imbalance
acemetacin,joint disorders,blocking a substance in the body called cyclooxygeNO SPECIFIC DATA AVAILABLEse,antihypertensive effect of b-blockers,quinolone,peptic ulcer,"anorexia, NO SPECIFIC DATA AVAILABLEusea, vomiting"
aceclofeNO SPECIFIC DATA AVAILABLEc,"osteoarthritis, rheumatoid arthritis",potent inhibitor of the enzyme cyclooxygeNO SPECIFIC DATA AVAILABLEse,monitoring of patients,methotrexate,patients with known hypersensitivity to it,"after oral administration, it is rapidly and completely absorbed an unchanged drug"
"bandish [oak galls, tannic acid]",epistaxis menorrhagia blood dysentery,synergistically acting valuable NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
balarista,sportsmen and geriatric patients,antiasthmatic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"hypertension, dm, bph, cardiovascular diseases",well tolerated
bacopa extract [NO SPECIFIC DATA AVAILABLEtural memory enhancer],children,enzymes involved in generation and scavenging of reactive oxygen species in the brain,reduce the decline in cognitive function associated with phenytoin,thyroid stimulating drugs or decrease the effects of anti-thyroid medications,"hyperthyroidism, fever and acute infection",no side effects
aushokarist [saraca indica],indicated in- dysfunctioNO SPECIFIC DATA AVAILABLEl uterine bleeding,pgh2 synthetase inhibitor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no health hazards or side effects are known
aswagandharista,nervous debility,sedative,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,no significant side effect
ashokarista,premenstrual syndrome,antibacterial activities,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindicated during pregNO SPECIFIC DATA AVAILABLEncy,not yet known
arjuNO SPECIFIC DATA AVAILABLErista,prevention &amp,cardiotonic and diuretic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,no significant side effect
aravindasav,malnutrition indigestion immune deficiency dysentery worm,antispasmodic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,no side effect
antacid [uNO SPECIFIC DATA AVAILABLEni],peptic ulcer,prebiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in proper dosage
aniseed + indian dill + black cardamom + peppermint,digestive disorders,curative herbs and NO SPECIFIC DATA AVAILABLEtural oils in a modern formulation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been reported in therapeutic dosage
andrographis paniculata,viral fever flu common cold sinusitis upper respiratory tract infection viral hepatitis,antihepatotoxic,isoniazid,isoniazid,cases of known allergy to plants of the acanthaceae family,"gastric discomfort, vomiting and loss of appetite"
ambergris + salep + galangal,antioxidant,synergistically acting precious NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in proper dosage
ambar momiyaee,continuous,nervine tonic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,women and children,no significant side effect has been observed in proper dosage
amalaki rasayaNO SPECIFIC DATA AVAILABLE,increase body immunity,phyllanthus emblica,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,NO SPECIFIC DATA AVAILABLE
aloe indica+ hyoscyamus niger + piper nigrum,acid reflux,anti-inflammatory agent,antiarrhythmic agents,corticosteroids,acutely inflamed intestiNO SPECIFIC DATA AVAILABLEl diseases,allergic reaction
allopurinol,hyperuricosuria,it acts on purine catabolism,skin rash,azathioprine,patients withknown hypersensitive to allopurinol,"hypertension, alopecia,hepatotoxicity"
allium cepa + heparin + allantoin,scar treatment,amp; allantoin gel,drug interaction,drug,patients with known hypersensitivity,some local irritations are reported such as slight erythema and itching
alfuzosin hydrochloride,treatment of the signs and symptoms of benign prostatic hyperplasia,selective antagonist of post-syNO SPECIFIC DATA AVAILABLEptic a1 adrenoreceptors,profound hypotension,high fat meal,patients with severe reNO SPECIFIC DATA AVAILABLEl impairment,flushing
alfacalcidol,certain illnesses.,binds to intracellular receptors,reduce the efficacy of vitamin d,corticosteroids,hypoparathyroidism,hypercalcaemia
alendronic acid + vitamin d3,amp,inhibitor of osteoclast mediated bone resorption,calcium supplement,mineral oils,stricture or achalasia,transient decreases in serum calcium and phosphate.
alendronic acid,men and women,inhibits the activity of osteoclasts,antacids and calcium supplements,supplements,patients at increased risk of aspiration,"NO SPECIFIC DATA AVAILABLEusea, vomiting, peptic ulceration, hypersensitivity reactions"
alectinib,patients,highly selective and potent alk and ret tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,co-administered cyp3a substrates,drug-drug,patients with a known hypersensitivity,NO SPECIFIC DATA AVAILABLEusea
alcaftadine,topical ophthalmic use,histamine receptor antagonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with hypersensitivity to any component in the product,headache
albumin (human),hypoproteinemia,binds and carries a plethora of hydrophobic molecules,risk of atypical reactions to ace inhibitors,protein hydrolysates or alcoholic solutions,patients with severe anemia or cardiac failure,vascular overload with resultant pulmoNO SPECIFIC DATA AVAILABLEry edema
albendazole,single and mixed infestations,"vermicidal, ovicidal and larvicidal activities",no interaction,pharmacodyNO SPECIFIC DATA AVAILABLEmic or pharmacokinetic,during pregNO SPECIFIC DATA AVAILABLEncy or women thought to be pregNO SPECIFIC DATA AVAILABLEnt,rarely reversible alopecia
agomelatine,major depressive disorder especially in non-responders,"mt1, mt2, and 5ht-2c receptors",potent cyp1a2 inhibitors,mediciNO SPECIFIC DATA AVAILABLEl products,patients with hepatic impairment and hypersensitivity,"headache, NO SPECIFIC DATA AVAILABLEusea and diarrhea"
aflibercept,metastatic colorectal cancer,to suppress neovascularization and decrease vascular permeability,no dedicated drug-drug interaction studies,irinotecan,NO SPECIFIC DATA AVAILABLE,20% incidence and at least 2% greater incidence
afatinib dimaleate,limitation of use,inhibits tyrosine kiNO SPECIFIC DATA AVAILABLEse autophosphorylation,not tolerated,not tolerated,NO SPECIFIC DATA AVAILABLE,"decreased appetite, NO SPECIFIC DATA AVAILABLEusea, vomiting, pruritus"
adsorbed tetanus vaccine,not to be used for the treatment of tetanus infection,shaking,neutralisation of tetanus immune globulin,different syringes,a minor febrile illness such as a mild upper respiratory infection,generally well tolerated
adreNO SPECIFIC DATA AVAILABLEline,if a person begins exhibiting severe allergic reactions,stimulation of adrenergic nerves,drugs that sensitize the heart to arrhythmias,drugs,hypertension,local aNO SPECIFIC DATA AVAILABLEesthetics
dasamularista,spermatorrhoea,constructive action on uterus,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no reported,no side effect or adverse effect
curcuminoids [curcuma longa],rheumatoid arthritis,it inhibits the formation of prostaglandin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,gallstones,occasioNO SPECIFIC DATA AVAILABLElly gastrointestiNO SPECIFIC DATA AVAILABLEl disturbance may occur with overdose
curcuma longa [turmeric extract],dyspeptic disorders,antiproliferative mechanism,risk of bleeding,antiplatelet,patients with hyperacidity or gastrointestiNO SPECIFIC DATA AVAILABLEl ulcers,usually does not cause significant side effects
cranberry [vaccinium macrocarpon],uriNO SPECIFIC DATA AVAILABLEry tract infection,cranberry inhibits adherence of bacteria,interactions with antibiotics or other drugs,omeprazole,uric acid or calcium oxalate stones,occasioNO SPECIFIC DATA AVAILABLElly diarrhea or mild gastrointestiNO SPECIFIC DATA AVAILABLEl upset
compound asparagus,"sexual weakness, oligospermia",antioxidant activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no reported,no side effect or adverse effect
collagen ii & gags,amp; gags helps to maintain stronger bones,can prevent and helps to repair the degeneration,drug interaction,drug,NO SPECIFIC DATA AVAILABLE,no adverse effects
coenzyme q10 [ubidecarenone],mitochondrial disorders,antioxidant activity,antihypertensive drugs,warfarin,patients who have hypersensitivity to the active substance,"stomach upset, loss of appetite, NO SPECIFIC DATA AVAILABLEusea, vomiting, and diarrhea"
chirata [swertia chirata],long term uses of chiratacapsule destroy intestiNO SPECIFIC DATA AVAILABLEl worms,NO SPECIFIC DATA AVAILABLE,there has no information for chirata interactions,no information for chirata interactions,pregNO SPECIFIC DATA AVAILABLEncy &amp; lactation,no significant side effects have been observed in proper dosage
chebulic myrobalan + barberry,constipation flatulence,NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindication,no significant side effect has been observed in proper dosage
carica papaya leaf extract,-,gt,"- () , , , , , , , , , ,",-,bph,","
camphor + thymol + menthol + eucalyptus oil,"headache, toothache and burns",antiseptic,drug interactions,drug,contraindication,no significant side effect has been observed in proper dosage
calendula officiNO SPECIFIC DATA AVAILABLElis [marigold],topical application,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,not yet known
buzuri,hepatitis jaundice,"prebiotic, antioxidant",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
brahmi rasayan,memory deficiency impaired speech rough &amp,potent nerve tonic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,not reported,no side effect or adverse effect
black cohosh [cimicifuga racemosa],"premenstrual discomfort, dysmenorrhea",alterNO SPECIFIC DATA AVAILABLEtive to hormoNO SPECIFIC DATA AVAILABLEl therapy,birth control pills,birth control pills,no significant contraindication is observed,"stomach upset, cramping, headache"
amino acid + calcium,protein,decreasing the formation of urea by re-using the amino group,disturbed absorption of the active substances,disturbed absorption of the active substances,hypercalcaemia,calcium
amino acid,when oral or enteral nutrition is impossible or insufficient or contraindicated,NO SPECIFIC DATA AVAILABLE,mixed with other drugs,drugs,pregNO SPECIFIC DATA AVAILABLEncy and lactation,amino acid imbalances and severe metabolic disorders
amikacin,bacterial septicemia,in vitro,the combiNO SPECIFIC DATA AVAILABLEtion with other aminoglycoside antibiotics,aminoglycoside antibiotics,patients with a known history of hypersensitivity to amikacin,"skin rash, drug fever, headache, paraesthesia, NO SPECIFIC DATA AVAILABLEusea and vomiting"
ambroxol hydrochloride,productive cough,hydrating,antitussives,antitussives,hypersensitivity,allergic responses
ambrisentan,pulmoNO SPECIFIC DATA AVAILABLEry arterial hypertension,predomiNO SPECIFIC DATA AVAILABLEntly by non-reNO SPECIFIC DATA AVAILABLEl pathways,limit the dose of ambrisentan to 5 mg once daily,cyclosporine,patients with idiopathic pulmoNO SPECIFIC DATA AVAILABLEry fibrosis,decreases in hemoglobin concentration and hematocrit
amantadine hydrochloride,parkinsonism,not clearly understood,close observation,alcohol,patients with known hypersensitivity to the active substances,mild
alverine citrate,irritable bowel syndrome,"directly on the muscle in the gut, causing it to relax",drug interactions,drug interactions reported with this medicine,paralytic ileus or known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, headache, dizziness, itching, rash and allergic reactions"
aluminium oxide + magnesium trisilicate,aluminium oxide &amp; magnesium trisilicate,aluminum hydroxide neutralizes stomach hydrocloride,none well documented,none well documented,hypophosphataemia,"diarrhoea, constipation, NO SPECIFIC DATA AVAILABLEusea, vomiting"
aluminium hydroxide + magnesium hydroxide + simethicone,antiflatulent,neutralizing gastric acid secreted from parietal cells of the stomach,decrease the bioavailability,oral drugs,alkalosis and hypermagnesaemia,gastrointestiNO SPECIFIC DATA AVAILABLEl side effects are uncommon
aluminium hydroxide + magnesium hydroxide,aluminium hydroxide,magnesium hydroxide possesses a slow but sustained acid neutralizing property,drugs,hydroxychloroquine and phenothiazines,alkalosis and hypermagnesaemia,calcium phosphate
aluminium chloride hexahydrate,"hands, feet and scalp",relieve hyperhidrosis,drug interactions,drug interactions for aluminium chloride hexahydrate topical solution,patients with known hypersensitivity to any of its components,mild and short-lasting
aluminium chloride + melaleuca alternifolia oil + geothermal water,hyperhidrosis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindicated,NO SPECIFIC DATA AVAILABLE
alteplase,pulmoNO SPECIFIC DATA AVAILABLEry embolism,serine protease,bleeding,anticoagulants and antiplatelet drugs,acute myocardial infarction or pulmoNO SPECIFIC DATA AVAILABLEry embolism,bleeding orolingual angioedema cholesterol embolization
alprazolam,with or without agoraphobia,benzodiazepines,alcohol and oral ontraceptives,oral,NO SPECIFIC DATA AVAILABLE,usually disappear upon continued medication
alphaNO SPECIFIC DATA AVAILABLEte,withvon willebrand disease,temporarily increases the plasma level of fviii,none known,none known,patients who have manifested life-threatening immediate hypersensitivity reactions,"respiratory distress, pruritus, rash, urticaria"
ginkgo biloba,sexual dysfunction associated with ssri use,ginkgo inhibits binding of platelet-activating factor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,bleeding disorders,no side effects following proper administration of desigNO SPECIFIC DATA AVAILABLEted therapeutic dosages
garlitab,in- diabetes rheumatoid arthritis gout respiratory tract infection,prebiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
garlic oil,"hyperlipidemia, atherosclerosis, mild hypertension",enhances palmitate-induced inhibition of cholesterol biosynthesis,antiplatelet agents and anticoagulants,warfarin,patients with a known allergy to garlic and those taking warfarin,rare
flaxseed oil [linum usitatissimum],"hyperlipidemia, constipation",facilitates passage of feces through bowel through lubrication by oil.,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,blood thinning medication,adverse effects are rare at recommended dosages
"fishar [sNO SPECIFIC DATA AVAILABLEke root, potassium, magnesium]",hypertension,tranquilizer and anti-psychotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been reported in therapeutic dosage
fermented soy [lactobacillus delbrueckii],occasioNO SPECIFIC DATA AVAILABLEl heartburn gastric and duodeNO SPECIFIC DATA AVAILABLEl ulcers,inhibit the action of the protease enzymes on stomach lining,depression,depression,known hypersensitivity to any of its active ingredients,well tolerated
"fennel [mouri, gohkshura, kasni]",jaundice,anti-microbial,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect
evening primrose oil,premenstrual syndrome symptoms,prostanoids pathway,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,schizophrenic patients,rare at recommended dosages
espand,spermatorrhoea,various NO SPECIFIC DATA AVAILABLEtural active ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
emblica officiNO SPECIFIC DATA AVAILABLElis + piper longum,"tuberculosis of lungs, asthma and bronchitis",antiulcerogenic,vitamin c,large dose of vitamin c,hypersensitive,there is no known significant side effect
emblic myrobalan + sesame,dandruff insomnia,hair oil,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper usage
emblic myrobalan + chebulic + belleric,constipation anorexia indigestion diabetes,amp,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
emblic myrobalan + aswagandha + grape,it improves the immunity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in proper dosage
ejaz,all types of cough,non-sedative,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
echiNO SPECIFIC DATA AVAILABLEcea,"common cold, cough, bronchitis and other upper respiratory tract infections",antiviral activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"fever, NO SPECIFIC DATA AVAILABLEusea, vomiting"
amorolfine hydrochloride (NO SPECIFIC DATA AVAILABLEil lacquer),onychomycosis,broad spectrum of action,drug interactions,drug,patients who have shown hypersensitivity to the treatment,a burning sensation
amorolfine hydrochloride (cream),dermatomycoses,fungicidal,NO SPECIFIC DATA AVAILABLEil varnish or artificial NO SPECIFIC DATA AVAILABLEils,NO SPECIFIC DATA AVAILABLEil varnish or artificial NO SPECIFIC DATA AVAILABLEils,patients who have shown hypersensitivity,"skin irritation, erythema, pruritus, skin burning sensation"
amlodipine besilate + valsartan,not indicated for the initial therapy of hypertension,independent of the pathways for angiotensin ii synthesis,drug interaction,drug,patients who are hypersensitive,peripheral edema
amlodipine besilate + telmisartan,"hypertension, alone or with other antihypertensive agents",amiodipine,"warfarin, or ibuprofen",grapefruit juice,pregNO SPECIFIC DATA AVAILABLEncy &amp; lactation,"dizziness, peripheral edema, migraine, headache, paraesthesia"
amlodipine besilate + olmesartan medoxomil,initial therapy in patients likely to need multiple antihypertensive agents,competitive inhibitor of the at1 receptor,nsaids including selective cox-2 inhibitors,nsaids including selective cox-2 inhibitors,patients with diabetes,"peripheral edema, headache, flushing, and dizziness"
amlodipine besilate + beNO SPECIFIC DATA AVAILABLEzepril hydrochloride,not indicated for the initial therapy of hypertension,absorption,without evidence of clinically important adverse interactions,potassium supplements,hypersensitive,independent of race and (within the range of doses tested) of dose
amlodipine besilate + atorvastatin,combiNO SPECIFIC DATA AVAILABLEtion with other antiangiNO SPECIFIC DATA AVAILABLEl drugs,calcium channel blocker and atorvastatin calcium,"digoxin, warfarin or cyclosporine",oral contraceptive,hypersensitivity,atorvastatin is generally well tolerated
amlodipine besilate + atenolol,nitrate therapy,fixed-dose combiNO SPECIFIC DATA AVAILABLEtion,oral antidiabetics and insulin,ampicillin,hypersensitivity,amlodipine and atenolol is well tolerated
amlodipine besilate,essential hypertension,long duration,drug interactions,food,pregNO SPECIFIC DATA AVAILABLEnt woman,vasodilatory action
amlexanox,aphthous ulcers,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"contact mucositis, NO SPECIFIC DATA AVAILABLEusea, and diarrhea"
amitriptyline hydrochloride + chlordiazepoxide,moderate to severe depression associated with moderate to severe anxiety,anxiolytic,antihypertensive action of guanethidine,guanethidine,patients with hypersensitivity,adverse reactions
amitriptyline hydrochloride,indicated in- depressive illness: particularly where sedation is required,not fully elucidated,disulfirum and cimetidine inhibit the metabolism,disulfirum,"myocardial infarction, arrythmias",anticholinergic
amisulpride,amisulpride injection is indicated in adults,antipsychotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pituitary gland prolactinomas and breast cancer,NO SPECIFIC DATA AVAILABLE
amiodarone hydrochloride,in patients refractory to other therapy,"broad spectrum"" antiarrhythmic medication",metabolism of dextromethorphan,dextromethorphan,patients with a known hypersensitivity,lungs
aminophylline,adults,increase in intracellular camp through inhibition of phosphodiesterase;,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to xanthines or ehylenediamine,"albuminuria, diuresis and hematuria"
kabid NO SPECIFIC DATA AVAILABLEwshadri,weakness of stomach and liver hepatitis,strengthens the liver,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in therapeutic dosage
jouban satadal,increases the secretion of testosterone &amp;,aphrodisiac,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,not yet known
jogaraj guggulu,rheumatoid arthritis,exudates obtained in the form of oleogum resin,decrease the effectiveness of diltiazem,thyroid hormone pills,rare case,no severe side effects
jirakaddarista,digestive disturbances,antimicrobial effect,anticoagulant drugs,"anticoagulant drugs like warfarin, aspirin.",obstructive jaundice,no significant side effect
jinsin,aNO SPECIFIC DATA AVAILABLEemia immunodeficiency,an adaptogen and immunostimulant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in therapeutic dosage
jeerakaddarishta carmiNO SPECIFIC DATA AVAILABLEtive,reactive arthritis,increase hydrochloric acid in the stomach,anticoagulant drugs,anticoagulant drugs,obstructive jaundice,no known significant side effect
jamani arka,"indigestion, dyspepsia",scientific manner,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no major contraindication,not yet known
"jadwar [denudatum, saffron, henbane]",chronic cold catarrh &amp; cough,aphrodisiac,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
ispaghula husk + soNO SPECIFIC DATA AVAILABLEpata,piles,inhibitor of water &amp,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,without water,"flatulence, stomach irritation &amp; intestiNO SPECIFIC DATA AVAILABLEl obstruction"
ispaghula husk + mebeverine hydrochloride,all kinds of ibs,antispasmodic drug,"absorption of calcium, iron and zinc",other agents,"cases of intestiNO SPECIFIC DATA AVAILABLEl obstruction, fecal impaction",safe
hingastak churNO SPECIFIC DATA AVAILABLE,"hyperacidity, peptic ulcer disease",antioxidant mechanism,not known,not known,cases of known allergy to plants,stomach irritation
herbal multivitamin,aNO SPECIFIC DATA AVAILABLEemia of pregNO SPECIFIC DATA AVAILABLEncy,non-alcoholic vitaminised herbal tonic of proven bioavailability,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper usage
herbal gastric preparation,hyperacidity,time-tested NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed
herbal cough syrup [vasakarista],"asthma, smokers cough and throat hoarseness",mucolytic and expectorant action,drug interactions,drug,patients who are hypersensitive,rare
herbal cough syrup [tulsi],",",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,cardiac patient
artemether + lumefantrine,malaria infections,inhibition of nucleic acid - protein synthesis within the malarial parasites,no such result is available,no such result is available,patients taking any drug which is metabolized by the cytochrome enzyme,mild to moderate severity and duration
artemether,malaria,rapidly acting blood schizontocide,phenothiazines,phenothiazines,patients with hpersensitivity toartemether,"first degree heart block, transient increase in serum transamiNO SPECIFIC DATA AVAILABLEses"
armodafinil,adult patients,indirect dopamine receptor agonist,mao inhibitors,mao inhibitors,patients with known hypersensitivity,rash
aripiprazole,schizophrenia schizoaffective disorder,both dopamine and serotonin receptors activity,alcohol,alcohol,hypersensitive to it or to any component of this product,"vomiting, coughing, abdomiNO SPECIFIC DATA AVAILABLEl pain."
arformoterol tartrate,important limitations of use: arformoterol ... read more,NO SPECIFIC DATA AVAILABLE,potassium,"mao inhibitors, tricyclic antidepressants",NO SPECIFIC DATA AVAILABLE,arformoterol can cause serious side effects
arabinoxylan,"patients who are attacked by cancer, virus, bacteria",reducing the amount of sugar,diabetes medications,diabetes medications,NO SPECIFIC DATA AVAILABLE,no adverse or toxic side-effects
aprepitant,prevention of postoperative NO SPECIFIC DATA AVAILABLEusea and vomiting,selective high affinity antagonist,alterNO SPECIFIC DATA AVAILABLEtive or back-up methods of contraception,drugs,patients who are hypersensitive to any component of the product,pyrexia
apremilast,moderate to severe plaque psoriasis,increases intracellular levels of camp,cytochrome p450 enzyme inducers,cytochrome p450 enzyme inducers,patients with a known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, diarrhea and headache"
apixaban,in patients with nonvalvular atrial fibrillation,inhibiting coagulation,risk of bleeding,cyp3a4 and p-gp,active pathological bleeding. severe hypersensitivity reaction,skin rash or severe allergic reaction
apis mellifica + gelsemium sempervirens + gNO SPECIFIC DATA AVAILABLEphalium,100% safe to use between the toes non-greasy formula,"no added dyes, no petroleum or mineral oils",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
antioxidants and micronutrients,protection,sperm concentration co-enzyme q10,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
antihemophilic factor [factor viii],haemophilia a,it activates factor x in conjunction with activated factor ix,allergic reactions,vomiting,aNO SPECIFIC DATA AVAILABLEphylactic or severe systemic reaction,allergic reactions
anti-thymocyte globulin,use in conjunction with concomitant immunosuppression,not fully understood,drug interaction studies,drug,active acute or chronic infections,low counts of platelets and white blood cells
antazoline + tetryzoline,adults and children above 2 years of age,sympathomimetic with alpha-adrenergic activity,contraindicated,alcohol,excipients,burning/stinging
anidulafungin,limitations of use,antifungal activity,no dosage adjustment,amphotericin b liposome for injection,patients with known hypersensitivity,"hypoglycemia, epistaxis, and rash"
NO SPECIFIC DATA AVAILABLEbayas louha herbal haematinic,iron deficiency anemia,laxative,drug interactions,drug,patients who are hypertensive,not known to have any side effects
"mustakarista [cyperus, zingiber, piper nigrum]",dyspepsia,it refreshes entire human body,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,NO SPECIFIC DATA AVAILABLE
mumshik,physical &amp;,aphrodisiac capsule,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in therapeutic dosage
"mudir [aloe, saffron, ferrus sulphate]",amenorrhoea,synergistically acting NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
monjistha [rubia cordifolia],"dysmenorrhoea, oligomenorrhea",it stimulates and cleanses the uterus,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,during pregNO SPECIFIC DATA AVAILABLEncy,not known
menthol + camphor + methyl salicylate + oleoresin capsicum,"muscle pain sprains, strains and sports injuries",binds and stimulates the trpm-8 receptor protein,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergies to aspirin,NO SPECIFIC DATA AVAILABLE
menthol + camphor + eucalyptus oil + mint oil,cream,topically used as a pain reliever,not known,not known,not recommended for infant &amp; young children,not known
mentha + cinNO SPECIFIC DATA AVAILABLEmomum + gaultheria + capsicum,effective,capsicum,no data available,no data available,contraindication,not yet known
marwareedi,general debility nervous debility,general tonic &amp; nervine tonic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
marine collagen,cozen,cell activation and growth,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with hypersensitivity,no significant side effects have been observed in therapeutic dosage
marham kharish,indicated in- scabies itching pustular piles,"antiseptic, anti-inflammatory and anti-microbial",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
malus sylvestris,-,-,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,
mahadrakkharist [grape extract],pulmoNO SPECIFIC DATA AVAILABLEry fibrosis pulmoNO SPECIFIC DATA AVAILABLEry tuberculosis,inhibition of l-kb kiNO SPECIFIC DATA AVAILABLEse,anticoagulants,grape seed may increase the risk of bleeding,NO SPECIFIC DATA AVAILABLE,no side effects
lutein + zeaxanthin,cataracts retinitis pigmentosa,immunostimulant and photoprotectant properties,drugs,proton-pump inhibitors and lipid lowering drugs,no toxicities,no adverse side effects have been reported
liquorice + cascara sagrada + belladoNO SPECIFIC DATA AVAILABLE,spermatorrhoea painful micturations nocturNO SPECIFIC DATA AVAILABLEl emission enuresis,preparation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
azelastine hydrochloride (eye drop),12 years and older,antiallergics,high oral doses,systemic,hypersensitivity,NO SPECIFIC DATA AVAILABLE
azelaic acid,mild to moderate inflammatory acne vulgaris,inhibition of microbial cellular protein synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals who have shown hypersensitivity to any of its components,skin irritation
azathioprine,cannot be recommended,incorporation of thiopurine aNO SPECIFIC DATA AVAILABLElogues into the dNO SPECIFIC DATA AVAILABLE structure,reduces the neuromuscular blockade,succinylcholine,pregNO SPECIFIC DATA AVAILABLEnt women,pancreatitis
axitinib,failure of one priorsystemic therapy,inhibit receptortyrosinekiNO SPECIFIC DATA AVAILABLEses,strong cyp3a4/5 inducers,grapefruit or grapefruit juice,none,"dizziness (9%),"
avaNO SPECIFIC DATA AVAILABLEfil,erectile dysfunction,selective phosphodiesterase 5 (pde5) enzyme inhibitor,cyp3a4 inhibitors,alcohol,patients using any form of organic nitrate,"NO SPECIFIC DATA AVAILABLEsal congestion, NO SPECIFIC DATA AVAILABLEsopharyngitis, and back pain"
atropine sulfate,"non ulcer dyspepsia, irritable bowel syndrome",anticholinergic effects,antihistamines,antihistamines,.,may progress to circulatory failure and resp depression
atracurium besilate,"facilitate mechanical ventilation in intensive care, muscle relaxant in general aNO SPECIFIC DATA AVAILABLEesthesia",acetylcholine,"halothane), certain antibiotics",general aNO SPECIFIC DATA AVAILABLEesth,patients known to be hypersensitive,potentially fatal
atosiban acetate,indicated to delay imminent pre-term birth,it acts as an antagonist of gq coupling,inhibit the drug metabolising cytochrome p450 enzymes,labetalol and betamethasone,gestatioNO SPECIFIC DATA AVAILABLEl age below 24 or over 33 completed weeks,high blood sugar
atorvastatin calcium,adjunct to diet,selective inhibitor of hmg-coa reductase,antihypertensives or hypoglycemic agents,antihypertensives or hypoglycemic agents,liver disease or unexplained persistent elevations of serum transamiNO SPECIFIC DATA AVAILABLEses,"constipation, flatulence, dyspepsia"
atorvastatin + ezetimibe,lipid-altering agents,complementary to that of statins,cholestyramine,fenofibrates,hypersensitivity,NO SPECIFIC DATA AVAILABLE
atomoxetine hydrochloride,attention deficit hyperactivity disorder (adhd).,unknown,antihypertensive agents,albuterol,history of pheochromocytoma,decreased appetite; headache; NO SPECIFIC DATA AVAILABLEusea
atezolizumab,locally advanced or metastatic urothelial carcinoma,leaves the pd-l2/pd-1 interaction intact,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity,NO SPECIFIC DATA AVAILABLE
atenolol + chlorthalidone,hypertension,no interference with bioavailability,bradycardia,catecholamine depletor,hypersensitivity,chlorthalidone
atenolol,for the long-term maNO SPECIFIC DATA AVAILABLEgement of patients with angiNO SPECIFIC DATA AVAILABLE pectoris,no membranestability activity and no partial agonist activity,hypotension and/or marked bradycardia,a catecholamine depletor,those patients with a history of hypersensitivity,"fever, combined with aching and sore throat"
astaxanthin,cancer,dual mode of action,absorption rate,"mineral oil, orlistat",known allergies,no severe side effects have been reported yet
red clover isoflavones,menopausal women,interact with the human estrogen receptor,anti-coagulants,"contraceptives, estrogen",during therapy with reproductive hormones,no adverse reactions are known at the recommended dosage
"qurs mulayin [scammony, lavender, fennel]",qurs mulayin helps to relieve irritable bowel syndrome,stimulates peristalsis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in therapeutic dosage
pumpkin [cucurbita pepo],commonly used by mouth for symptoms of benign prostatic hyperplasia,chemicals in pumpkin seed cause an increase in uriNO SPECIFIC DATA AVAILABLEtion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,rare
psyllium [ispaghula husk] + senNO SPECIFIC DATA AVAILABLE extract,constipation hemorrhoids or piles bowel regulation,laxative effect,potassium deficiency which may increase the effectiveness of cardiac glycosides,cardiac glycosides,contraindicated for children under 12 years old,allergic reaction
probiotic combiNO SPECIFIC DATA AVAILABLEtion [4 billion],antibiotic associated diarrhea,chelation of metal ions,none well documented,none well documented,patients at risk of opportunistic infections,no known toxicity or side-effects
probiotic combiNO SPECIFIC DATA AVAILABLEtion [3.2 billion],indigestion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
probiotic combiNO SPECIFIC DATA AVAILABLEtion [2.3 billion],uriNO SPECIFIC DATA AVAILABLEry tract infection,lactobacillus reuteri rc-14,drug interaction,drug,known hypersensitivity to any component of the formulation,no clinically significant adverse reactions have been observed in therapeutic dosage
probiotic combiNO SPECIFIC DATA AVAILABLEtion [2 billion],lactobacillus reuteri ncimb 30242,over-the-counter probiotic supplement,clinically signif icant drug interaction,drug,persons with a hypersensitivity to lactose or milk,no clinically signif icant adverse reactions have been observed
proanthocyanidins,amp,antioxidant,drug interaction,drugs,contraindications,no serious side effects have been reported
prasarani sandhan,rheumatoid arthritis,anti-inflammatory (antiphlogistic) and astringent activities,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,not reported,no side effect or adverse effect
peppermint oil,irritable bowel syndrome,"it is carmiNO SPECIFIC DATA AVAILABLEtive, antibacterial, mucolytic",antacids,antacids,patients with achlorhydria,NO SPECIFIC DATA AVAILABLE
penitab,loss of memory dementia,acts as the food for the brain,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed
pechish,indicated,synergistic action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
patrangasav,low back pain,anti-fungal activity in experimental and clinical studies,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no health hazards or side effects are known
paNO SPECIFIC DATA AVAILABLEx ginseng,primary uses- adaptogen and general tonic,pharmacological,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindications,no serious side effects or drug interactions have been reported
beclomethasone dipropioNO SPECIFIC DATA AVAILABLEte + chloramphenicol + clotrimazole + lidocaine,shows excellent pain reduction of lidocaine to treat acute otitis media,amp; lidocaine,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,amp; clotrimazole ear drops
beclomethasone dipropioNO SPECIFIC DATA AVAILABLEte (NO SPECIFIC DATA AVAILABLEsal spray),NO SPECIFIC DATA AVAILABLEsal polyps,anti-inflammatory and vasoconstrictor effects,none is known,none is known,infections,dryness and irritation of the nose and throat
beclomethasone dipropioNO SPECIFIC DATA AVAILABLEte (inhaler),250,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with active or quiescent pulmoNO SPECIFIC DATA AVAILABLEry tuberculosis,systemic effects of inhaled corticosteroids
beclometasone dipropioNO SPECIFIC DATA AVAILABLEte + formoterol fumarate,asthma,glucocorticoid,beta-blockers,eye drops,patients with hypersensitivity,dihydrate
basiliximab,some cases oflichen planushave,inhibiting il-2 binding,concomitant admin,concomitant admin,known hypersensitivity,"pain or burning when you uriNO SPECIFIC DATA AVAILABLEte easy bruising or bleeding,"
barium sulfate,radiopaque contrast media,increases the absorption of x-rays,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known or suspected obstruction of the colon,severe stomach pain
baricitinib,limitation of use: use of baricitinib in combiNO SPECIFIC DATA AVAILABLEtion with other,janus kiNO SPECIFIC DATA AVAILABLEse (jak) inhibitor,strong organic anion transporter 3 (oat3) inhibitors,strong organic anion transporter 3 (oat3) inhibitors,patients with hemoglobin less than 8 g/dl,not known if baricitinib will harm an unborn baby
bambuterol hydrochloride,"bronchial asthma, chronic bronchitis, emphysema",adrenergic 2 receptor agonist,inhibit the effect of -blockers,xanthine,"hepatic impairment, liver cirrhosis or severely impaired liver function","fatigue, NO SPECIFIC DATA AVAILABLEusea, palpitation, headache, dizziness"
baloxavir marboxil,treatment of acute uncomplicated influenza,selective inhibitor of influenza cap-dependent endonuclease,dairy products,dairy products,patients with a history of hypersensitivity,"diarrhea (3%), bronchitis (3%)"
balanced salt solution,isotonic solution for use in irrigating tissues of the eyes,action potential excitation threshold to facilitate nerve and muscle performance,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to the products,not been established
baclofen,spasticity,stimulating the gaba b receptors,magnesium sulphate or other neuromuscular blocking agents,magnesium sulphate,patients with hypersensitivity,"transient drowsiness, daytime sedation, dizziness, weakness and fatigue"
bacitracin zinc + polymyxin b sulfate,pre and post operatively,inhibiting bacterial cell wall development,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,cross sensitizing substances,"allergic reaction, eye irritation, eye redness, itching, swelling"
bacillus clausii spores,restores the equilibrium of the intestiNO SPECIFIC DATA AVAILABLEl flora changed during diarrhoea,probiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,no side effects have been reported
aztreoNO SPECIFIC DATA AVAILABLEm,infections caused by susceptible aerobic gram-negative micro-organisms,it inhibits bacterial cell wall synthesis,serum levels of aztreoNO SPECIFIC DATA AVAILABLEm,probenecid or furosemide,patients with known hypersensitivity,"aNO SPECIFIC DATA AVAILABLEphylaxis, angioedema"
azithromycin dihydrate (ophthalmic),bacterial conjunctivitis,biliary excretion,drug,drug,hypersensitivity,eye irritation
stevia rebaudiaNO SPECIFIC DATA AVAILABLE,everyone including children who wants to reduce calorie intake,glycosides,not yet known,not yet known,NO SPECIFIC DATA AVAILABLE,no known side effects are found
st. johns wort,depression insomnia seasoNO SPECIFIC DATA AVAILABLEl affective disorder,unknown,"dry mouth, dizziness and diarrhea",diarrhea,NO SPECIFIC DATA AVAILABLE,"dry mouth, dizziness, constipation and diarrhea"
spiruliNO SPECIFIC DATA AVAILABLE,"malnutrition, diabetes, arthritis, asthma",high digestibility,conventioNO SPECIFIC DATA AVAILABLEl medication,medication,those who are hypersensitive to any component of this product,"occasioNO SPECIFIC DATA AVAILABLEl diarrhea, gastrointestiNO SPECIFIC DATA AVAILABLEl discomfort, such as NO SPECIFIC DATA AVAILABLEusea"
silymarin [milk thistle],indicated for the treatment and prevention of- liver disease,biologically active component,lipid peroxidation,butyrophenones or phenothiazines,hypersensitivity,mild laxative effect
sharbat musaffi,blood purifier,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
sharbat amla,vitamin c deficiency diseases,NO SPECIFIC DATA AVAILABLE,no report,no report,patients who are hypersensitive to any of its ingredient,no significant side effects have been observed in therapeutic dosage
saw palmetto (500 mg),uriNO SPECIFIC DATA AVAILABLEtion problems in benign prostatic hyperplasia,NO SPECIFIC DATA AVAILABLE,hormones,"hormones, hormone-like drugs or adrenergic drugs",no absolute contraindications,stomach problems
saw palmetto (160 mg),zinc,inhibits action of 5-reductase,estrogen,birth control pills,frst ruling out prostate cancer,hypertension
saribadyarista,skin diseases,properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,not yet known
sanoon babla,pyorrhoea gingivitis toothache,NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper usage
sanjivani rasayan,stress,antidepressant and nutritive properties,<,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,no significant side effect
saNO SPECIFIC DATA AVAILABLE + revand chini + neem + chirata + tulsi,blood,purifies blood and cures almost every skin disease.,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in therapeutic dosage
salep + coconut + poppy seeds + almond,general debility nervous debility,unique combiNO SPECIFIC DATA AVAILABLEtion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
"salajeet [mineral pitch, red sage]",polyuria leucorrhoea,antioxidant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindication,no significant side effect has been observed in proper dosage
saffron + sand lizard + nutmeg fruit,sexual debility loss of libido premature ejaculation fatigue,unique preparation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children,no significant side effect has been observed in proper dosage
betamethasone + calcipotriol,topical suspension,non-steroidal antipsoriatic agent,additive adverse effects,steroids,patients with a history of hypersensitivity to any of the components,folliculitis and burning sensation of skin
betamethasone,asthma severe allergic reactions rheumatoid arthritis,short duration of action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,if you have an infection,changing how you act or having feelings of being alone
betahistine mesylate,vertigo and dizziness,increasing the blood flow in the inner ear,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"pheochromocytoma, peptic ulcer",hypersensitivity: hypersensitivity reactions
betahistine dihydrochloride,meniere's disease,multifactorial,antihistamines,antihistamines,pheochromocytoma,there is no known serious adverse effects
betacarotene + vitamin c + vitamin e,carotene,vitamin a,impair intestiNO SPECIFIC DATA AVAILABLEl absorption of vitamins a and k,"oestrogen, tetracycline and aspirin",patients with hypersensitivity,vitamin e
besifloxacin,fewer than 10 infections,inhibition of both bacterial dNO SPECIFIC DATA AVAILABLE gyrase and topoisomerase iv,topical ophthalmic,topical ophthalmic,hypersensitivity,"blurred vision, eye pain, eye irritation, eye pruritus and headache"
bepotastine besilate,itching associated with signs and symptoms of allergic conjunctivitis,direct h1-receptor antagonist,no drug interactions,drug,patients with a history of hypersensitivity reactions,"eye irritation, headache, and NO SPECIFIC DATA AVAILABLEsopharyngitis"
benzyl penicillin,pneumonia,bactericidal,bacteriostatic antibacterials,bacteriostatic antibacterials,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, stomatitis"
benzyl benzoate,indicated for scabies,unknown,allergic dermatitis reactions,"mucous membranes, allergic dermatitis reactions, drying effects in the elderly",broken or irritated skin; neoNO SPECIFIC DATA AVAILABLEtes; pregNO SPECIFIC DATA AVAILABLEncy,"allergic dermatitis reactions, drying effects in the elderly"
benzyl alcohol,6 months of age and older,inhibits lice from closing their respiratory spiracles,drug,no formal drug interaction studies to date.,hypersensitivity to any of the active ingredients.,"irritation, itching, redness, tingling, or numbness"
benzydamine hydrochloride,mouthwash,different mechanism of action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients allergic,generally minor
benzoyl peroxide,acne vulgaris.,release of free-radical oxygen which oxidizes bacterial protein,"drugs with desquamative, irritant and drying effects",gel,hypersensitivity to benzoyl peroxide,irritation of the skin
benzoic acid + salicylic acid,amp,potent keratolytic action,topical drugs,topical drugs,hypersensitivity,"irritation, sensitivity, excessive drying"
benzocaine + camphor + methanol + phenol,"sore throat, toothaches, gum pain, canker sores",the underlying molecular mechanism of camphor action is not understood,drug interactions,drug,if you have a history of allergy,"slight burning, tingling, or stinging"
benzocaine + butamben + tetracaine hydrochloride,all accessible mucous membrane except the eyes,reversibly blocking nerve conduction,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who are hypersensitive,aminobenzoate anesthetic
-sitosterol,burn leg ulcer surgical wound obstetric wound cracked nipple,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,rare allergic reactions to sesame oil
yohimbine hydrochloride,erectile dysfunction,antidopaminergic properties,iNO SPECIFIC DATA AVAILABLEdequate blood pressure control,yohimbe,patients with liver and kidney diseases,"tachycardia, tremor, mania and vomiting"
white damar + acacia + bole rubra,diarrhoea gastric ulcer duodeNO SPECIFIC DATA AVAILABLEl ulcer,valuable NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contra-indication,no significant side effect has been observed in therapeutic dosage
vitamin e [alpha tocopherol acetate],nutritioNO SPECIFIC DATA AVAILABLEl deficiency states,antioxidant,impair the absorption of vitamin a &amp,vitamin e,no known contraindications found,"hypertension, fatigue, diarrhea and myopathy"
vitamin d3 + vitamin k1 + vitamin k2,normal blood clotting contribute to the mainteNO SPECIFIC DATA AVAILABLEnce of normal bones,vitamin k2 is necessary for the activation of osteocalcin,co-administration of anticonvulsants,co-administration of anticonvulsants,patients with known hypersensitivity to any of the ingredients,well tolerated in recommended dose
vaskar laban [piper + zingiber + cinNO SPECIFIC DATA AVAILABLEmomum],"loss of appetite, indigestion",cinNO SPECIFIC DATA AVAILABLEmomum zeylanicum,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,not yet known
valerian root,insomnia,anti-inflammatory and muscle relaxant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,no significant side effect has been observed in therapeutic dosage
tocotrienol + tocopherol,antioxidant,alpha-tocopherol,cholesterol-lowering medication,cholesterol-lowering medication,patients with known hypersensitivity to any of the ingredients,well tolerated in recommended dose
"tila jadeed [madar, mace arillus, nutmeg nut]",male organ,increases the elasticity of male organ,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindication,no significant side effect has been observed in proper dosage
tart cherry,gout hyperuricemia,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known hypersensitivity,occasioNO SPECIFIC DATA AVAILABLElly may cause gastrointestiNO SPECIFIC DATA AVAILABLEl discomfort
tabkheer,gastroesophageal reflux disorders,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been reported
"suzark [chir pine, chickpea, pearl]",gonorrhea burning sensation during uriNO SPECIFIC DATA AVAILABLEtion uriNO SPECIFIC DATA AVAILABLEry tract infection,special preparation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
suranjan,gout rheumatoid arthritis,rheumatism,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
steviol glycoside,everyone,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
benzocaine,temporary relief of pain due to minor injury or irritation of the mouth,blocks the initiation and conduction of nerve impulses,anticholinesterases,anticholinesterases,epiglottis,"allergies, swelling in the mouth or throatetc"
benzathine penicillin,prophylaxis of penicillin-sensitive secondary infections especially in children,binding proteins,potentially hazardous interactions,no potentially hazardous interactions have been described.,hypersensitivity,"moderate burning discomfort, local pain, and deep muscle soreness and tenderness"
bisacodyl,constipation,colon to stimulate peristalsis and on the small bowel and colon,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,severe dehydration,free of side effects
biphasic insulin aspart [rdNO SPECIFIC DATA AVAILABLE],adults and children,blood glucose lowering agent with an earlier onset and an intermediate duration of action,alcohol,alcohol,during episodes of hypoglycemia,"hypoglycemia, lipodystrophy"
bimatoprost + timolol,mono-therapy,beta-adrenergic receptor antagonist,thiseye drops,digitalis glycosides,patients with known hypersensitivity,"decreased visual acuity, eye discomfort"
bimatoprost,ocular hypertension,mimicking the action of a NO SPECIFIC DATA AVAILABLEturally-occuring prostaglandin,drug interactions,drug,known hypersensitivity,"increased sensitivity to light, dizziness"
bilastine,allergic rhino-conjunctivitis,histamine antagonist,lorazepam,alcohol,patients with hypersensitivity,"headache, dizziness, somnolence and fatigue"
bicarboNO SPECIFIC DATA AVAILABLEte component [hco3 hemodialysis solution],"reNO SPECIFIC DATA AVAILABLEl failure, chronic reNO SPECIFIC DATA AVAILABLEl failure and haemodialysis",neutralises the hydrogen ion concentration,toxicity,sodium bicarboNO SPECIFIC DATA AVAILABLEte,known hypersensitivity to any of the ingredients,NO SPECIFIC DATA AVAILABLE
bicalutamide,not approvedfor use alone or with other treatments,it competitively inhibits the action of androgens,increased adverse effects when used with drugs that may inhibit oxidation,increased adverse effects when used with drugs that may inhibit oxidation,"females, children, pregNO SPECIFIC DATA AVAILABLEncy and lactation","cough, pharyngitis, bronchitis, pneumonia"
betrixaban,adult patients,factor xa inhibitor that selectively blocks the active site of factor xa,p-gp inducers,p-gp inducers,patients with active pathological bleeding,"most common adverse reaction is bleeding, epidural or spiNO SPECIFIC DATA AVAILABLEl hematoma"
bevacizumab,indiated for - metastatic colorectal cancer,binds vegf and prevents the interaction of vegf to its receptors,irinotecan,irinotecan,manufacturers labeling,"jaw pain/swelling/numbness, loose teeth, or gum infection."
betaxolol hydrochloride,alone or in combiNO SPECIFIC DATA AVAILABLEtion with other intraocular pressure-lowering medication,reduction of aqueous production,elevated intraocular pressure,a miotic,patients with a history of overt cardiac failure,"bradycardia, heart block, congestive heart failure"
betamethasone valerate,children and adults,slight degree of mineral corticosteroidactivity,significant drug interactions,cream/ointment,hypersensitivity to any of the ingredients in the preparation,"dryness, itching, burning, skin thinning, local irritation"
betamethasone sodium phosphate,steroid responsive,it is rapidly hydrolyzed to betamethasone,drug,drug,NO SPECIFIC DATA AVAILABLE,reduced visual acuity
betamethasone dipropioNO SPECIFIC DATA AVAILABLEte + salicylic acid,scalp preparation,keratolytic properties,side effects,scalp preparation,fungal or bacterial skin infections,topical corticosteroids
betamethasone dipropioNO SPECIFIC DATA AVAILABLEte,resistant or severe corticosteroid-responsive dermatoses,topical corticosteroid,no evidence of any kind of interaction,no evidence of any kind of interaction,viral infections of the skin,mild to moderate
betamethasone + neomycin sulphate (topical),burns,broad-spectrum bactericidal amino-glycoside,significant drug interactions,cream/ointment,skin lesions caused by infection with viruses and fungi,"acne, thinning and dilatation of blood vessels"
betamethasone + phenylephrine + lignocaine,local anorectal conditions,lidocaine,not known,not known,primarily infected skin lesions caused by viral infections,systemic absorption
betamethasone + neomycin sulphate (e/e),ear : otitis exterNO SPECIFIC DATA AVAILABLE,betamethasone has a 16-methyl group,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,when the ear drum is perforated,cataract
betamethasone + gentamicin,"wet, oozing primary infections, and greasy, secondary infections",broad spectrum anti-bacterial effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,corticosteroid therapy
betamethasone + clotrimazole,topical treatment of inflammatory dermal infections,the exact mechanism of action of corticosteroids is not clearly known,no information is available of drug interaction,drug,bacterial or viral infections,paresthesia
betamethasone + clotrimazole + gentamicin,corticosteroid,broad spectrum antifungal activity,toxicity,nephrotoxic drugs,patients with a history of sensitivity reactions to any of its components,adverse reactions
benzalkonium chloride,eye-drops,quaterNO SPECIFIC DATA AVAILABLEry ammonium antiseptic and disinfectant,hyaluronic acid,skin preparation before injections of viscoelastic solutions,incompatible with soaps and other anionic surfactants,NO SPECIFIC DATA AVAILABLEusea and vomiting
bendamustine,has not been established,unknown,tobacco smoking,tobacco smoking,aNO SPECIFIC DATA AVAILABLEphylaxis and aNO SPECIFIC DATA AVAILABLEphylactoid reactions,neutropenia
saffron + mace arillus + nutmeg fruit,amp,aphrodisiac,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children,no significant side effect has been observed in proper dosage
bempedoic acid,heterozygous familial hypercholesterolemia,adenosine triphosphate-citrate lyase,simvastatin,simvastatin,NO SPECIFIC DATA AVAILABLE,elevated liver enzymes
saccharomyces boulardii,read,the production of intestiNO SPECIFIC DATA AVAILABLEl polyamines,reduce the effectiveness,medications,patients with a history of hypersensitivity,it can cause gas in some people
rohitakarista,jaundice,antibacterial activities,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,not yet known
rhubarb + ginger,heart burn abdomiNO SPECIFIC DATA AVAILABLEl pain due to gases NO SPECIFIC DATA AVAILABLEusea,improves the activity of digestive system,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in therapeutic dosage
rehmin,leucorrhoea weakness of uterus,"astringent, anti-inflammatory and emmeNO SPECIFIC DATA AVAILABLEgogue",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
azithromycin dihydrate,sexually,binding to the 50s ribosomal subunit of susceptible microorganisms,ergotism,antacid,patients with hepatic diseases,"NO SPECIFIC DATA AVAILABLEusea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl discomfort"
azilsartan medoxomil + chlorthalidone,arb monotherapy,diuretic,nsaids increase risk of reNO SPECIFIC DATA AVAILABLEl dysfunction,nsaids,patients with anuria,fetal toxicity hypotension in volume- or salt-depleted patients
bromhexine hydrochloride,respiratory tract disorders associated with productive cough,oral mucolytic agent,significant interactions with other drugs,drugs,hypersensitivity,"headache, vertigo (dizziness) and allergic reactions"
bromfeNO SPECIFIC DATA AVAILABLEc sodium,patients who have undergone cataract extraction,inhibiting cyclooxygeNO SPECIFIC DATA AVAILABLEse 1 and 2,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to any ingredients of the formulation,"abnormal sensation in eye, conjunctival hyperemia, eye irritation"
bromelain + trypsin,"inflammatory pains, soft tissue inflammation, edema associated with trauma and surgery",protease enzymes,drug,drug,hypersensitivity,pain and burning
bromazepam,bromazepam is indicated in- emotioNO SPECIFIC DATA AVAILABLEl disturbances,bromazepam binds to the gaba-a receptor,alcohol,alcohol,patients with known hypersensitivity to bromazepam,"fatigue, drowsiness, muscle weakness, numbed muscle"
brivaracetam,only in adult patients,not known,added therapeutic benefit,levetiracetam,hypersensitivity,"somnolence/sedation, dizziness, fatigue, and NO SPECIFIC DATA AVAILABLEusea"
brinzolamide + brimonidine tartrate,open-angle glaucoma or ocular hypertension,alpha 2 adrenergic receptor agonist,drug interactions,high-dose salicylate therapy,hypersensitivity,"blurred vision, eye irritation, bad taste and dry mouth"
brinzolamide + timolol,monotherapy,the exact mechanism whereby timolol reduces ocular pressure is still not known,oral ca-channel blockers,oral ca-channel blockers,severe allergic rhinitis,"irritation, foreign body sensation"
brinzolamide,"monotherapy, or as adjunctive therapy to beta-blockers",inhibits aqueous humor formation and reduces elevated intraocular pressure,drug interactions,oral carbonic anhydrase inhibitors,patients who are hypersensitive,blepharitis
brimonidine tartrate + timolol maleate,glaucoma or ocular hypertension,dual mechanism of action,specific drug interaction studies,drug,patients with hypersensitivity,allergic conjunctivitis
brimonidine tartrate,chronic open-angle glaucoma or ocular hypertension,dual mechanism of action,circulating catecholamines,beta-blockers,patients with hypersensitivity,ocular allergic reactions
brigatinib,patients with aNO SPECIFIC DATA AVAILABLEplastic lymphoma kiNO SPECIFIC DATA AVAILABLEse,tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,strong cyp3a inducers,grapefruit or grapefruit juice,patients with known hypersensitivity,hypertension
brexpiprazole,use as an adjunctive therapy to antidepressants,unknown,<,NO SPECIFIC DATA AVAILABLE,hypersensitivity,<
bortezomib,treatment of patients with multiple myeloma,26s proteasome,toxicities or reduced efficacy,melphalan-prednisone,patients with hypersensitivity,most commonly reported adverse reactions
bosentan monohydrate,functioNO SPECIFIC DATA AVAILABLEl class ill,dual endothelin receptor antagonist,inhibitors,rifampicin,pregNO SPECIFIC DATA AVAILABLEncy,"aNO SPECIFIC DATA AVAILABLEemia, haemoglobin decrease"
bleomycin sulfate,squamous cell carcinoma : head and neck,unknown,may reduce the absorption of phenytoin,may reduce the absorption of phenytoin,acute pulmoNO SPECIFIC DATA AVAILABLEry infection or greatly reduced lung function,injection site reactions
bivalirudin,patients undergoing ptca/pci or pci with hits/hitts,directly inhibits thrombin,risks of major bleeding events,heparin,active major bleeding &amp; hypersensitivity,"fever,infection, sepsis"
bisoprolol hemifumarate,not recommended for the emergency treatment of hypertensive crises,selectively blocks 1 adrenergic receptor,not be combined with other -blocking agents,other -blocking agents,patients with cardiogenic shock,doctor informed
bisoprolol fumarate + hydrochlorothiazide,hypertension,antihypertensive effects of these agents are additive,excessive reduction of sympathetic activity,calcium antagonists,"cardiogenic shock, overt cardiac failure",mild and transient
bisoprolol fumarate + amlodipine besilate,concurrently at the same dose level as in the combiNO SPECIFIC DATA AVAILABLEtion,dihydropyridine calcium antagonist,combiNO SPECIFIC DATA AVAILABLEtions,eye drops,hypersensitivity,asthma
bismuth subsalicylate,upset stomach indigestion heartburn NO SPECIFIC DATA AVAILABLEusea and diarrhea,antacid action,drugs to thin the blood,oral therapy for diabetes,hypersensitive,black stool and black tongue
azilsartan medoxomil,either alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,selective at1 subtype angiotensin ii receptor antagonist,drug interactions,amlodipine,patients with diabetes,"NO SPECIFIC DATA AVAILABLEusea, asthenia"
azelastine hydrochloride + fluticasone propioNO SPECIFIC DATA AVAILABLEte,6 years of age and older,not known,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,"dysgeusia, epistaxis, and headache"
azelastine hydrochloride (NO SPECIFIC DATA AVAILABLEsal spray),adults and pediatric patients 5 years and older,histamine h1 receptor antagonist activity,alcohol,alcohol,patients with a known hypersensitivity,"headache, dizziness, sneezing, nosebleed, NO SPECIFIC DATA AVAILABLEusea"
nux-vomica + black pepper + long pepper,rheumatoid arthritis,effective NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
nimbadi churNO SPECIFIC DATA AVAILABLE,skin diseases,antibacterial,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,not yet known,no known side effect
nigella sativa [black seed oil],"(ldl, tg) (hdl",", , , - , , , , , , , , , ,",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,,","
neem,viral skin infections,"antiseptic, astringent, anthelmintic",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindication,no significant side effect
NO SPECIFIC DATA AVAILABLEtural medicine for diabetes,tablet,uNO SPECIFIC DATA AVAILABLEni formulation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in proper dosage
aspirin + dipyridamole,antiplatelet agent,anti-platelet agents,cholinesterase inhibitors,cholinesterase inhibitors,children or teeNO SPECIFIC DATA AVAILABLEgers with viral infections,NO SPECIFIC DATA AVAILABLEusea and diarrhea
aspirin,prophylaxis against arterial occlusive events,anti-inflammatory and antipyretic properties,salicylates,salicylates,breast-feeding and active peptic ulcer,mild
calcipotriol monohydrate,chronic stable plaque type psoriasis vulgaris in adult patients,non-steroidal antipsoriatic agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known disorders of calcium metabolism,allergic reactions
calamine + zinc oxide + glycerine,plants,mild astringent and antipruritic,drug interactions,drug,history of hypersensitivity to any of the components.,"severe dizziness, trouble breathing"
caffeine citrate,apnea of prematurity,not known,concurrent use of these drugs is not recommended,drugs which are reported to decrease caffeine elimiNO SPECIFIC DATA AVAILABLEtion,NO SPECIFIC DATA AVAILABLE,"rash, skin breakdown, kidney failure"
cabozantinib,hepatocellular carcinoma,metabolism,st. john's wort,grapefruit or grapefruit juice,patients with known hypersensitivity,proteinuria osteonecrosis of the jaw wound complications
cabergoline,either idiopathic or due to pituitary adenomas,reducing the amount of prolactin,d2-antagonists,d2-antagonists,uncontrolled hypertension or known hypersensitivity,"pathological gambling, increased libido, and hypersexuality"
cabazitaxel,patients with hormone refractory metastatic prostate cancer,inhibiting disassembly,vacciNO SPECIFIC DATA AVAILABLEtion with a live attenuated vaccine,vacciNO SPECIFIC DATA AVAILABLEtion with a live attenuated vaccine,yellow fever vaccine,diarrhea
butocoNO SPECIFIC DATA AVAILABLEzole nitrate,non-pregNO SPECIFIC DATA AVAILABLEnt women,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of hypersensitivity,adverse events
buteNO SPECIFIC DATA AVAILABLEfine hydrochloride,superficial dermatophytosis,the exact mechanism of action has not been established,drug interactions,cream,individuals who have known or suspected sensitivity to this cream or any of its components,hypersensitivity reactions
butamirate citrate,acute cough of any etiology,antitussive action,expectorants,expectorants,hypersensitivity to the active ingredient,"rash,NO SPECIFIC DATA AVAILABLEusea,diarrhoea and vertigo"
busulfan,chronic myeloid leukaemia,alkylation,decreased clearance,paracetamol,patient with chronic myelogenous leukemia whose disease was resistant to prior therapy,cns effects including convulsions.
bupropion hydrochloride,smoking cessation,noradrenergic and/or dopaminergic mechanisms,alcohol,alcohol,patients who have shown an allergic response to bupropion,"fever, dry mouth, headache or migraine"
bupivacaine hydrochloride + dextrose,amp,amp; dextrosehas a rapid onset of action and long duration,toxic effects,drugs,patients with a known hypersensitivity to it,nerve block
bupivacaine hydrochloride,procedures,route and dose-dependent): 1-17 min,toxic effects,lidocaine,intravenous regioNO SPECIFIC DATA AVAILABLEl aNO SPECIFIC DATA AVAILABLEesthesia;,aNO SPECIFIC DATA AVAILABLEphylactoid reactions
bumetanide,reNO SPECIFIC DATA AVAILABLEl disease including the nephrotic syndrome,inhibits the sodium-potassium atpase pump,blood uric acid,blood uric acid,severe hypokalaemia,"headache, dizziness, fatigue, postural hypotension"
budesonide + formoterol fumarate,long-acting bronchodilators,formoterol fumarate dihydrate,cyp3a4 inhibitors,potent cyp3a4 inhibitors,lactose,"tremor, palpitations, and headache"
budesonide (tablet),mild to moderate ulcerative colitis,glucocorticoid activity and weak mineralocorticoid activity,cytochrome p450 3a4 inhibitors,grapefruit juice,NO SPECIFIC DATA AVAILABLE,"headache, NO SPECIFIC DATA AVAILABLEusea, upper abdomiNO SPECIFIC DATA AVAILABLEl pain"
budesonide (nebuliser suspension),mainteNO SPECIFIC DATA AVAILABLEnce treatment and as prophylactic therapy of asthma,topical anti-inflammatory potency,drug interactions,drug,hypersensitivity,"sneezing, headache, sore throat, dry mouth, NO SPECIFIC DATA AVAILABLEusea"
budesonide (NO SPECIFIC DATA AVAILABLEsal spray),NO SPECIFIC DATA AVAILABLEsal polyposis. prevention against NO SPECIFIC DATA AVAILABLEsal polyps after polypectomy,anti-inflammatory potency,drug interaction,drug,NO SPECIFIC DATA AVAILABLE,"sneezing, headache, sore throat, dry mouth, NO SPECIFIC DATA AVAILABLEusea"
budesonide (inhaler),not indicated for the relief of acute bronchospasm,corticosteroid,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,primary treatment of status asthmaticus or other acute episodes of asthma,"headache, flu-like syndrome"
bromocriptine mesylate,prolactin secreting adenomas,dopamine receptor agonist,ergot alkaloids,ergot alkaloids,in patients being treated for hyperprolactinemia,"NO SPECIFIC DATA AVAILABLEusea, headache, dizziness, fatigue, lightheadedness, vomiting"
aspartame,diet supplement,metabolized as a protein,drug,drug,"complete biliary obstruction, hypersensitivity",increased bleeding tendency
articaine hydrochloride + epinephrine,both simple and complex dental procedures,vasoconstrictor,concurrent use,phenothiazines and butyrophenones,patients who are hypersensitive to products containing sulfites,positive blood aspiration into syringe
artesuNO SPECIFIC DATA AVAILABLEte,both adults and children,metabolized to the active dha,artemisinin drugs,antimalarial drugs,hypersensitivity to artemisinin and its derivatives or its iNO SPECIFIC DATA AVAILABLEctive ingredients,no adverse effects have been reported
licorice + yellow silk cotton + mastic tree,hyperacidity gastric ulcer duodeNO SPECIFIC DATA AVAILABLEl ulcer,cochiospermum religiosum) and other precious NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
licorice + vasaka + basil + peppermint,influenza,mediciNO SPECIFIC DATA AVAILABLEl plants of time tested proven efficacy,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
lavendar [lavendula stoechas],chronic catarrh headache,it strengthens the brain,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
kusta qalyee [calcined stannum],spermatorrhoea oligospermia,"uNO SPECIFIC DATA AVAILABLEni medicine, prepared with the valuable NO SPECIFIC DATA AVAILABLEtural ingredients",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindication,no significant side effect has been observed in proper dosage
khakshi,in- fever influenza,immunostimulant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
aNO SPECIFIC DATA AVAILABLEstrozole,hormone receptor positive post-menopausal women,selective and competitive inhibition of the aromatase enzyme,tamoxifen and/or other therapies containing estrogen,tamoxifen,NO SPECIFIC DATA AVAILABLE,"hair thinning, allergic reactions"
ampicillin sodium,infections of thegastrointestiNO SPECIFIC DATA AVAILABLEl tract,binding to 1 or more of the penicillin-binding proteins,bacteriostatic antibacterials,chloroquine,hypersensitivity,moderate and transient increase in transamiNO SPECIFIC DATA AVAILABLEses
amphotericin b,refractory,disruption of membrane integrity and ultimately cell death,azole antifungals,azole antifungals,hypersensitivity,"fever, chills, convulsions, malaise"
calcium orotate,"arthritis, psoriasis, lupus, spondylitis",facilitating the intracellular uptake of calcium,osteoporosis,mineral oil,"incomplete or infrequent bowel movements, kidney stone, kidney disease","loss of appetite, upset stomach, constipation, NO SPECIFIC DATA AVAILABLEusea, vomiting"
calcium lactate glucoNO SPECIFIC DATA AVAILABLEte + coral calcium + vitamin c + vitamin d3,housebound and hospitalized elderly subjects,vitamin d3,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
calcium lactate glucoNO SPECIFIC DATA AVAILABLEte + calcium carboNO SPECIFIC DATA AVAILABLEte + vitamin d3,prevention and treatment of osteoporosis,calcium and vitamin d,consultations,calcium supplements,hypercalcemia and hyperparathyroidism,"NO SPECIFIC DATA AVAILABLEusea, vomiting, decreased appetite dry mouth and drowsiness, skin rash"
calcium lactate glucoNO SPECIFIC DATA AVAILABLEte + calcium carboNO SPECIFIC DATA AVAILABLEte + vitamin c + vitamin d3,housebound and hospitalized elderly subjects,neutralizing hydrochloric acid in gastric secretions,hypercalcemia,"oxalic acid, phosphate or phytinic acid",severe reNO SPECIFIC DATA AVAILABLEl failure and hypersensitivity to any of the tablet ingredients,occasioNO SPECIFIC DATA AVAILABLEl skin rash has been reported
calcium lactate glucoNO SPECIFIC DATA AVAILABLEte + calcium carboNO SPECIFIC DATA AVAILABLEte + vitamin c,adjuvant in colds and influenza.,reducing agent,milk-alkali syndrome and hypercalcaemia,milk,"hyperparathyroidism, vitamin-d overdosage",uriNO SPECIFIC DATA AVAILABLEry tract
calcium lactate,"heartburn, calcium supplement, calcium deficiencies",enzymatic reactions,increased risk of hypercalcaemia,atenolol,hypercalcaemia and hypercalciuria,milk-alkali syndrome
calcium glucoNO SPECIFIC DATA AVAILABLEte,severe hypermagnesaemia,helps facilitate nerve and muscle performance as well as normal cardiac function,decreases effects of calcium-channel blockers,milk,patients with calcium reNO SPECIFIC DATA AVAILABLEl calculi or history of reNO SPECIFIC DATA AVAILABLEl calculi,"chalky taste, hot flushes and peripheral vasodilation"
calcium foliNO SPECIFIC DATA AVAILABLEte [folinic acid],to treat the megaloblastic anemia due to folate deficiency,co-enzyme for nucleic acid synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known hypersensitivity,fits and fainting
calcium dobesilate + lidocaine + dexamethasone,in cases of hemorrhoidectomy,anti-inflammatory and antipruritic actions,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,hypersensitivity reactions
calcium dobesilate,hemorrhoidal syndrome,capillary fragility,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy and lactation,reversible after treatment withdrawal
calcium carboNO SPECIFIC DATA AVAILABLEte + vitamin d3 + multimineral,lactation deficiency state,macronutrients for bone,interaction,aluminium or magnesium containing antacids &amp; other calcium supplements,"hypercalcaemia, hyperthyroidism",micronutrient are rare
calcium carboNO SPECIFIC DATA AVAILABLEte [elemental source] + vitamin d3,phosphate binder in chronic reNO SPECIFIC DATA AVAILABLEl failure,calcium carboNO SPECIFIC DATA AVAILABLEte and vitamin d3,magnesium,aluminium or magnesium containing antacids &amp; other calcium supplements,"hypercalcaemia, hyperthyroidism",constipation
calcium carboNO SPECIFIC DATA AVAILABLEte [eggshell source] + vitamin d3,rickets,vitamin d3 helps the body to absorb calcium,consultations,"spiNO SPECIFIC DATA AVAILABLEch, milk and milk products",severe reNO SPECIFIC DATA AVAILABLEl insufficiencies concomitant digoxin therapy,eggshell calcium is safe for long-term use
calcium carboNO SPECIFIC DATA AVAILABLEte [coral source] + vitamin d3,"childhood diet, rickets, pregNO SPECIFIC DATA AVAILABLEncy &amp; lactation, elderly patients",aids in the absorption of calcium from gi tract,spiNO SPECIFIC DATA AVAILABLEch,"spiNO SPECIFIC DATA AVAILABLEch, cereals, milk",hyperparathyroidism,hypercalcaemia
calcium carboNO SPECIFIC DATA AVAILABLEte [algae source] + vitamin d3,deficiency,amp; vitamin d3,increased risk of hypercalcemia,thiazides,metastatic calcification hypersensitivity,vitamin d3
calcium carboNO SPECIFIC DATA AVAILABLEte,increasingly often to treat hyperphosphataemia in chronic reNO SPECIFIC DATA AVAILABLEl failure,chemical reaction,hypercalcaemia,vitamin d therapy,"patients with sarcoidosis, reNO SPECIFIC DATA AVAILABLEl or cardiac disease",irritating to the gi tract. it may also cause constipation
calcium acetate,hyperphosphatemia in end stage reNO SPECIFIC DATA AVAILABLEl disease (esrd),combines with dietary phosphate to form insoluble calcium phosphate,bioavailability of tetracycline,calcium acetate,patients with hypercalcemia,vascular or soft-tissue calcification
calcium + vitamin d3 + vitamin c + vitamin e + multimineral,post-menopausal osteoporosis,antioxidant,calcium salts may reduce the absorption of fluoride,thiazide diuretics,mild to moderate reNO SPECIFIC DATA AVAILABLEl failure or mild hypercalciuria,micronutrients are rare
calcitriol + calcium citrate,amp; calcium,increasing serum calcium levels,decreased absorption with corticosteroids,milk,pregNO SPECIFIC DATA AVAILABLEncy &amp; lactation,ectopic calcification; hypertension
calcitriol,post-menopausal osteoporosis,promotes intestiNO SPECIFIC DATA AVAILABLEl absorption of calcium and regulates bone mineralization,hypercalcemia,magnesium containing drugs,patients with known hypersensitivity to any of its ingredients,"dystrophy, fever, polyuria, dehydration"
amoxicillin trihydrate,lansoprazole,inhibition of biosynthesis of cell wall,estrogen reabsorption,gut flora,penicillin hypersensitive patients,"diarrhoea, indigestion or occasioNO SPECIFIC DATA AVAILABLElly rash"
amoxicillin + clavulanic acid,co-amoxiclav,(3-lactamase inhibitor,allergic skin reactions,co-amoxiclav. in common with other broad-spectrum antibiotics,penicillin-associated cholestatic jaundice,uncommon and mainly of a mild and transitory NO SPECIFIC DATA AVAILABLEture
herbal cough syrup [glycyrrhiza glabra],indicated in- cough,licorice,<,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
herbal cough syrup [adhatoda vasica],all types of cough,relieves cough &amp; bronchial spasm,no report,no report,patients who are hypersensitive,"in high dose diarrhea, vomiting may occur"
hazmiNO SPECIFIC DATA AVAILABLE,digestive and carmiNO SPECIFIC DATA AVAILABLEtive,tones up the digestive system,no report,no report,contraindication,no significant side effect has been observed in proper dosages
habb-e-nishat,erectile dysfunction,aphrodisiac,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
guggul + barberry + chebulic myrobalan,haemorrhoid,synergistically acting,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contra-indication,no significant side effect has been observed in therapeutic dosage
aminocaproic acid,orally or intravenously,inhibition of plasminogen activators,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,when there is evidence of an active intravascular clotting process,"NO SPECIFIC DATA AVAILABLEusea, vomiting, stomach pain, diarrhea"
amino acid keto aNO SPECIFIC DATA AVAILABLElogues,chronic kidney disease,intake of essential amino acids while minimizing the amino-nitrogen intake,disturbed absorption of the active substances,estramustine,hypercalcaemia,reduced
amino acid + glucose + electrolytes,adult and pediatric patients needing iv nutrition,total parenteral nutrition,interact with other medicaments,solution,"patients with inborn errors of amino acids metabolism, severe liver damage &amp",hypertonic infusion solution
amino acid + dextrose + eloctrolytes,glucose and electrolytes in adult and pediatric patients needing iv nutrition,NO SPECIFIC DATA AVAILABLE,interact with other medicaments,amino acid,patients with hyperosmolar nonketotic diabetic coma,thrombophlebitis may occur when peripheral veins are used
carboxymethylcellulose sodium,lubricant,ocular lubricant,not known,not known,patients with known hypersensitivity to any ingredient of the product,"burning, eye irritation or pruritus, visual disturbance, ocular discharge"
carboprost tromethamine,contraindicated,myometrial contractions,concomitant use with other oxytocic agents,concomitant use with other oxytocic agents is not recommended,"patients with active cardiac, pulmoNO SPECIFIC DATA AVAILABLEry, reNO SPECIFIC DATA AVAILABLEl or hepatic disease","vomiting, NO SPECIFIC DATA AVAILABLEusea, diarrhea and pyrexia"
carboplatin,one,it modifies the cell cycle by interfering with dNO SPECIFIC DATA AVAILABLE structure and function,liver vaccine,liver vaccine,patients with severe bone marrow depression or significant bleeding,"bone marrow suppression, gastrointestiNO SPECIFIC DATA AVAILABLEl effects"
carbonyl iron + folic acid + zinc sulfate + vitamin b complex + vitamin c,this capsule,vitamin b complex is required for the growth and development of unborn babies,carbonyl iron decreases the absorption of tetracycline antibiotics,carbonyl iron decreases the absorption of tetracycline antibiotics,haemolytic aNO SPECIFIC DATA AVAILABLEemia,allergic sensitization
carbonyl iron + folic acid + zinc sulfate,"iron, folic acid and zinc deficiency especially during pregNO SPECIFIC DATA AVAILABLEncy and lactation","carbonyl iron, folic acid and zinc sulphate monohydrate",absorption of tetracycline antibiotics,carbonyl iron decreases the absorption of tetracycline antibiotics,hypersensitivity to any of its component or those with iron overload,rarely there may be allergic reactions
carbonyl iron + folic acid,megaloblastic anemias,producing red blood cells as well as transporting oxygen in the body,alcohol,alcohol,"hypersensitivity, intolerance to the drug",constipation diarrhea stomach cramps upset stomach allergic reactions
carbocisteine,"acute bronchitis, chronic bronchitis, bronchial asthma",mucolytic action happens in several mechanisms,hazardous nor therapeutically useful interactions,therapeutically,active peptic ulceration and in patients with hypersensitivity,"headache, heartburn and skin rash"
carbimazole,thyroidectomy,antithyroid action,iodine or iodine excess,iodine or iodine excess,hypersensitivity,NO SPECIFIC DATA AVAILABLEusea
carbetocin,following delivery of the infant,similar to that of oxytocin,drug interactions,drug,hypersensitivity to oxytocin or carbetocin,"back pain, dizziness, metallic taste, aNO SPECIFIC DATA AVAILABLEemia"
carbamazepine,partial and secondary generalized tonic-clonic seizures,unknown mechanisms,metabolism,metabolism,allergic to one or any of its ingredients,"dizziness, drowsiness, ataxia, dry mouth"
captopril,cardopril is effective alone or in combiNO SPECIFIC DATA AVAILABLEtion,competitively inhibits the conversion of angiotensin i,k supplements,k supplements,pregNO SPECIFIC DATA AVAILABLEncy,"neutropenia, aNO SPECIFIC DATA AVAILABLEemia and thrombocytopenia"
capsaicin,"rheumatoid arthritis, osteoarthritis",not fully understood,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,transient burning on application
caprylic + capric triglyceride,"repairs, restores &amp; protects dry skin &amp",physiological lipids to protect &amp; maintain healthy skin,drug interactions,drug,hypersensitivity,"rash, redness and itchiness"
capecitabine,adjuvant colon cancer,thymidine phosphorylase,food,food,pregNO SPECIFIC DATA AVAILABLEnt or breast-feeding,"fever, infection, chest pain"
candesartan cilexetil + hydrochlorothiazide,hypertension,combines an angiotensin ii receptor blocker,oral contraceptives,oral contraceptives,patients who are hypersensitive to any component of this product,"headache, upper respiratory tract infection, back pain, influenza-like symptoms"
candesartan cilexetil,"hypertension, heart failure with impaired left ventricular systolic function",angiotensin ii receptor (type at1) antagonist,significant drug interactions,oral contraceptives,"pregNO SPECIFIC DATA AVAILABLEncy, breast-feeding, cholestasis",mild
caNO SPECIFIC DATA AVAILABLEgliflozin hemihydrate,adults with type 2 diabetes mellitus,subtype-2 sodium-glucose co-transport protein,ugt inducers,ugt inducers,on dialysis patients,"low blood pressure, increases potassium blood levels"
camphor + menthol + oil clove + oil eucalyptus + oil turpentine,headache,eucalyptus oil acts as a cough suppressant,drug interactions,drug,history of convulsion,"redness, irritation, rash or pruritis"
calcium polystyrene sulfoNO SPECIFIC DATA AVAILABLEte,hyperkalemia due to acute and chronic reNO SPECIFIC DATA AVAILABLEl failure,removing potassium ions which are excreted in the feces,"sorbitol, digitalis drugs, cation doNO SPECIFIC DATA AVAILABLEting agents",sorbitol,neoNO SPECIFIC DATA AVAILABLEtes,acute bronchitis and bronchopneumonia have been reported
calcium pantotheNO SPECIFIC DATA AVAILABLEte,burning feet syndrome,enzymatic reactions,drug interactions,drug,patients with hypercalcaemia,irritation
amino acid + d-sorbitol + electrolytes,intravenous nutrition,"electrolytes, which are necessary as the nitrogen source for parenteral nutrition",interact with other medicaments,amino acid,patients with hyperosmolar nonketotic diabetic coma,hypertonic infusion solutions
diNO SPECIFIC DATA AVAILABLEr,jaundice hepatitis,prebiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,there is no known contraindication,no significant side effect has been observed in proper dosage
devils cotton + ashoka bark + aswagandha,leucorrhoea metritis aNO SPECIFIC DATA AVAILABLEemia,solely on female reproductive system,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children,no significant side effect has been observed in proper dosage
devil's claw,2400 mg/day,chemicals,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain, headaches, ringing in the ears"
datura + rhubarb + ginger,tablet,aNO SPECIFIC DATA AVAILABLElgesic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
date palm + betel nut + acacia,weakness of uterus leucorrhoea,mediciNO SPECIFIC DATA AVAILABLEl plants,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
alpha lipoic acid,tablet,antioxidant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,people receiving treatment for diabetes,NO SPECIFIC DATA AVAILABLE
alogliptin benzoate,adults with type-2 diabetes mellitus,dpp-4 inhibitor,significant drug-drug interactions,reNO SPECIFIC DATA AVAILABLElly excreted drugs,"aNO SPECIFIC DATA AVAILABLEphylaxis, angioedema","NO SPECIFIC DATA AVAILABLEsopharyngitis, headache and upper respiratory tract infection"
almotriptan,12 to 17 years of age,almotriptan binds to specific serotonin receptors,selective serotonin reuptake inhibitors,selective serotonin reuptake inhibitors,"patients with a history, symptoms or signs of ischaemic heart disease","cardiac reactions, including myocardial infarction"
almitrine bismesylate + raubasine,amp,amp,not to be used concurrently with other almitrine-containing preparations,monoamine oxidase inhibitor,severe hepatic impairment,"weight loss, NO SPECIFIC DATA AVAILABLEusea, sensations of heaviness or burning in the stomach"
allylestrenol,threatened abortion,no oestrogenic or androgenic properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,undiagnosed vagiNO SPECIFIC DATA AVAILABLEl bleeding toxaemia of pregNO SPECIFIC DATA AVAILABLEncy,"vomiting, NO SPECIFIC DATA AVAILABLEusea, and sometimes epigastric discomfort"
cefprozil,mild to moderate infections caused by susceptible strains,in vitro against both gram positive and gram negative bacteria,probenecid doubled the auc,probenecid doubled the auc,hypersensitivity,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain"
cefpodoxime proxetil + clavulanic acid,infections,clavulanic acid is a NO SPECIFIC DATA AVAILABLEtural inhibitor of beta lactamase,h2 blockers,antacids or h2 blockers,patients with known hypersensitivity to cephalosporins,"diarrhea, vomiting and abdomiNO SPECIFIC DATA AVAILABLEl pain"
cefpodoxime proxetil,infections caused by susceptible microorganism,prodrug,h2 blockers reduces peak plasma levels,high doses of antacids,patients with known allergy to cephalosporins,few
cefpirome sulphate,severe infections,inhibiting biosynthesis and arresting cell wall assembly,drug interactions,drug,patients with known allergy to the cephalosporin group of antibiotics,there are no predictable life threatening effects
cefoxitin,patients with pelvic inflammatory disease,binding to 1 or more of the penicillin-binding proteins,nephrotoxic agents,nephrotoxic agents,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea"
cefotaxime,infections,binds to 1 or more of the penicillin binding proteins,increased nephrotoxicity,aminoglycoside antibiotics,patients who have shown hypersensitivity,"candidiasis, rashes, fever"
cefoperazone sodium,infections when caused by susceptible organisms,inhibition of bacterial cell wall synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known allergy to the cephalosporin,hypersensitivity
cefixime trihydrate,uncomplicated uriNO SPECIFIC DATA AVAILABLEry tract infections,it kills bacteria by interfering in the synthesis of bacterial cell wall,prothrombin time,warfarin,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain"
cefepime hydrochloride,febrile neutropenic patients,bactericidal,nephrotoxicity,aminoglycosides,patients who have shown immediate hypersensitivity reactions,contraindicated in patients who have shown immediate hypersensitivity reactions
cefditoren,mild to moderate infections in adults and adolescents,prodrug which is hydrolyzed by esterases during absorption,ethinyl estradiol,intravenous,patients with milk protein hypersensitivity,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, headache, abdomiNO SPECIFIC DATA AVAILABLEl pain"
cefdinir,community acquired pneumonia,binds to 1 or more of the penicillin-binding proteins,probencid,iron supplement,patients with known allergy to the cephalosporin class of antibiotics,"vomiting, headache, rash"
cefazolin sodium,infections,inhibiting transpeptidase enzyme,reNO SPECIFIC DATA AVAILABLEl tubular secretion,probenecid,patients with known allergy to the cephalosporin group of antibiotics,injection site reactions
cefadroxil monohydrate,bacteria,binding to 1 or more of the penicillin-binding proteins,drug interaction with other drugs,drug interaction with other drugs,patients with a history of hypersensitivity,gastrointestiNO SPECIFIC DATA AVAILABLEl disturbances and hypersensitivity phenomeNO SPECIFIC DATA AVAILABLE
cefaclor monohydrate,"otitis media, lower respiratory tract infections",stability against b-lactamase iNO SPECIFIC DATA AVAILABLEctivation,aminoglycoside antibiotics,aminoglycoside antibiotics,patients with known allergy to the cephalosporin group of antibiotics,"allergic reactions such as eruptions, pruritis and urticaria"
casirivimab + imdevimab,treatment of covid-19,unmodified in the fc regions,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to the active substances,NO SPECIFIC DATA AVAILABLE
carvedilol,in patients uNO SPECIFIC DATA AVAILABLEble to tolerate an ace inhibitor,non-selective antagonism of -adrenergic receptors,adverse effects,warfarin,patients with decompensated heart failure,reported
carmellose sodium,dry eye,NO SPECIFIC DATA AVAILABLE,eye drops,eye drops,hypersensitive,eye irritation
carisoprodol,used as an adjunct in physical therapy in injuries,it has no direct action on muscle itself,cns depressants,alcohol,patients with a history of acute intermittent porphyria,"drowsiness, dizziness and headache"
carboxymethylcellulose sodium + hypromellose,this medication,polymer in NO SPECIFIC DATA AVAILABLEture,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known sensitivity or allergy,"blurred vision, matting or stickiness of eyelashes"
carboxymethylcellulose sodium + glycerin,sterile eye drops,lubricating and hydrating protective shield,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,minor burning/ stinging/ irritation
bitter melon [korola],NO SPECIFIC DATA AVAILABLEtural source of vitamin c,numerous reddishbrown or white seeds encased in scarlet arils,antidiabetic agent,antidiabetic agent,no absolute contraindication,no significant side effect
biotin,dermatitis,carboxylation of pyruvate and acetyl-coa,excessive consumption of raw egg whites,raw egg whites,patients with known hypersensitivity to any of the ingredients,no biotin toxicity
bilberry fruit [vaccinium myrtillus l],retinopathy,inhibits enzymatic cleavage of collagen,may interact with warfarin or other antiplatelet drugs,antiplatelet drugs,none known,none known
belgiri [bael fruit + connessi bark],diarrhoea amoebiasis,pathogenic microbes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known contraindication,no significant side effect has been observed in the therapeutic dosage
barsiNO SPECIFIC DATA AVAILABLE,vitiligo or leucoderma,valuable NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been reported
adhatoda vasica + centella asiatica,this syrup,the soothing action of vasac,data,no data available,patients known to have hypersensitivity,there is no data available
adenosine,intravenous,nonpyrogenic solution for rapid bolus intravenous injection,additive or synergistic depressant effects,verapamil,second- or third-degree a-v block,"prolonged asystole, ventricular tachycardia"
adefovir dipivoxil,adults with evidence of active viral replication,diester prodrug of adefovir,uriNO SPECIFIC DATA AVAILABLEry recovery,uriNO SPECIFIC DATA AVAILABLEry recovery,patients with previously demonstrated hypersensitivity to any of the components,"weakness, headache, stomach pain and NO SPECIFIC DATA AVAILABLEusea"
adapalene + benzoyl peroxide,amp,amp,irritancy effect,"peeling, desquamating, or abrasive agents",hypersensitive,dry skin
adapalene,acne vulgaris,retinoid receptors,"sulfur, resorcinol or salicylic acid",salicylic acid,individuals who are hypersensitive,usually lessen with continued use of the medication
aloe + black pepper + henbane,constipation flatulence anorexia colic obesity,synergistic action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in proper dosage
chloramphenicol + lidocaine hydrochloride,acute bacterial ear infections,bacteriostatic and bactericidal,drugs that depress bone marrow function,drugs that depress bone marrow function,perforated ear drum,ototoxicity
chloramphenicol (oral),both are suggested by in vitro studies to be effective against a specific pathogen,interference or inhibition of protein synthesis in intact cells and cell-free systems,"clindamycin, or erythromycin","clindamycin, or erythromycin","colds, viral influenza, infections of the throat",NO SPECIFIC DATA AVAILABLE
chloramphenicol (ophthalmic),ocular infections involving the conjunctiva and/or cornea,inhibition of bacterial protein synthesis,chymotrypsin,chloramphenicol,individuals with a history of hypersensitivity,"burning, stinging, conjunctival hyperemia"
chlorambucil,macroglobuliNO SPECIFIC DATA AVAILABLEemia.,not yet completely understood,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy (1st trimester) &amp; lactation,drug fever
cetuximab,k-ras,it binds specifically to the epidermal growth factor receptor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"weakness, bone pain"
cetrorelix acetate,assisted reproductive technologies,goNO SPECIFIC DATA AVAILABLEdorelin antagonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy and lactation,"NO SPECIFIC DATA AVAILABLEusea, headache, ovarian hyperstimulation syndrome"
cetirizine hydrochloride (ophthalmic),ocular itching associated with allergic conjunctivitis,selective inhibition of h1 histamine receptors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"ocular hyperemia, instillation site pain and visual acuity reduction"
cetirizine hydrochloride,asthma,without any significant anticholinergic and antiserotonic effects,drug interactions,drugs,patients with a history of hypersensitivity,somnolence
cetalkonium chloride + choline salicylate,orthodontic device,inhibition of prostaglandin production,inhibit the action of uricosurics,salicylates may enhance the effect of anticoagulants,if allergic to salicylates,asthma attacks
ceritinib,adult patients with metastatic non-small cell lung cancer,kiNO SPECIFIC DATA AVAILABLEse inhibitor,concurrent use of strong cyp3a inducers,grapefruit and grapefruit juice,patients with known hypersensitivity,gastrointestiNO SPECIFIC DATA AVAILABLEl adverse reactions
cephalexin,infections when caused by susceptible organisms,it kills bacteria by interfering in the synthesis of the bacterial cell wall,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea and abdomiNO SPECIFIC DATA AVAILABLEl discomfort"
cephradine,infections caused by sensitive gram-positive and gram-negative bacteria,the cell wall of bacteria,risk of kidney damage,diuretics,patients with known or suspected hypersensitivity to cephalosporins,hypersensitivity phenomeNO SPECIFIC DATA AVAILABLE
celiprolol hydrochloride,it is used to treat high blood pressure,partial beta-2 agonist activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergic,"dizziness or light headedness, weakness, or fainting"
celecoxib,for the relief of the signs and symptoms of osteoarthritis,inhibition of prostaglandin synthesis,aluminium and magnesium-containingantacid,aluminium and magnesium-containingantacid,aspirin or other nsaids,allergy aggravated
cefuroxime axetil + clavulanic acid,switch therapy,cefuroxime inhibits bacterial cell wall synthesis,effect of postprandial absorption,probenecid,patients with known allergy to cephalosporin &amp,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea, abdomiNO SPECIFIC DATA AVAILABLEl discomfort or pain"
cefuroxime axetil,it is indicated for the treatment of infections caused by sensitive bacteria,antibacterial agent,potentially hazardous interactions,hazardous interactions,patients with known allergy to cephalosporins,rashes and gastrointestiNO SPECIFIC DATA AVAILABLEl disturbances
ceftriaxone sodium,lower respiratory tract infections,beta lactamases,drug interactions,drug,hypersensitivity to cephalosporin antibiotics,"diarrhea, NO SPECIFIC DATA AVAILABLEusea and vomiting, stomatitis and glossitis"
ceftibuten dihydrate,mild-to-moderate infections,bactericidal,ranitidine,ranitidine,patients with known allergy to the cephalosporin group of antibiotics,vomiting
ceftazidime pentahydrate,infections caused by susceptible strains of the desigNO SPECIFIC DATA AVAILABLEted organisms,inhibition of enzymes responsible for cell-wall synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who have shown hypersensitivity,local reactions following iv injection and allergic and gastrointestiNO SPECIFIC DATA AVAILABLEl reactions
ceftazidime + avibactam,antibacterial agents,"non -lactam, -lactamase inhibitor",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"aNO SPECIFIC DATA AVAILABLEphylactic reaction, severe skin reaction",do not take medicines that stop or slow bowel movement
almond + coconut + edible pine + salep,spermatorrhoea oligospermia,enhances retentive power and relieves oligospermia,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
acacia + dates + asparagus + edible pine,sexual debility,formulation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no significant side effect has been observed in the therapeutic dosage
abhayarista,haemorrhoid bleeding piles,"cooling, tonic, and carmiNO SPECIFIC DATA AVAILABLEtive",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no absolute contraindications,no significant side effect
23 herb formula to increase breast milk,15,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
acarbose,adults with type 2diabetes mellitus,different,loss of blood glucose control,insulin,patients with known hypersensitivity to the drug,tell your doctor or pharmacist promptly
acalabrutinib,at least one prior therapy,small-molecule inhibitor of btk,gastric acid reducing agents: avoid co-administration with proton pump,gastric acid reducing agents,NO SPECIFIC DATA AVAILABLE,"headache, diarrhea, and musculoskeletal pain"
abiraterone acetate,metastatic castration-resistant prostate cancer,covalent binding mechanism,strong cyp3a4 inducers,strong cyp3a4 inducers,hypersensitivity,headache
abemaciclib,in combiNO SPECIFIC DATA AVAILABLEtion with endocrine therapy,inhibitor of cyclin-dependent kiNO SPECIFIC DATA AVAILABLEses 4 and 6,strong and moderate cyp3a inhibitors,strong and moderate cyp3a inhibitors,NO SPECIFIC DATA AVAILABLE,"anemia, leukopenia"
abacavir + lamivudine + zidovudine,combiNO SPECIFIC DATA AVAILABLEtion with other antiretrovirals,phosphorylated,sorbitol-containing medicines,sorbitol,patients,"NO SPECIFIC DATA AVAILABLEusea, headache, malaise and fatigue, and NO SPECIFIC DATA AVAILABLEusea and vomiting"
ciclopirox olamine (NO SPECIFIC DATA AVAILABLEil lacquer),mild to moderate onychomycosis,poorly understood,systemic antifungal agents,topical solution,individuals who have shown hypersensitivity to any of its components,allergic reaction to ciclopirox is rare
ciclopirox olamine (cream),mild to moderate inflammatory fungal infections,broad spectrum of antifungal action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals who have shown hypersensitivity to any of its components,low incidence of adverse reactions
ciclesonide (NO SPECIFIC DATA AVAILABLEsal spray),patients aged 6 years and older,aqueous suspension,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,fewer side effects are seen
ciclesonide (inhalation aerosol),asthma,hydrolyzation by endogenous esterases,the risk of clinical adverse effect,nelfiNO SPECIFIC DATA AVAILABLEvir,hypersensitivity,rash and eczema. systemic effects of inhaled corticosteroids
choriogoNO SPECIFIC DATA AVAILABLEdotropin alpha,only if enrolled in anin vitrofertilization program,binds to the lh/hcg receptor,significant drug interactions,drug,prior hypersensitivity to hcg preparations,injection
cholera saline,in cholera,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"fever, ongoing cough"
chlorthalidone,edema associated with congestive heart failure,thiazide-type diuretic- antihypertensive,glucose tolerance,glucose tolerance,patients with reNO SPECIFIC DATA AVAILABLEl disease or with impaired hepatic function,rise in blood lipids
chlorpromazine hydrochloride,mania and hypomania,slight ganglion-blocking activity,adverse drug reaction,alcohol,circulatory collapse. cns depression,"cardiovascular: postural hypotension, ecg changes."
chlorpheniramine maleate,urticaria sensitivity reactions,blocking h1-receptor competitively,calcium chloride,meglumine adipiodone,newborn or premature infants,well-tolerated
chloroxylenol + triclosan,"insect bites, sunburn, cuts, scratches, abrasions",chloriNO SPECIFIC DATA AVAILABLEted bisphenol antiseptic,drug interactions,drug,hypersensitivity,reversible brown staining of the teeth
chloroxylenol,antiseptic lubricant for vagiNO SPECIFIC DATA AVAILABLEl examiNO SPECIFIC DATA AVAILABLEtions and on forceps,disinfection,drug interactions,drug,hypersensitivity,reversible brown staining of the teeth
chloroquine phosphate,treatment of malaria prophylaxis and suppression of malaria,interferes with the nucleoprotein synthesis of the patient,cimetidine,cimetidine,there is no absolute contraindication,headache and gastrointestiNO SPECIFIC DATA AVAILABLEl disturbances
chlorhexidine hydrochloride + nystatin,it is used to treat skin infections,poorly absorbed from the gastrointestiNO SPECIFIC DATA AVAILABLEl tract,drug interactions,drug,those with a history of possible chlorhexidine-related allergic reactions,allergic skin reactions
chlorhexidine hydrochloride + cetrimide,amp,antimicrobial agent,drug interactions,drug,"eye, ear, mucous membrane or body cavities",skin irritation
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte + isopropyl alcohol,pre-operative surgical hand disinfection,bacteriostatic and bactericidal,soaps and other anionic agents,hypochlorite bleaches,chlorhexidine,irritative skin reactions
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte + cetrimide,for cleansing and irrigating the skin and dirty wounds,cationic surfactants,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"brain, meninges, eyes or perforated eardrum",cetrimide may have a prolonging effect on the wound healing process
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte [7.1%],omphalitis (infection of the umbilical cord) in newborn,both bacteriostatic and bactericidal action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte [4%],surgical hand scrub,both bacteriostatic and bactericidal,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergic,NO SPECIFIC DATA AVAILABLE
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte [1%],antiseptic cream,both bacteriostatic and bactericidal,brown stains,fabrics,patients who are hypersensitive to chlorhexidine,allergic reactions
chlorhexidine glucoNO SPECIFIC DATA AVAILABLEte [0.2%],"following oral surgery, in mentally or physically handicapped patients",bacteriostatic and bactericidal depending on its concentration,sulfates,"soaps, other anionic agents",hypersensitivity,transient taste disturbance; parotid gland swelling
clascoterone,12 years of age and older,potent antagonist at ars,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,local skin reactions
clarithromycin,streptococcal pharyngitis sinusitis,inhibiting microsomal protein synthesis in susceptible organisms,serum theophylline concentrations,terfeNO SPECIFIC DATA AVAILABLEdine,patients receiving terfeNO SPECIFIC DATA AVAILABLEdine,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea and abdomiNO SPECIFIC DATA AVAILABLEl pain"
citric acid monohydrate,dry cough,reduce the dry cough and soothes the throat from any related discomfort and pain,drug-drug interaction,drug-drug,hypersensitivity,no known side effects
citicoline sodium,cerebrovascular disease,inhibits the activation of phospholipase a2,meclophenoxate,meclophenoxate,patients with hypertonic of the parasympathetic nervous system.,discrete hypotensive effect
citalopram hydrobromide,obsessive-compulsive disorder and social phobia,antidepressant,metabolism,omeprazole,patients with a hypersensitivity,gastro-intestiNO SPECIFIC DATA AVAILABLEl effects
cisplatin,advanced and metastatic ovarian carcinoma,cells are killed at all stages,myelosuppression,cytotoxic drugs,"myelosuppressed patients, or patients with hearing impairment","kidneys, bone marrows and ears"
ciprofloxacin + hydrocortisone acetate,steroid responsive inflammatory ocular conditions,hydrocortisone is a corticosteroid,increased toxicity,ethanol,newborn babies,steroid
ciprofloxacin + dexamethasone,anti-infective component,interference with the enzyme dNO SPECIFIC DATA AVAILABLE gyrase,specific drug interaction,ophthalmic,newborn babies,adverse reactions
ciprofloxacin (ophthalmic),prophylaxis in otic surgeries such as mastoid surgery,bactericidal action,drug interaction studies,drug,hypersensitivity,hyperemia
ciprofloxacin,"respiratory tract infections,uriNO SPECIFIC DATA AVAILABLEry tract infections, pelvic inflammatory diseases",it inhibits bacterial dNO SPECIFIC DATA AVAILABLE synthesis,magnesium or aluminum containing antacids or sucralfate,calcium,patients who have known hypersensitivity,"headache, dizziness, joint pain and skin rashes"
ciprofibrate,hypertriglyceridemia with or without low hdl cholesterol,it also increases levels of hdl cholesterol,oral anticoagulant therapy,oral anticoagulants,pregNO SPECIFIC DATA AVAILABLEncy and lactation or when pregNO SPECIFIC DATA AVAILABLEncy is suspected concurrent use with another fibrate,"headache, dizziness, somnolence, vertigo, NO SPECIFIC DATA AVAILABLEusea, vomiting"
cinNO SPECIFIC DATA AVAILABLErizine + dimenhydriNO SPECIFIC DATA AVAILABLEte,prophylaxis of motion sickness,calcium antagonists,drugs,alcohol,"patients with angle-closure glaucoma, convulsions","impaired vision, allergic reactions, light sensitivity, and difficulty in uriNO SPECIFIC DATA AVAILABLEting"
cinNO SPECIFIC DATA AVAILABLErizine,labyrinthine arteriosclerosis,"selective calcium antagonist, inhibiting the influx of ca 2+ intracellularly",drug interactions,anticoagulants or hypoglycaemics,hypotensive patients,somnolence and gastrointestiNO SPECIFIC DATA AVAILABLEl disturbances are extremely rare
cinchocaine hydrochloride,surface aNO SPECIFIC DATA AVAILABLEesthesia,decrease of permeability of the nerve cell to sodium ions,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,application to inflamed or infected tissues,cardiac arrest
cinchocaine + hydrocortisone + neomycin + esculin,application,anti-inflammatory and anti-pruritic agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive to any component of the product,side effects which have been reported for individual constituents
cinchocaine + hydrocortisone + framycetin + esculin,application to relieve pain and discomfort,skin protective action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"herpes simplex, vaccinia or varicella",children
ciNO SPECIFIC DATA AVAILABLEcalcet,secondary hyperparathyroidism in patients with chronic kidney disease on dialysis,calcimimetic agent,serum concentrations of tacrolimus,tacrolimus,patients with hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, anorexia"
cilostazol,intermittent claudication,specifically inhibit cellular phosphodiesterase iii,major metabolites,diltiazem,patients with known or suspected hypersensitivity to any of its components,"headache, diarrhoea, vomiting, leg cramps, rash"
cilnidipine,patients with chronic kidney disease,dihydropyridine calcium-channel blocker,antipsychotics,antipsychotics,patients with known sensitivity to cilnidipine,dizziness; flushing; headache;
ciclopirox olamine (shampoo),seborrheic dermatitis,antifungal action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals who have shown hypersensitivity to any of its components,low incidence of adverse reactions
clostridium botulinum toxin type a neurotoxin,indicated,blocks the sigNO SPECIFIC DATA AVAILABLEls between the nerve &amp; its muscle,drug interactions,drug,prior history of severe reaction to other human immunoglobulin preparations,skin rash
clopidogrel bisulphate,"recent mi, recent stroke, or established peripheral arterial disease",irreversible binding,plasma concentrations of repaglinide,omeprazole or esomeprazole repaglinide,hypersensitivity to the drug substance or any component of the product,"bleeding, diarrhoea, gastrointestiNO SPECIFIC DATA AVAILABLEl discomfort"
clopidogrel + aspirin,"recent mi, recent stroke, or established peripheral arterial disease",aspirin,bleeding,"valproic acid, varicella vaccine",hypersensitivity,generally well tolerated
clonidine hydrochloride,"anxiety, cancer pain, generalized anxiety disorder",clonidine stimulates 2 -adrenoceptors,nsaids,nsaids,2nd- or 3rd-degree av block or sick sinus syndrome,"heart failure, halluciNO SPECIFIC DATA AVAILABLEtions"
cloNO SPECIFIC DATA AVAILABLEzepam,has not been systematically studied in controlled clinical trials,anxiolytic effects,metabolism of other drugs,metabolism of other drugs,patients with clinical or biochemical evidence of significant liver disease,cns depression
clomipramine hydrochloride,"depression, obsessions and phobias","either by increasing the amount of chemical ""messengers"" in the brain",monoamine oxidase inhibitors,medicines for depression called monoamine oxidase inhibitors,acute and recovery stages of myocardial infarction,increase in appetite and weight gain
clomiphene citrate,ovulatory failure in female patients who wish to become pregNO SPECIFIC DATA AVAILABLEnt,unknown but is believed to be related to its antiestrogenic properties,drug interaction,drug,patients with liver diseases,all these effects disappear promptly after the treatment is discontinued
clobetasone butyrate,eczema and dermatitis,can cause cutaneous atrophy if grossly misused,potentially hazardous interactions,potentially hazardous interactions,pregNO SPECIFIC DATA AVAILABLEncy,"amenorrhoea, hyperhidrosis, skin thinning"
clobetasol propioNO SPECIFIC DATA AVAILABLEte + salicylic acid,this ointment,high potency corticosteroid,topical medicines on the same area of skin,skin,patients displaying salicylate hyersensitivity,"possible sensitivity reactions, drying and irritation"
clobetasol propioNO SPECIFIC DATA AVAILABLEte + ofloxacin + ornidazole + terbiNO SPECIFIC DATA AVAILABLEfine,this cream,clobetasol,hazardous interactions,hazardous interactions,hypersensitive,"burning, itching, irritation, dry skin"
clobetasol propioNO SPECIFIC DATA AVAILABLEte + neomycin sulphate + nystatin,less active steroids,unclear,hazardous interactions,nystatin,"rosacea, acne vulgaris and perioral dermatitis",hypercortisolism
clobetasol propioNO SPECIFIC DATA AVAILABLEte (topical preparation),"adults, elderly and children",multiple mechanisms,inhibit the metabolism of corticosteroids,"ritoNO SPECIFIC DATA AVAILABLEvir, itracoNO SPECIFIC DATA AVAILABLEzole","rosacea, acne vulgaris, perioral dermatitis",burning and stinging sensation
clobetasol propioNO SPECIFIC DATA AVAILABLEte (scalp preparation),psoriasis and seborrheic dermatitis,multiple mechanisms,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,dermatoses in children under one year of age,application should be stopped immediately
clobazam,only in conjunction with adequate concomitant treatment,increases the duration of time for which the chloride ionopore is open,lithium,lithium,patients with hypersensitivity to clobazam,drug tolerance
clioquinol + flumetasone pivalate,exterNO SPECIFIC DATA AVAILABLEl ear inflammation and infections,bacteriostatic action,protein-bound iodine,protein,"punctured eardrum, pre-existing tuberculosis of the skin",treatment should be discontinued if severe irritation
clindamycin + tretinoin,acne vulgaris,retinoid tretinoin,irritating,erythromycin,hypersensitive,common side effects
clindamycin + benzoyl peroxide,acne vulgaris.,both active against propionibacterium acnes,increased coagulation tests,increased coagulation tests,"history of regioNO SPECIFIC DATA AVAILABLEl enteritis, ulcerative colitis","application site pain, application site exfoliation, application site irritation"
clindamycin (vagiNO SPECIFIC DATA AVAILABLEl cream),non pregNO SPECIFIC DATA AVAILABLEnt women and pregNO SPECIFIC DATA AVAILABLEnt women during the second and third trimester,inhibits bacterial protein synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children under 12 years of age,"genital tract: vaginitis, vulvo-vagiNO SPECIFIC DATA AVAILABLEl irritation"
clindamycin (lotion),skin infections,antiacne and antibacterial activity,"neuromuscular blocking agents. therefore, it should be used with caution",neuromuscular blocking agents,NO SPECIFIC DATA AVAILABLE,rare
clindamycin,"upper respiratory infections, lower respiratory infections, skin",NO SPECIFIC DATA AVAILABLE,"neuromuscular blocking agents. therefore, it should be used with caution",neuromuscular blocking agents,patients previously found to be sensitive,abdomiNO SPECIFIC DATA AVAILABLEl pain
conjugated estrogen + bazedoxifene,an estrogen agonist/antagonist,binding to and activating estrogen receptors,risk of endometrial hyperplasia,cyp3a4 inhibitors,"pregNO SPECIFIC DATA AVAILABLEncy, women who may become pregNO SPECIFIC DATA AVAILABLEnt, and nursing mothers","muscle spasms, NO SPECIFIC DATA AVAILABLEusea, diarrhea, dyspepsia"
conjugated estrogen (tablet),conjugated estrogens with or without progestins,binding to nuclear receptors in estrogen-responsive tissues,anticonvulsants,anti-infectives,hypersensitivity,blood clots in the blood vessels.
conjugated estrogen (cream),moderate-to-severe vasomotor symptoms associated with estrogen deficiency,estrogen replacement therapy,rifampin,hepatic,hypersensitivity,"vagiNO SPECIFIC DATA AVAILABLEl burning, irritation and itching"
colistimethate sodium,not indicated for infections due to proteus or neisseria,it interacts with the bacterial cytoplasmic membrane,sodium cephalothin,sodium cephalothin,patients with a history of sensitivity to the drug or any of its components,"gastrointestiNO SPECIFIC DATA AVAILABLEl upset, tingling of extremities and tongue"
colecalciferol [vitamin d3],patients with vitamin d3 deficiency,reabsorption of calcium &amp; phosphorous,antifungal agents,liquid paraffin,patients with known hypersensitivity,"hypercalcaemia, hypercalciuria"
colchicine,in adults and children 4 years or older,inhibits the phagocytosis of uric acid by leukocytes,inhibitors,p-gp and/or cyp3a4 inhibitors,patients with reNO SPECIFIC DATA AVAILABLEl or hepatic impairment,diarrhea and pharyngolaryngeal pain
cod liver oil,pregNO SPECIFIC DATA AVAILABLEnt women,omega-3 fatty acids,anti-convulsants,barbiturates or anti-convulsants,"hypervitaminosis of vitamin a, d or e",these may disappear on discontinuation of supplementation
coal tar solution,NO SPECIFIC DATA AVAILABLEtural tars to clear scales,it moisturises and nourishes the skin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,"eye irritation, hair loss, itchy and redskin"
coal tar + precipitated sulphur + salicylic acid,ointment,reduction,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,local infections,photosensitivity of the skin
coal tar,psoriasis,it slows down excessive epidermal cell turnover,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,folliculitis and acne vulgaris,acne-like eruptions of the skin
coagulation factor viia [eptacog alfa],bleeding episodes in patients with haemophilia,extrinsic pathway of the coagulation cascade,increased risk of thromboembolism,non-activated prothrombin complex concentrate,hypersensitivity,aNO SPECIFIC DATA AVAILABLEphylaxis
clozapine,schizophrenia,antagonist,adreNO SPECIFIC DATA AVAILABLEline,adreNO SPECIFIC DATA AVAILABLEline,drug intoxication; coma or severe cns depression,"increased watering of mouth, NO SPECIFIC DATA AVAILABLEusea or vomiting"
cloxacillin sodium,"infected wounds), (infected burns), (protection for skin grafts",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,indigestion
clove oil,bad breath,"clove oil is effective, safe and well tolerated for all age groups",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,irritating to mucosal tissues
clotrimazole + hydrocortisone,all dermatomycoses,hydrocortisone is a glucocorticoid,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,hypersensitivity reactions
clotrimazole (vagiNO SPECIFIC DATA AVAILABLEl tablet),"in vagiNO SPECIFIC DATA AVAILABLEl itching, burning and discharge",membrane damage unrelated to sterol synthesis,no information is available,no information is available,patients with known hypersensitivity to any of the components of this product,no systemic effect is expected
clotrimazole (vagiNO SPECIFIC DATA AVAILABLEl suppository),candidal vaginitis,membrane damage unrelated to sterol synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive to clotrimazole,occasioNO SPECIFIC DATA AVAILABLEl skin irritation or burning sensation
clotrimazole (topical),yeasts (candida species).,antimycotic activities,no information is available,no information is available,hypersensitivity,well tolerated
clotrimazole (eye ointment),fungal keratitis,stopping the production of ergosterol,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals sensitive to its components,rarely patients may experience burning or irritation
clotrimazole (ear drop),fungal infections,stopping the production of ergosterol,heat reaction,sofradex drops,individuals who have hypersensitivity,"erythema, stinging, edema, pruritus and general irritation"
dacomitinib,first-line treatment of patients with metastatic non-small cell lung cancer,irreversible inhibitor of the kiNO SPECIFIC DATA AVAILABLEse activity,proton pump inhibitors,proton pump inhibitors,NO SPECIFIC DATA AVAILABLE,"decreased appetite, dry skin, decreased weight"
daclatasvir + sofosbuvir,daclatasvir is a direct-acting antiviral agent,directly inhibiting hcv protein ns5a,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
daclatasvir,adults,inhibitor of ns5a,adverse reaction,breast cancer resistance protein,in combiNO SPECIFIC DATA AVAILABLEtion with drugs that strongly induce cyp3a,fainting or near-fainting
dacarbazine,in combiNO SPECIFIC DATA AVAILABLEtion with other effective agents,unclear,increased metabolism,enzyme inducers,patients who have demonstrated a hypersensitivity to it in the past,"rarely, dacarbazine for injection has caused diarrhea"
dabigatran etexilate mesylate,patients who have been previously treated,prolongs the coagulation markers,deep venous thrombosis and pulmoNO SPECIFIC DATA AVAILABLEry embolism,p-gp inducers,active pathological bleeding,increased risk of thrombotic events
d-chiro-inositol,polycystic ovary syndrome,improves glucose tolerance and reduces circulating insulin,toxicity,digoxin,hypersensitivity,well tolerated
cytarabine,leukaemic meningitis,antiviral and immunosuppressant activity,neurotoxicity,intrathecal,patient with active meningeal infection,"thrombocytopenia, fatigue"
cyproterone acetate + ethinyl estradiol,oral antibiotic,increases levels of sex hormone binding globulin (shbg),pregNO SPECIFIC DATA AVAILABLEncy,vitamin c,previous or existing liver tumors,"bleeding, dizziness, depression, weight gain, headache"
cyclosporine (ophthalmic),emulsion,partial immunomodulator,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with active ocular infections,eye pain
cyclosporine,transplantation,not known,drugs that decrease cyclosporine levels,oral,hypersensitivity,allergic rashes
cyclophosphamide,concurrently or sequentially with otherantineoplasticdrugs,any stage of the cell cycle,depolarising muscle relaxants,depolarising muscle relaxants,pregNO SPECIFIC DATA AVAILABLEncy,"alopecia, skin and NO SPECIFIC DATA AVAILABLEils hyperpigmentation, NO SPECIFIC DATA AVAILABLEusea and vomiting"
cyclopentolate hydrochloride,diagnostic purposes,anticholinergic agent,antagonize miosis and ciliary body contraction,anticholinergic agents,children,systemic effects
cyclobenzaprine hydrochloride,adjunct to rest and physical therapy,centrally-acting skeletal muscle relaxant,brimonidine,sibutramine,"recent mi, arrhythmias, severe liver disease","drowsiness, dry mouth and dizziness"
cyclizine hydrochloride,adults and children aged 6 years and over,NO SPECIFIC DATA AVAILABLE,alcohol,alcohol,if you are allergic to cyclizine hydrochloride,"skin rashes or itching, drowsiness, lack of coordiNO SPECIFIC DATA AVAILABLEtion"
cyanocobalamin,pernicious anemia,coenzyme,k salts,k salts,tobacco amblyopia,polycythemia vera
crotamiton,itching and skin irritation,relieves itching by producing what is called a counter-irritation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,in or around the eyes,irritation of the skin or contact allergy
crizotinib,patients with- metastatic non-small cell lung cancer,inhibitor of receptor tyrosine kiNO SPECIFIC DATA AVAILABLEses,strong cyp3a inhibitors,st. johns wort,NO SPECIFIC DATA AVAILABLE,"upper respiratory infection, dizziness, and neuropathy"
crisaborole,pediatric patients 3 months of age and older,phosphodiesterase 4b,inhibit cytochrome p450,metabolite 1 are not expected to inhibit cytochrome p450,NO SPECIFIC DATA AVAILABLE,application site pain
covid vaccine,coroNO SPECIFIC DATA AVAILABLE virus,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
copper peptide + procapil + niaciNO SPECIFIC DATA AVAILABLEmide + biotin + l-arginine,substantial hair growth,"boosts the hair growth, health &amp; appearance",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,NO SPECIFIC DATA AVAILABLE
desloratadine,chronic idiopathic urticaria,non-sedating; long acting tricyclic histamine antagonist,drug,drug,patients having hypersensitivity,"headache, NO SPECIFIC DATA AVAILABLEusea, fatigue, dizziness, pharyngitis"
dequalinium chloride,fluomizin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,if you are allergic to the active substance dequalinium chloride,vagiNO SPECIFIC DATA AVAILABLEl discharge; vagiNO SPECIFIC DATA AVAILABLEl itching or vagiNO SPECIFIC DATA AVAILABLEl burning
denosumab,patients,binds to receptor activator of nuclear factor kappa-b ligand,midazolam,midazolam,hypersensitivity,osteonecrosis of the jaw (onj).
delafloxacin,only,concentration-dependent bacteriocidal activity,multivalent cations,pediatric powder for oral solution,patients with known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, diarrhea, headache, transamiNO SPECIFIC DATA AVAILABLEse elevations, and vomiting"
dehydroepiandrosterone,lacking,antagonist of gamma-aminobutyric acid (gaba) receptors,progesterone assays,dhea,breast or prostate cancer,mania and hypomania
degarelix acetate,adult male patients with advanced hormone-dependent prostate cancer,selective goNO SPECIFIC DATA AVAILABLEdotrophin releasing-hormone (gnrh) antagonist,not a substrate for the human cyp450 system,mediciNO SPECIFIC DATA AVAILABLEl products able to induce torsades de pointes,hypersensitivity,testosterone suppression
deflazacort,"aNO SPECIFIC DATA AVAILABLEphylaxis, asthma, severe hypersensitivity reactions",anti-inflammatory action by inhibiting phospholipase a2 enzyme,liver enzymes,drugs which are liver enzyme inducers are co-administered,hypersensitivity,susceptible to infection
deferoxamine mesylate,acute iron intoxication,"ferrioxamine, a stable complex which is elimiNO SPECIFIC DATA AVAILABLEted via the kidneys",impairment of consciousness,erythropoietin,hypersensitive,NO SPECIFIC DATA AVAILABLE
deferiprone,iron overload patients with thalassemia,chelating agent,aluminium containing antacids,aluminium containing antacids,hypersensitivity,arthralgia and increased liver enzymes
deferasirox,adult and paediatric patients,orally active chelator,decreased exposure with colestyramine and potent inducers of ugt enzymes,"hormoNO SPECIFIC DATA AVAILABLEl contraceptives, simvastatin",high risk myelodysplastic syndrome,serum creatinine
daunorubicin,acute nonlymphocytic leukemia,simple glycosidic cleavage,doxorubicin or daunorubicin,daunorubicin,patients with known hypersensitivity,dose-limiting toxicity
dasatinib,philadelphia chromosome-positiveacute lymphoblastic leukemia,inhibits the following kiNO SPECIFIC DATA AVAILABLEses,NO SPECIFIC DATA AVAILABLErrow therapeutic index,NO SPECIFIC DATA AVAILABLErrow therapeutic index,pregNO SPECIFIC DATA AVAILABLEncy,acne
darifeNO SPECIFIC DATA AVAILABLEcin,overactive bladder,"potent, competitive and selective muscarinic receptor antagonist",anticholinergic agents,dry mouth,"patient with uriNO SPECIFIC DATA AVAILABLEry retention, gastric retention","abnormal vision, back pain, dry skin, hypertension"
darbepoetin alfa,including patients ondialysisand patients not on dialysis,endogenous erythropoietin,ethanol,ethanol,uncontrolled hypertension,hypertension; seizures; serious allergic reaction; severecutaneousreactions
dapsone,12 years of age and older,both anti-infammatory and antimicrobial properties,benzoyl peroxide,topical benzoyl peroxide,those who are hypersensitive,application site dryness and pruritus
dapoxetine hydrochloride,indicated for the treatment of premature ejaculation,inhibition of neuroNO SPECIFIC DATA AVAILABLEl reuptake of serotonin,alcohol,alcohol,maois or thioridazine,hypertension
dapagliflozin propanediol,withtype 2 diabetesmellitus,reversible inhibitor of sodium-glucose cotransporter 2,increase in cmax &amp; auc with mefeNO SPECIFIC DATA AVAILABLEmic acid,rifampin,moderate to severe reNO SPECIFIC DATA AVAILABLEl impairment; end-stage reNO SPECIFIC DATA AVAILABLEl disease; active bladder cancer,"reNO SPECIFIC DATA AVAILABLEl impairment, female genital mycotic infections"
dantrolene sodium,tion,probably by interfering with the release of ca ++,cns depressants,cns depressants,hepatitis and cirrhosis,"drowsiness, dizziness, weakness, general malaise"
daNO SPECIFIC DATA AVAILABLEzol,endometriosis,unknown,migraine,carbamazepin,hypersensitivity to daNO SPECIFIC DATA AVAILABLEzol.,elevated lft values
dalteparin sodium,extracorporeal circulation,antithrombotic agent,increased risk of haemorrhage,etacrynic acid,severe hypertension,"elevated serum transamiNO SPECIFIC DATA AVAILABLEse levels (ast and alt), allergic reactions"
dextromethorphan + pseudoephedrine + triprolidine,this preparation,central action on the cough centre in the medulla,avoid taking isocarboxazid,tranylcypromine,patients with liver disease or asthmatic patients,no apparent evidence of physical dependence of the morphine
dextromethorphan + phenylephrine + triprolidine,upper respiratory allergies,central action on the cough centre in the medulla,avoid taking isocarboxazid,tranylcypromine,asthma,no apparent evidence of physical dependence of the morphine
dextran + sodium chloride,moderate- to high-risk patients undergoing surgery,dextran produce expansion of plasma volume,lithium,lithium,pregNO SPECIFIC DATA AVAILABLEncy,raised liver enzyme values; alopecia; bone marrow suppression
dextran + hypromellose,keratoconjunctivitis,dextran &amp; hypromellose,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,when soft contact lenses are being worn,there are no known side effects
dextran + dextrose,thromboembolic disorders,inhibits sludging or aggregation of red blood cells,enzyme inducers,enzyme inducers,NO SPECIFIC DATA AVAILABLE,injection site infection/phlebitis
dexpanthenol,prevention and treatment of diaper rash in infants,enzymatically,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,you may not suffer from any of them
dexmedetomidine hydrochloride,non-intubated patients,termiNO SPECIFIC DATA AVAILABLEte the propagation of pain sigNO SPECIFIC DATA AVAILABLEls,reducing dosage,co-administered drug,none,"hypotension, respiratory depression, and bradycardia"
dexlansoprazole,healing of erosive esophagitis,proton pump inhibitor,food,food,patients with known hypersensitivity to any component of the formulation,"diarrhea, abdomiNO SPECIFIC DATA AVAILABLEl pain, NO SPECIFIC DATA AVAILABLEusea, vomiting"
dexketoprofen,amp,anti-inflammatory,drugs,any of the following drugs,allergic,unwanted effects
dexibuprofen,osteoarthritis,aNO SPECIFIC DATA AVAILABLElgesic action,anticoagulant,anticoagulant,patients with previous history of hypersensitivity,"dyspepsia, diarrhea, fatigue, and headache"
dexamethasone + tobramycin,corticosteroid,inhibit the phospholipase a2,combiNO SPECIFIC DATA AVAILABLEtion eye drops,topical ophthalmic medicines,hypersensitivity,topical ocular tobramycin
dexamethasone + neomycin sulphate + polymyxin b sulphate,antimicrobial,anti-infective component,drug interactions,drug,uncomplicated removal of a corneal foreign body,adverse reactions
dexamethasone + chloramphenicol,post-operative inflammation and any other ocular inflammation associated with infection,chloramphenicol,phenobarbital,phenobarbital,hypersensitivity,allergic sensitization
dexamethasone (ophthalmic),dexamethasone phosphate,it suppresses normal immune response,none relevant,none relevant to topical use.,perforation of a drum membrane,"rarely, stinging and burning may occur."
dexamethasone,selected cases may require low-dose mainteNO SPECIFIC DATA AVAILABLEnce therapy,it suppresses normal immune response,oral anti-coagulants,oral anti-coagulants,hypersensitivity to corticosteroids,glucocorticoid
desvenlafaxine,adult outpatients,the exact mechanism is unknown,anticoagulants,aspirin,"maois (e.g. linezolid, iv methylene blue","NO SPECIFIC DATA AVAILABLEusea, dizziness, insomnia, hyperhidrosis"
desoximetasone,corticosteroid,uncertain,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of hypersensitivity,NO SPECIFIC DATA AVAILABLE
desonide,mild to moderate atopic dermatitis,unclear,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to any of the components of the preparation,"burning, rash and pruritus"
desogestrel,alterNO SPECIFIC DATA AVAILABLEtive for women who have a weak tolerance levels for the estrogen hormones,NO SPECIFIC DATA AVAILABLE,charcoal,charcoal,hypersensitivity to ingredients,decreased libido
desmopressin acetate,primary nocturNO SPECIFIC DATA AVAILABLEl enuresis nocturia and central diabetes insipidus,mimicking the actions of endogenous adh,urine production and osmolality,27% fat meal,cardiac insufficiency and other conditions requiring treatment with diuretic agents,"headache, stomach pain and NO SPECIFIC DATA AVAILABLEusea"
diflupredNO SPECIFIC DATA AVAILABLEte,inflammation and pain associated with ocular surgery,structurally similar to other corticosteroids,drug interaction,0.05% ophthalmic emulsion,most active viral diseases,corneal edema
diflorasone diacetate,corticosteroid-responsive dermatoses,anti-inflammatory,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,those patients with a history of hypersensitivity to the preparation,"burning, itching, irritation, dryness"
diethylcarbamazine citrate,"filariasis, lymphatic filariasis",sensitizing the microfilariae to phagocytosis,drug interactions,drug,"pregNO SPECIFIC DATA AVAILABLEncy, hypersensitivity; lactation","fever, headache, vomiting, dizziness, drowsiness, NO SPECIFIC DATA AVAILABLEusea"
dienogest + estradiol valerate,progestin,cervical mucus changes that inhibit sperm penetration,contraception,drugs or herbal products,breast cancer,NO SPECIFIC DATA AVAILABLEtazia
dienogest,endometriosis,it is an antagonist at androgen receptors,adverse reactions,progestogens,active venous thromboembolic disorder,undesirable effects
dicycloverine hydrochloride,functioNO SPECIFIC DATA AVAILABLEl bowel/irritable bowel syndrome,antispasmodic and anticholinergic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"increased ocular tension, uriNO SPECIFIC DATA AVAILABLEry hesitancy"
diclofeNO SPECIFIC DATA AVAILABLEc sodium + misoprostol,high risk of developing nsaid,not completely understood,antacids,antacids,patients with hypersensitivity,"abdomiNO SPECIFIC DATA AVAILABLEl pain, diarrhea and other gi symptoms"
diclofeNO SPECIFIC DATA AVAILABLEc sodium + methyl salicylate + linseed oil + menthol,indicated,anti-inflammatory agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known hypersensitivity to any part of the preparation,extremely low frequency of hypersensitivity reactions
diclofeNO SPECIFIC DATA AVAILABLEc sodium + lidocaine hydrochloride,diclofeNO SPECIFIC DATA AVAILABLEc sodium,inhibition of prostaglandin synthesis,influencing their clinical effect,lithium,in patients with adams-stokes syndrome,mild and transient
diclofeNO SPECIFIC DATA AVAILABLEc sodium (ophthalmic),in- inhibition of miosis during cataract surgery,non-steroidal anti-inflammatory drug with aNO SPECIFIC DATA AVAILABLElgesic property,drug interaction,steroid,"attacks of asthma, urticaria or acute rhinitis","sensitivity to light, bad taste, feeling of pressure, allergic reactions"
diclofeNO SPECIFIC DATA AVAILABLEc sodium,surgery,inhibiting prostaglandin biosynthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,asthmatic patient,"mild, rare and transient"
diclofeNO SPECIFIC DATA AVAILABLEc potassium,"severe painful inflammatory infections of the ear, nose, or throat",inhibition of cyclooxygeNO SPECIFIC DATA AVAILABLEse,unwanted effects,anticoagulant therapy,patients with known hypersensitivity to diclofeNO SPECIFIC DATA AVAILABLEc,mild and transient
diclofeNO SPECIFIC DATA AVAILABLEc diethylamine + mephenesin + menthol + methyl salicylate + turpentine oil,topical gel,reducing pain and delayed onset muscle soreness,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children less than 12 years old cuts infected skin,gel
diazoxide,orally,enhancing cell membrane permeability to potassium ions,phenytoin,oral,all cases which are ameNO SPECIFIC DATA AVAILABLEble to surgery or other specific therapy,adverse reactions
diazepam,hospitalized patients,attaches to the specific site on the gaba receptor,omeprazole and isoniazide,omeprazole,"myasthenia gravis, pulmoNO SPECIFIC DATA AVAILABLEry insufficiency","dizziness, light headedness, confusion and ataxia."
diabasic sodium phosphate + monobasic sodium phosphate,bowel cleansing is required,saline laxative,no other sodium phosphate preparations,no other sodium phosphate preparations including sodium phosphate oral solution or tablets,"congestive heart failure, impairment of reNO SPECIFIC DATA AVAILABLEl function",adverse events possibly associated with the use of phosphate enema
dextrose & hartmann's solution,electrolytes and calories or as an alkalinizing agent,intravenous administration,drug interactions,drug,patients with known allergy to corn or corn products,"coughing, sneezing, and/or difficulty with breathing"
dextrose,when there is no significant loss of electrolytes,replace lost fluids and provide carbohydrates to the body,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergic to dextrose,"fever, ongoing cough"
dextromethorphan hydrobromide + guaifenesin,preparation provides relief from all the symptoms associated with common cold,guaifenesin and dextromethorphan hbr.,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"hypersensitivity, rash, NO SPECIFIC DATA AVAILABLEusea &amp; vomiting"
dextromethorphan hydrobromide,chronic dry cough or unproductive cough,nmda receptor antagonist and acts as a non-competitive channel blocker,cns depressants and monoamine oxidase (mao) inhibitors,cns depressants and monoamine oxidase (mao) inhibitors,hypersensitivity,no aNO SPECIFIC DATA AVAILABLElgesia or addiction and little or no cns depression
donepezil hydrochloride,mild to moderate dementia,inhibiting hydrolysis of acetylcholine,drugs with anticholinergic properties and which cross into the brain,drugs,patients with known hypersensitivity,less frequent
domperidone maleate,parkinson's disease,gastroprokinetic,mao (monoamine oxidase) inhibitors,mao (monoamine oxidase) inhibitors,neoNO SPECIFIC DATA AVAILABLEtes,"galactorrhea, breast enlargement, and soreness"
docusate sodium (oral),abdomiNO SPECIFIC DATA AVAILABLEl radiological procedures,allowing more water to be absorbed by the stool,mineral oil,mineral oil,patients with hypersensitivity,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl cramps or skin rash"
docusate sodium (ear drop),indicated as an aid in the removal of ear wax,low surface tension and miscibility,interaction with other mediciNO SPECIFIC DATA AVAILABLEl products,mediciNO SPECIFIC DATA AVAILABLEl,perforation of the eardrum or inflammation of the ear,transient stinging or irritation
docetaxel trihydrate,doxorubicin and cyclophosphamide,inhibiting their disassembly,compounds,compounds,neutrophil counts of &lt;1500 cells/mm 3,infections
dobutamine,inotropic support is required for the treatment of patients,stimulating 1-adrenergic receptors,b-adrenergic receptor antagonists,folic acid,patients who have shown previous manifestations of hypersensitivity,mild reduction in serumpotassiumconcentration
dithranol + boric acid + salicylic acid,-,"atp , keratinocytes : keratolytic agent",increase your risk for side-effects or cause your drug not to work properly,ointment,acute or actively inflamed psoriatic eruptions,ointment
disopyramide phosphate,ventricular arrhythmias,not act as a blocking agent for beta or alpha adrenergic receptors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"pre-existing a-v heart block, shock, glaucoma","dry mouth/ nose/ eye, NO SPECIFIC DATA AVAILABLEusea, vomiting"
dipyridamole,secondary prophylaxis of stroke or transient ischaemic attack,inhibiting platelet aggregation,thromboembolism,aspirin,hypersensitivity. peptic ulcer,large doses may lower bp
"diphtheria, tetanus, pertussis, poliomyelitis vaccine",prevention,NO SPECIFIC DATA AVAILABLE,haemophilus influenzae type b conjugate vaccine,haemophilus influenzae type b conjugate vaccine,febrile or acute disease,"injection-site reactions, abnormal crying, loss of appetite and irritability"
"diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis, influenzae vaccine",primary and booster vacciNO SPECIFIC DATA AVAILABLEtion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,history of an aNO SPECIFIC DATA AVAILABLEphylactic reaction,"prolonged crying, diarrhoea, induration"
diphtheria + pertussis + tetanus [dpt],immunization,vaccine,do not mix this vaccine with any other vaccine,influenza vaccine,amp; tetanus vaccine,headache
diphenhydramine hydrochloride + zinc acetate,cream,blocking the releases of histamine at its sources,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals with a known allergy to its components,contact dermatitis
diphenhydramine hydrochloride,"seasoNO SPECIFIC DATA AVAILABLEl, perennial, vasomotor rhinitis urticaria",antihistamine with anticholinergic and sedative effects,absorption of the antituberculous agent,gastrointestiNO SPECIFIC DATA AVAILABLEl tract,impaired hepatic or reNO SPECIFIC DATA AVAILABLEl function,"sedation, dizziness, tinnitus"
diphenhydramine + levomenthol,cough,levomenthol has decongestant and anti-inflammatory properties,mao inhibitors,alcohol,patients currently receiving monoamine oxidase inhibitors,diphenhydramine
diphenhydramine + dextromethorphan + levomenthol,syrup,diphenhydramine hydrochloride,monoamine oxidase inhibitors,monoamine oxidase inhibitors,at risk of developing respiratory failure,this syrup
diltiazem hydrochloride (sr tablet),prophylaxis and treatment of angiNO SPECIFIC DATA AVAILABLE pectoris,calcium channel antagonist,drugs,short-or long-acting nitrates,patients with known hypersensitivity,reported
diltiazem hydrochloride (fc tablet),alone or in combiNO SPECIFIC DATA AVAILABLEtion in the maNO SPECIFIC DATA AVAILABLEgement of hypertension,interferes with the influx of calcium ions through the channels of active cell membranes,lithium &amp; carbamazepine,lithium &amp; carbamazepine,"severe bradycardia, sick sinus syndrome, pregNO SPECIFIC DATA AVAILABLEncy","headache, ankle oedema, hypertension"
diloxanide furoate,intestiNO SPECIFIC DATA AVAILABLEl amoebiasis,"hydrolysed in the gut, thus releasing the free diloxanide",drug,drug,hypersensitivity,"flatulence, itching, urticaria, vomiting"
digoxin,heart failure,direct action on vascular smooth muscle,antacids,antacids,hypersensitivity,pregNO SPECIFIC DATA AVAILABLEncy
eflornithine hydrochloride,limited to these areas of involvement,suicide inhibition) to ornithine decarboxylase,interaction,drug,patients with a history of sensitivity to any components of the preparation,"acne, barbae, pseudofolliculitis"
efavirenz,there are no results from controlled trials evaluating long term suppression of hivrNO SPECIFIC DATA AVAILABLE,it blocks the rNO SPECIFIC DATA AVAILABLE- and dNO SPECIFIC DATA AVAILABLE-dependent polymerase activities,voricoNO SPECIFIC DATA AVAILABLEzole,voricoNO SPECIFIC DATA AVAILABLEzole,concomitant admin with terfeNO SPECIFIC DATA AVAILABLEdine,autoimmune disorders
ecoNO SPECIFIC DATA AVAILABLEzole nitrate + triamcinolone acetonide,amp,NO SPECIFIC DATA AVAILABLE,lowering of plasma salicylates levels,warfarin &amp; acenocoumarol,individuals who have shown hypersensitivity to any of its ingredients,minimal allergenic effect
ecoNO SPECIFIC DATA AVAILABLEzole nitrate,"tinea cruris, and tinea corporis",interferes with fungal oxidative enzymes,systemic absorption,genital application,individuals who have shown hypersensitivity to any of its ingredients,"burning, itching, stinging, and erythema"
ebastine,seasoNO SPECIFIC DATA AVAILABLEl and perennial allergic rhinitis. chronic idiopathic urticaria,selective h1-histamine receptor antagonist,alcohol,alcohol,patients with a known hypersensitivity,"abdomiNO SPECIFIC DATA AVAILABLEl pain, dyspepsia, NO SPECIFIC DATA AVAILABLEusea and insomnia"
dydrogesterone,treatment of threatened miscarriage treatment of habitual miscarriage,endogenous progesterone deficiency,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known or suspected progestogen dependent neoplasms,"migraines/headache, NO SPECIFIC DATA AVAILABLEusea, menstrual disorders"
dutasteride,in men with an enlarged prostate,dual inhibitor of 5-reductase,inhibit the in vitro metabolism,chronic cyp3a4 inhibitors,women who are pregNO SPECIFIC DATA AVAILABLEnt or may be pregNO SPECIFIC DATA AVAILABLEnt,testicle pain or swelling increased breast size breast tenderness
duloxetine hydrochloride,serotonin and norepinephrine reuptake inhibitor,selective serotonin and norepinephrine reuptake inhibitor,ciprofloxacin and enoxacin,quinolone antimicrobials,patients with substantial alcohol use or evidence of chronic liver disease,"NO SPECIFIC DATA AVAILABLEusea, dizziness, dry mouth, constipation"
dulaglutide,adults with type 2 diabetes mellitus,dulaglutide activates the glp-1 receptor,oral medications,oral medications,patients with a prior serious hypersensitivity reaction,"NO SPECIFIC DATA AVAILABLEusea, diarrhea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain, and decreased appetite"
drotaverine,uterine tetanus,inhibition of phosphodiesterase-iv,aNO SPECIFIC DATA AVAILABLElgesics,additive,patients with known hypersensitivity to the products and its constituents,"headache, dizziness, rhinitis, sinusitis"
drospirenone,oral contraception,antiandrogenic activity,"enzymes (for example, cyp3a4) may decrease the effectiveness",drugs or herbal products,undiagnosed abnormal uterine bleeding,hyperkalemia bleeding irregularities and amenorrhea
doxylamine succiNO SPECIFIC DATA AVAILABLEte,hypersensitivity reactions,antimuscarinic and pronounced sedative effects,enhance effects of cns depressants,alcohol,premature infants or full-term neoNO SPECIFIC DATA AVAILABLEtes,antimuscarinic effects
doxycycline hydrochloride,infections,primarily a bacteriostatic antibiotic,penicillin,penicillin,pregNO SPECIFIC DATA AVAILABLEnt women and to the lactating mothers,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, skin rashes"
doxorubicin hydrochloride,patients who have not previously received bortezomib,binding to dNO SPECIFIC DATA AVAILABLE and inhibition of nucleic acid synthesis,antibiotics,antibiotics,"cardiac disease, neoNO SPECIFIC DATA AVAILABLEtes, pregNO SPECIFIC DATA AVAILABLEncy and lactation","blurred vision, headache, seizures, paraesthesia"
doxophylline,bronchial asthma bronchospasm,selectively inhibits phosphodiesterase 4,together with other xanthine derivatives,xanthine derivatives,"patients with hypotension, in lactating women &amp","NO SPECIFIC DATA AVAILABLEusea, vomiting, headache, upset stomach and heartburn"
doxepin (topical),adult patients with atopic dermatitis,unknown,mao inhibitors,cream,individuals who have shown previous sensitivity to any of its components,antimuscarinic
doxepin (oral),3 months,unknown,alcohol,alcohol,maois or has used maois within the past two weeks,suicide
dorzolamide + timolol,beta blockers,intraocular pressure reduction,concurrent use,cyp2d6 inhibitors,patients who are hypersensitive,"mild burning, ocular hyperemia, blurred vision"
doripenem,only,binding to several penicillin-binding proteins,seizures,valproic acid,hypersensitivity,"thrombocytopenia, neutropenia"
dopamine hydrochloride,after open heart surgery,"can stimulate , and dopamine receptors",ergot alkaloids,ergot alkaloids,patients with known hypersensitivity to dopamine,elevated blood pressure
eptifibatide,patients with acute coroNO SPECIFIC DATA AVAILABLEry syndrome,reversibly inhibits platelet aggregation,potentially additive pharmacologic effects,gp iib/iiia,severe hypertension,allergic reactions and hypotension
epoetin beta,patients on dialysis,identical in its amino acid and carbohydrate composition,myelotoxicity,cytostatic mediciNO SPECIFIC DATA AVAILABLEl products,poorly controlled hypertension,"headaches, pain in the limbs, malaise and/or bone pain"
eplerenone,hypertension,blocks the binding of aldosterone,cyp3a4 inhibitors,hypotensive effect of 1-blockers,hyperkalaemia severe reNO SPECIFIC DATA AVAILABLEl impairment,"rash, itching, swelling, severe dizziness, trouble breathing"
epirubicin hydrochloride,patients with evidence of axillary node tumor involvement,generates cytotoxic free radicals,radiation,radiation,"uriNO SPECIFIC DATA AVAILABLEry infections, bladder inflammation or catheterisation problems",drops
epiNO SPECIFIC DATA AVAILABLEstine hydrochloride,allergic conditions,does not penetrate the blood-brain barrier,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who are hypersensitive,upper respiratory infections
ephedrine hydrochloride,little value in hypotensive crisis,action toward both alpha and beta receptors,volatile aNO SPECIFIC DATA AVAILABLEesthetics,volatile aNO SPECIFIC DATA AVAILABLEesthetics,coroNO SPECIFIC DATA AVAILABLEry thrombosis,"NO SPECIFIC DATA AVAILABLEusea, vomiting, anorexia"
eperisone hydrochloride,lumbago,centrally-acting skeletal muscle relaxant,methocarbamol,methocarbamol,patients with a history of hypersensitivity,"excessive relaxation, stomachache, NO SPECIFIC DATA AVAILABLEusea, vertigo"
epalrestat,diabetic peripheral neuropathy,may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms,drug interactions,drug,if you are pregNO SPECIFIC DATA AVAILABLEnt or breastfeeding,"abdomiNO SPECIFIC DATA AVAILABLEl pain, NO SPECIFIC DATA AVAILABLEusea, rash"
entecavir,adults and pediatric patients 2 years of age and older,inhibits all three activities of the hbv polymerase,adverse events,lamivudine or adefovir dipivoxil,patients with previously demonstrated hypersensitivity to entecavir,"headache, fatigue, dizziness and NO SPECIFIC DATA AVAILABLEusea"
entacapone,levodopa,inhibition of comt enzyme leading to an increased levodopa concentration,additive sedative effects with other cns depressants,additive sedative effects with other cns depressants,concomitant use w/ non-selective maois,increased liver enzymes
enoxaparin sodium,concurrently with aspirin,primarily metabolised in the liver.,agents which affect hemostasis,strictly indicated,patients with active major bleeding,spiNO SPECIFIC DATA AVAILABLEl/epidural anesthesia
encephalitis vaccine,"adults, adolescents, children and infants aged 2 months and older",not well understood,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,persons with acute severe febrile conditions,"NO SPECIFIC DATA AVAILABLEusea, influenza like illness, fever, other injection site reactions"
eNO SPECIFIC DATA AVAILABLElapril maleate,all grades of essential hypertension and renovascular hypertension,inhibits angiotensin converting enzyme (ace),supervision,concomitant propranolol,peripheral vascular disease or generalized atherosclerosis,less than 2% of patients
empagliflozin + metformin hydrochloride,separate tablets,antihyperglycemic drug,hypoglycemia,alcohol,"lactic acidosis, diabetic ketoacidosis",metformin (&gt
empagliflozin + liNO SPECIFIC DATA AVAILABLEgliptin,liNO SPECIFIC DATA AVAILABLEgliptin,liNO SPECIFIC DATA AVAILABLEgliptin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,uriNO SPECIFIC DATA AVAILABLEry tract infection
empagliflozin,adults with type 2 diabetes mellitus,sodium glucose co-transporter-2 (sglt-2) inhibitor,risk for hypoglycemia,insulin or insulin secretagogues,"severe reNO SPECIFIC DATA AVAILABLEl impairment, end-stage reNO SPECIFIC DATA AVAILABLEl disease, or dialysis","dehydration, hypotension"
emollient [cepalin+allantoin],relief of dry skin,softens and hydrates skin. it is also a mild cleanser,drug interactions,drug,acne or greasy skin,skin irritation
eluxadoline,adults,delta opioid receptor antagonist,oral contraceptive,oral contraceptive,pancreatitis,"constipation, NO SPECIFIC DATA AVAILABLEusea and abdomiNO SPECIFIC DATA AVAILABLEl pain"
eltrombopag olamine,chronic immune (idiopathic) thrombocytopenia,uncovered mechanism of action,polyvalent cations,calcium-rich foods,no contraindications,"NO SPECIFIC DATA AVAILABLEusea, diarrhea, upper respiratory tract infection, vomiting, increased alt"
elagolix,moderate to severe pain associated with endometriosis,gnrh) receptor antagonist,estrogen-containing contraceptives,estrogen,women: who are pregNO SPECIFIC DATA AVAILABLEnt,"headache, NO SPECIFIC DATA AVAILABLEusea, insomnia, amenorrhea"
estriol (oral),tablet,rapidly and almost completely absorbed from the gastrointestiNO SPECIFIC DATA AVAILABLEl tract,activated charcoal,activated charcoal,pregNO SPECIFIC DATA AVAILABLEncy,"breast enlargement, vagiNO SPECIFIC DATA AVAILABLEl candidiasis, change in vagiNO SPECIFIC DATA AVAILABLEl"
estradiol valerate,ovulation induction intrauterine insemiNO SPECIFIC DATA AVAILABLEtion in vitro fertilization,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,anticonvulsants,.
estradiol,advancing age,NO SPECIFIC DATA AVAILABLE,glucose tolerance,sex steroids,"otosclerosis with deterioration during pregNO SPECIFIC DATA AVAILABLEncy, severe diabetes with vascular changes",NO SPECIFIC DATA AVAILABLE
esomeprazole + amoxicillin + clarithromycin,"active chronic gastric, duodeNO SPECIFIC DATA AVAILABLEl and gastric ulcers",inhibition of cell wall biosynthesis,interactions,terfeNO SPECIFIC DATA AVAILABLEdine,patients with known hypersensitivity,diarrhoea and NO SPECIFIC DATA AVAILABLEusea
esomeprazole (mups tablet),gastro-esophageal reflux disease,single optical isomer,gastric acid secretion,"diazepam, phenytoin, or quinidine",patient with known hypersensitivity,"headache, diarrhoea, NO SPECIFIC DATA AVAILABLEusea, flatulence, abdomiNO SPECIFIC DATA AVAILABLEl pain"
esmolol hydrochloride,short-term treatment,no significant intrinsic sympathomimetic or membrane stabilizing activity,avoid concomitant use,substances,pulmoNO SPECIFIC DATA AVAILABLEry hypertension,adverse reactions
esomeprazole,duodeNO SPECIFIC DATA AVAILABLEl ulcer disease,proton pump inhibitor,gastric acid secretion,oral contraceptives,hypersensitivity,"headache, diarrhoea, NO SPECIFIC DATA AVAILABLEusea, flatulence"
eslicarbazepine acetate,partial seizure,blocking voltage-gated sodium channels,contraception,phenytoin,hypersensitivity,adverse reactions
escitalopram oxalate,treatment of major depressive episodes,selective serotonin reuptake inhibitor,ssri or related antidepressants,fluoxetine,patients with known hypersensitivity,ssris
erythropoietin alfa,in patients on dialysis and not on dialysis,NO SPECIFIC DATA AVAILABLE,significant drug interactions,haematinic agent such as ferrous sulphate,patients who develop pure red cell aplasia,adverse reactions
erythropoietin,including patients on dialysis and patients not on dialysis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,uncontrolled hypertension,palpitations
erythromycin (lotion),bacterial skin infections susceptible to erythromycin.,unknown,clindamycin,clindamycin,hypersensitivity,"erythema, desquamation, burning sensation, eye irritation"
erythromycin (oral),clinical infections,500 mg. of the base of stearate,toxicity,theophylline,known hypersensitivity,"abdomiNO SPECIFIC DATA AVAILABLEl discomfort after oral administration, sometimes with NO SPECIFIC DATA AVAILABLEusea and vomiting"
ertugliflozin,adults with type 2 diabetes mellitus,an inhibitor of sglt2,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients on dialysis,insulin secretagogues
ertapenem,adult patients and pediatric patients,ertapenem binding to penicillin binding proteins,reNO SPECIFIC DATA AVAILABLEl excretion,valproic acid/divalproex sodium,patients with a known hypersensitivity to local anesthetics,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, headache and infused vein complication"
erlotinib,mainteNO SPECIFIC DATA AVAILABLEnce,NO SPECIFIC DATA AVAILABLE,dose modifications,gastric ph,NO SPECIFIC DATA AVAILABLE,the most common adverse reactions
eribulin mesylate,two,tubulin-based antimitotic mechanism,no drug-drug interactions,without ketocoNO SPECIFIC DATA AVAILABLEzole,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, and constipation"
ergotamine tartrate + caffeine,vascular headache,cranial vasoconstrictor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,sepsis,extrapyramidal effects
ergometrine maleate,"excessive uterine bleeding,postpartum and post-abortion bleeding",contraction of the uterine muscle,halothane,halothane,"preeclampsia, eclampsia or threatened spontaneous abortion","NO SPECIFIC DATA AVAILABLEusea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain, diarrhoea"
erdosteine,improves the symptoms associated with short episodes of chronic bronchitis,reducing the viscosity of mucus and purulent sputum,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"25 ml/min, or with severe liver failure","headache, cold, taste alterations, NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea"
ethyl butylacetylaminopropioNO SPECIFIC DATA AVAILABLEte,over 30 years,no killing action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
etodolac,acute and long-term,inhibition of the enzyme cycooxygeNO SPECIFIC DATA AVAILABLEse,increased adverse effects,aspirin,"patients who have experienced asthma, urticaria or other allergic type reactions","abdomiNO SPECIFIC DATA AVAILABLEl pain, constipation, diarrhea"
ethyl alcohol + hydrogen peroxide + glycerol,pre-operative surgical hand disinfection,glycerol,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
ethosuximide,indicated for the control of absence (petit mal)epilepsy,suppresses the paroxysmal three cycle per second spike and wave activity,"antipsychotics, antidepressants",isoniazid,pregNO SPECIFIC DATA AVAILABLEncy and lactation,"increased libido, myopia, vag bleeding"
ethinyl estradiol + lynestrenol (0.05 mg),,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,", - , ; ; - - , -",","
ethinyl estradiol + lynestrenol (0.0375 mg),,NO SPECIFIC DATA AVAILABLE,",",",",-,","
ethinyl estradiol + levonorgestrel + ferrous fumarate,except smoker and who use tobacco regularly,cervical mucus changes that inhibit sperm penetration,caffeine,"caffeine, dairy foods, phytic acid",hypersensitivity,"headache, NO SPECIFIC DATA AVAILABLEusea, mood changes"
ethinyl estradiol + gestodene,this pill is indicated for the prevention of pregNO SPECIFIC DATA AVAILABLEncy,progesterone,non hormoNO SPECIFIC DATA AVAILABLEl back-up method of contraception,amp,NO SPECIFIC DATA AVAILABLE,2-3 months
ethinyl estradiol + drospirenone + levomefolate,premenstrual dysphoric disorder,NO SPECIFIC DATA AVAILABLE,contraception,drugs or herbal products,liver tumors or liver disease pregNO SPECIFIC DATA AVAILABLEncy,contraception
ethinyl estradiol + drospirenone (hrt),hormone replacement therapy,synthetic progestogen,ne,alcohol,endometrial cancer,breast pain
ethinyl estradiol + drospirenone (24 tablet),moderate acne vulgaris,inhibit ovulation by suppressing goNO SPECIFIC DATA AVAILABLEdotropin release,non hormoNO SPECIFIC DATA AVAILABLEl back-up method of contraception,non hormoNO SPECIFIC DATA AVAILABLEl back-up method of contraception,known or suspected pregNO SPECIFIC DATA AVAILABLEncy if you have heart disease,oral contraceptive
ethinyl estradiol + drospirenone (21 tablet),oral contraception,antimineralocorticoid and antiandrogenic properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,if any of the conditions appear for the first time during their use,contraceptives some undesirable effects may have seen with this tablet
ethinyl estradiol + desogestrel + ferrous fumarate,contraception,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
ethinyl estradiol + desogestrel (0.03 mg),oral contraceptives are a very effective method of birth control,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,do not use the combined pill if you have any of the conditions listed below,"breast tenderness, pain and secretion"
ethinyl estradiol + desogestrel (0.02 mg),if used correctly it does not interrupt sex,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergy,"NO SPECIFIC DATA AVAILABLEusea, vomiting"
ethanol + isopropyl alcohol,rubbing alcohol,disinfectant properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
ethambutol,at least one other antituberculous drug,it is active against susceptible bacteria only when they are undergoing cell division,aluminium hydroxide,aluminium hydroxide,patients who are known to be hypersensitive,"retiNO SPECIFIC DATA AVAILABLEl haemorrhage, hypersensitivity reactions"
etanercept,moderately to severely active rheumatoid arthritis,tumor necrosis factor (tnf) blocker,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with serious active infections,allergic reactions
eszopiclone,first sedative approved long-term use,allosterically coupled to benzodiazepine receptors,alcohol (which causes sedation) and drugs that have sedating effects,alcohol,having thoughts of suicide,few side effects
estriol (vagiNO SPECIFIC DATA AVAILABLEl),at least 12 months since their last NO SPECIFIC DATA AVAILABLEtural period,slowly released and absorbed into the surrounding area and into the bloodstream,irregular bleeding,st john's wort,vagiNO SPECIFIC DATA AVAILABLEl cancer,cream
ferrous ascorbate + folic acid + zinc sulfate,prophylaxis,three nutritioNO SPECIFIC DATA AVAILABLEl supplements,antibiotics,meals,patients with haemolytic aNO SPECIFIC DATA AVAILABLEemia,mild and transient
ferrous ascorbate,iron deficiency anemia,iron replenishes the iron stores in your body,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"hemosiderosis, hemochromatosis",slightly increased
ferric pyrophosphate citrate,adult patients with hemodialysis-dependent chronic kidney disease,NO SPECIFIC DATA AVAILABLE,drug interaction studies,drug,NO SPECIFIC DATA AVAILABLE,"headache, peripheral edema, asthenia"
ferric derisomaltose,adult patients,releases iron,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of serious hypersensitivity,rash and NO SPECIFIC DATA AVAILABLEusea
ferric citrate,not on dialysis,by binding phosphate in the gi tract and decreasing absorption,blood levels of the concomitant medication,monitoring clinical responses or blood levels of the concomitant medication,patients with iron overload syndromes,discolored feces
ferric carboxymaltose,ofiron deficiency anemiain adult patients,a carbohydrate polymer that releases iron,drug,drug,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, hypertension, flushing, decreased blood phosphorus"
fenticoNO SPECIFIC DATA AVAILABLEzole nitrate [vagiNO SPECIFIC DATA AVAILABLEl tablet],genital candidiasis,inhibiting the biosynthesis of ergosterol,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,no systemic effects should occur
fenticoNO SPECIFIC DATA AVAILABLEzole nitrate [vagiNO SPECIFIC DATA AVAILABLEl cream],vulvovagiNO SPECIFIC DATA AVAILABLEl candidiasis,antibacterial action,interactions with other drugs,systemic absorption of fenticoNO SPECIFIC DATA AVAILABLEzole,hypersensitivity,"slight transient burning may occasioNO SPECIFIC DATA AVAILABLElly occur, which usually disappears rapidly."
fentanyl citrate,week or longer,aNO SPECIFIC DATA AVAILABLElgesia and sedation,adverse drug effects,grapefruit juice,patients with known intolerance or hypersensitivity,respiratory depression
fenofibrate,hyperlipidemias,rapidly hydrolyzed after oral ingestion,hmg-coa reductase inhibitors,hmg-coa reductase inhibitors,patients with hypersensitivity to fenofibrate,"headache, dizziness, vertigo, fatigue, hair loss"
febuxostat,patients with gout,"non-purine, selective xanthine oxidase",toxicity,"azathioprine, mercaptopurine or theophylline",patients being treated,"liver function abnormalities, NO SPECIFIC DATA AVAILABLEusea, arthralgia, and rash"
favipiravir,cases in which other influenza antiviral drugs are ineffective or not sufficiently effective,different from that of the existing influenza antiviral drugs,toxicity,humans,pregNO SPECIFIC DATA AVAILABLEnt women and women who may possibly be pregNO SPECIFIC DATA AVAILABLEnt,diarrhea and increase of blood uric acid levels
famotidine,zollinger-ellison syndrome,completely inhibits the action of histamine on h2- receptors,clinically important drug interactions,cytochrome p450-linked drug,known hypersensitivity,rarely occur
famciclovir,hiv-infected patients,biotransformation,active metabolite,raloxifen,hypersensitivity to famciclovir and penciclovir,"abnormal leukocyte counts, purpura, angioedema"
ezetimibe,homozygous familial hypercholesterolaemia,inhibits absorption of cholesterol,fibrates,fibrates,patients with active liver disease,alone or with an hmg-coa reductase inhibitor
everolimus,"advanced hormone receptor-positive, her2-negative breast cancer",proliferation sigNO SPECIFIC DATA AVAILABLEl inhibitor,vaccines,grapefruit juice &amp; live vaccines,with or without respiratory impairment,"stomatitis, constipation"
eucalyptol+ menthol + thymol,amp; thymol mouthwash,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,diminish the effects of the mouthwash
eucalyptol + menthol + methyl salicylate + thymol + sodium fluoride,dental cavities,local anesthetic action,drug interactions,drug,hypersensitivity,"local irritation of mouth, NO SPECIFIC DATA AVAILABLEusea &amp; vomiting"
etoricoxib,acute gouty arthritis,"specific inhibitor within, and significantly above, the clinical dose range",meals,take without regards to meals,allergic-type reactions,"influenza-like symptoms, ecchymosis"
etoposide,"testicular cancer,small cell lung cancer",inhibits dNO SPECIFIC DATA AVAILABLE synthesis resulting in the arrest of the cell cycle,drugs that inhibit phosphatase activity,cyclosporin a,"hypersensitivity, pregNO SPECIFIC DATA AVAILABLEncy, lactation","leukopenia, NO SPECIFIC DATA AVAILABLEusea and vomiting"
fluocinolone acetonide,eczema and dermatitis,hydrocortisone derivative,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,primary infections,"rare, but as with all topical corticosteroids"
fluNO SPECIFIC DATA AVAILABLErizine,prophylaxis,selective calcium channel antagonist,metabolism,hepatic enzyme inducers,patients with a history of depressive illness,depression
fludrocortisone acetate,primary and secondary adrenocortical insufficiency,raisesextracellular fluid volume and blood pressure and lowers potassium levels,oral contraceptives and ketocoNO SPECIFIC DATA AVAILABLEzole,oral,"systemic fungal infection, hypersensitivity",unwanted effects
fludarabine phosphate,previously untreated or non-refractorypatients,inhibitingdNO SPECIFIC DATA AVAILABLE polymerasealpha,adenosine uptake inhibitors,cytarabine,pregNO SPECIFIC DATA AVAILABLEncy and lactation. concomitant use of live vaccines,progressive encephalopathy and blindness (high doses).
flucoNO SPECIFIC DATA AVAILABLEzole (ophthalmic),fungal corneal ulcers/ keratitis.,fungistatic,alter pharmacokinetics of certain drugs undergoing hepatic metabolism,hepatic metabolism,patients with hypersensitivity to azoles,eosinophillia
flucoNO SPECIFIC DATA AVAILABLEzole,"vagiNO SPECIFIC DATA AVAILABLEl candidiasis, oropharyngeal &amp;",potent inhibitor of fungal cytochrome p-450 dependent enzymes,rifampicin level,amp,patients with known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain"
flucloxacillin sodium,during major surgical procedures,inhibiting the formation of cell wall of bacteria,increased level of flucloxacillin in blood,blood,penicillin hypersensitive patients,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, dyspepsia"
flibanserin,premenopausal women,5-ht1a and 5-ht2a receptors,cyp3a4 inducers,cyp3a4 inducers,patients with hepatic impairment,"NO SPECIFIC DATA AVAILABLEusea, fatigue, insomnia, dry mouth"
flavoxate hydrochloride,cystitis,anticholinergic-parasympatholytic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pyloric or duodeNO SPECIFIC DATA AVAILABLEl obstruction,"increased ocular tension, blurred vision, disturbance in eye accommodation"
finerenone,adult patients,"nonsteroidal, selective antagonist of the mineralocorticoid receptor",strong or moderate cyp3a4 inducers,grapefruit or grapefruit juice,with adreNO SPECIFIC DATA AVAILABLEl insufficiency,hyperkalemia
fiNO SPECIFIC DATA AVAILABLEsteride [for b.p.h.],treatment and control of benign prostatic hyperplasia,competitive inhibitor of the 5 reductase enzyme,clinically important drug interactions,cytochrome p450 linked drug,women and paediatric patient,"impotence (3.7%), decreased libido"
fiNO SPECIFIC DATA AVAILABLEsteride [for androgenic alopecia],only,no androgenic or antiandrogenic effects,drug interactions,drug,women and paediatric patient,"decreased libido (1.8%), erectile dysfunction"
filgrastim,cancer patients receiving myelosuppressive chemotherapy,glycoprotein,drugs which may potentiate the release of neutrophils,lithium should be used with caution,hypersensitive,"transient decrease in blood glucose, raised uric acid"
fexofeNO SPECIFIC DATA AVAILABLEdine hydrochloride,adults and children,selective peripheral h1-receptor antagonist activity,aluminium and magnesium hydroxide containing antacid reduces the absorption,erythromycin or ketocoNO SPECIFIC DATA AVAILABLEzole,patients with known hypersensitivity,"headache, fatigue, drowsiness, NO SPECIFIC DATA AVAILABLEusea"
ferrous sulfate + folic acid + zinc sulfate,zinc deficiency especially during pregNO SPECIFIC DATA AVAILABLEncy and lactation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,those with iron overload,zinc may also produce a gastrointestiNO SPECIFIC DATA AVAILABLEl upset
ferrous sulfate + folic acid,iron,folic acid is an important factor in cell division,magnesium,magnesium trisilicate-containing antacid,patients receiving repeated blood transfusions or in patients with aNO SPECIFIC DATA AVAILABLEemias,NO SPECIFIC DATA AVAILABLEusea and epigastric pain
ferrous sulfate,routine administration of iron is necessary,NO SPECIFIC DATA AVAILABLE,antacids,tea,haemachromatosis and haemosiderosis,side effects can be reduced by taking it with or immediately after food
ferrous glucoNO SPECIFIC DATA AVAILABLEte,iron-deficiency anemia,it also allows transportation of oxygen via haemoglobin,"absorption of levodopa, methyldopa and penicillamine",quinolones or tetracyclines,"haemochromatosis, haemolytic anemia",gi symptoms
ferrous fumarate + folic acid,concomitant folic acid deficiency in adults,arresting the aNO SPECIFIC DATA AVAILABLEemia process,absorption of both drugs are reduced,tetracycline,magnesium trisillicate and antacid containing carboNO SPECIFIC DATA AVAILABLEte,"gastric distress, abdomiNO SPECIFIC DATA AVAILABLEl cramps, diarrhoea, allergic reaction"
ferrous fumarate,prevent or treat iron deficiency aNO SPECIFIC DATA AVAILABLEemia,prevention and treatment of iron deficiency,reduce the absorption of ferrous fumarate from the gi tract,gi tract,hemochroma,diarrhoea or constipation
fluticasone propioNO SPECIFIC DATA AVAILABLEte (NO SPECIFIC DATA AVAILABLEsal spray),NO SPECIFIC DATA AVAILABLEsal mucosa without detectable systemic activity,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a hypersensitivity to any of its ingredients,fewer side effects
fluticasone propioNO SPECIFIC DATA AVAILABLEte (inhaler),patients aged 4 years and older,anti-inflammatory activity,systemic corticosteroid adverse effects,not recommended,primary treatment of status asthmaticus or other acute episodes of asthma,headache
fluticasone furoate,once-daily,wide range of actions on multiple cell types,coadministration of ritoNO SPECIFIC DATA AVAILABLEvir,coadministration of ritoNO SPECIFIC DATA AVAILABLEvir,patients with a hypersensitivity to any of its ingredients,fewer side effects are seen
flutamide,in combiNO SPECIFIC DATA AVAILABLEtion with lhrh agonists,by blocking androgen uptake,increased prothrombin time,warfarin,"hypersensitivity, severe hepatic impairment, pregNO SPECIFIC DATA AVAILABLEncy and lactation","NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea"
flurbiprofen,individual patient treatment goals,potent inhibitor of platelet aggregation,reduced antihypertensive effect of ace inhibitors,"glyburide, metformin","asthma, urticaria, or allergic-type reactions",rash
flurazepam,acute or chronic medical situations requiring restful sleep,binds to an allosteric site on gaba-a receptors,cns depressants,alcohol,patients with known hypersensitivity to benzodiazepines,"severe sedation, lethargy, disorientation and coma"
flupheNO SPECIFIC DATA AVAILABLEzine decanoate,long-term maNO SPECIFIC DATA AVAILABLEgement,dopaminergic d1 and d2 receptors,lithium toxicity,alcohol,patients with hypersensitivity to the drug,"tardive dyskinesia, sedation, mental confusion"
flupheNO SPECIFIC DATA AVAILABLEzine + nortriptyline,mild to moderate,piperazine side chain,central depressants,alcohol,younger children,agranulocytosis
flupentixol + melitracen,anxiety depression,not seem to influence the pharmacokinetic properties of the individual compounds,mao-inhibitors may cause hypertensive crises,tablet,excitable or overactive patients,rare
flupentixol,"psychoses,depression with or without anxiety",blocking postsyNO SPECIFIC DATA AVAILABLEptic dopamine receptors,dopamine,tcas. reduced efficacy of levodopa,mania; porphyria; coma; preexisting cns depression,potentially fatal: neuroleptic maligNO SPECIFIC DATA AVAILABLEnt syndrome
fluoxetine hydrochloride,fluoxetine,selectively inhibit the reuptake of serotonin,cns active drugs,cns active drugs,patients known to be hypersensitive to it,"excessive sweating, pruritus, skin rashes"
fluorouracil,alone or in combiNO SPECIFIC DATA AVAILABLEtion,inhibiting the enzyme thymidylate kiNO SPECIFIC DATA AVAILABLEse,reduced hepatic blood flow,intravenous,pregNO SPECIFIC DATA AVAILABLEnt or breastfeeding women,elopathy
fluorometholone acetate,acute and chronic non-infectious conjunctivitis,immunosuppressive,drug,drug,infections,suppression of host immunity
fluorometholone + tetrahydrozoline,post-operative conditions,tetrahydrozoline is an alpha agonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,infectious conjunctivitis or keratitis,systemic effects
fluorometholone + gentamicin,postoperative infection,anti-inflammatory effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,viral infections,delay wound healing
fluormetholone + neomycin sulphate,before and after surgery,ocular corticosteroids,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,if you are hypersensitive,increased eye pressure
fluorescein sodium,diagnostic examiNO SPECIFIC DATA AVAILABLEtions,responds to electromagnetic radiation and light between the wavelengths of 465- 490 nm,none known,none known,acute necrotising pancreatitis,"staining of the skin, clothing and soft contact lenses"
fluocinolone acetonide + neomycin sulfate,eczema and dermatitis,neomycin sulfate actively transported across the bacterial cell membrane,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,primary infections,topical corticosteroids
fluocinolone acetonide + hydroquinone + tretinoin,use a sunscreen,unknown,medications with photosensitizing effects,alcohol,"hypersensitivity, allergy or intolerance","mild to moderate redness, peeling, burning, dryness or itching"
fluocinolone acetonide + clioquinol,inflammatory skin conditions,antifungal and antibacterial actions,mixing on the skin,mixing on the skin,children under one year of age,skin irritation
fusidic acid (ophthalmic),superficial bacterial infections,prolonged contact with the conjunctival sac,antistaphylococcal penicillin,antistaphylococcal penicillin,patients who are hypersensitive to any component of this preparation,very few adverse effects
furosemide + spironolactone,in- essential hypertension,complementary,indomethacin,sucralfate,hypersensitive,"ataxia, mental confusion, and skin rashes"
furosemide,fluid retention associated with chronic congestive cardiac failure,acid-base balance changes,toxic effects of nephrotoxic antibiotics,toxic effects of nephrotoxic antibiotics,"anuria, electrolyte deficiency and pre-comatose states",hyperglycemia and glycosuria
fucidic acid + betamethasone,eczematous dermatoses,fusidic acid is a potent topical antibacterial agent,increased hyperglycaemia,thiazide diuretics,"tb or syphilis, perioral dermatitis and rosacea",rarely
fructose,may be used in diabetic patients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,methyl alcohol poisoning,"facial flushing, abdomiNO SPECIFIC DATA AVAILABLEl pain and sweating"
fosfomycin trometamol,only for the treatment of uncomplicated uriNO SPECIFIC DATA AVAILABLEry tract infections,iNO SPECIFIC DATA AVAILABLEctivation of the enzyme enolpyruvyl transferase,lowers the serum concentration,metoclopramide,patients with known hypersensitivity,"sgpt increased, skin disorder, somnolence, and vomiting"
formoterol fumarate + glycopyrrolate + budesonide,asthma,inhaled long-acting beta2-adrenergic agonist,anticholinergics,anticholinergics,patients who have demonstrated hypersensitivity,asthma
formoterol fumarate,may be clinically indicated in patients who do not have persistent asthma,inhibitor of the release ofmast cellmediators,beta-adrenergic blockers,beta-adrenergic blockers,hypersensitivity,"viral infection, bronchitis, chest infection"
fondaparinux sodium,conjunction with warfarin sodium,selective inhibitor of activated factor x,increased risk of bleeding,lmwh,"clinically significant bleeding, acute bacterial endocarditis",treatment of venous thromboembolism
follitropin beta,anovulatory infertile patients,it stimulates ovarian follicular growth,drug-drug interaction studies,drug-drug,uncontrolled thyroid or adreNO SPECIFIC DATA AVAILABLEl dysfunction,mild systemic allergic reactions
follitropin alfa + lutropin alfa,injection,recombiNO SPECIFIC DATA AVAILABLEnt dNO SPECIFIC DATA AVAILABLE technology,active substances,mixture with other mediciNO SPECIFIC DATA AVAILABLEl products,hypersensitivity to the active substances,NO SPECIFIC DATA AVAILABLE
follitropin alfa,theanovulatoryinfertilepatient,it stimulates ovarian follicular growth,ovarian response,gnrh agonist-induced pituitary desensitisation,"pregNO SPECIFIC DATA AVAILABLEncy, lactation",mild systemic allergic reactions
follicle stimulating hormone [urofollitropin],hcg,in vivo biological activity,drug/drug interaction studies,drug/drug,pregNO SPECIFIC DATA AVAILABLEncy or lactation,"headache, vagiNO SPECIFIC DATA AVAILABLEl bleeding, NO SPECIFIC DATA AVAILABLEusea, and hot flashes"
folic acid + zinc sulfate monohydrate,tablet,amp,drug interactions,calcium,untreated cobalamine deficiency,zinc
folic acid,"pregNO SPECIFIC DATA AVAILABLEncy, infancy, or childhood",receptor-mediated endocytosis,none has been reported,none has been reported,patients who have shown previous intolerance to the drug,gastro-intestiNO SPECIFIC DATA AVAILABLEl disturbances may occur
fluvoxamine maleate,maprotiline hydrochloride,not been fully determined,cytochrome p450 isoenzymes,tricyclic antidepressants,linezolid or intravenous methylene blue,"decreased libido, dry mouth, rhinitis"
fluvastatin,lipid-altering agents,competitively inhibiting hmg-coa reductase,hiv protease inhibitors,niacin (nicotinic acid,pregNO SPECIFIC DATA AVAILABLEncy and lactation,increased blood creatinine phosphokiNO SPECIFIC DATA AVAILABLEse
fluticasone propioNO SPECIFIC DATA AVAILABLEte + formoterol fumarate,adults only,formoterol fumarate dihydrate,co-administration with such drugs,co-administration of strong cyp 3a4 inhibitors,asymptomatic,undesirable effects
fluticasone propioNO SPECIFIC DATA AVAILABLEte (topical),corticosteroid responsive eczema/dermatitis,anti-inflammatorypotency,no information is available,no information is available,"rosacea, acne vulgaris, perioral dermatitis",local burning and pruritus
fluticasone propioNO SPECIFIC DATA AVAILABLEte (nebuliser suspension),high dose inhaled or oral corticosteroid therapy,unknown,drug interactions,drug,patients with a history of hypersensitivity to any component of the preparation,"cataract, glaucoma"
glibenclamide,ineffective in completely pancreatectomized patients,it stimulates the mobilization of endogenous insulin,hypoglycemic effect,alcohol,pregNO SPECIFIC DATA AVAILABLEncy,"NO SPECIFIC DATA AVAILABLEusea, vomiting, epigastric pain"
glecaprevir + pibrentasvir,not both,inhibits the assembly of proteins and production of mature hcv particles,coadministration of carbamazepine,st. johns wort,patients with severe hepatic impairment,headache and fatigue
gentian violet,topical antiseptic,free-radical mechanism,drug,drug,ulcerative lesion,"redness, irritation, swelling or pain"
gentamicin sulfate (topical),minor surgical wounds,bactericidal antibiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy and myasthenia gravis,irritation
gentamicin sulfate (ophthalmic),mastoidectomy or tympanoplasty,eye drops,eye/ear drops,eye/ear drops,individuals with a history of sensitivity reaction to any of its components,eye/ear drop
gentamicin sulfate (injection),"septicaemia, meningitis, respiratory tract infections",cell death results,potentially nephrotoxic or ototoxic drug substances,potent diuretics,NO SPECIFIC DATA AVAILABLE,adverse reNO SPECIFIC DATA AVAILABLEl effects
gentamicin + hydrocortisone acetate,surgery to infected mastoid cavities,corticosteroid,hyperglycaemia and hypokalaemia,ethanol,pregNO SPECIFIC DATA AVAILABLEncy; hepatic impairment,allergic
gemifloxacin,acute bacterial exacerbation of chronic bronchitis,inhibiting dNO SPECIFIC DATA AVAILABLE synthesis,aluminium or magnesium containing antacids and iron salts,sucralfate administration,children under 18 years of age,fungal overgrowth in body
gemfibrozil,hyperlipoproteinemia,anti-lipemic agent,risks,lovastatin,"alcoholism, hepatic impairment, gallstone, and pregNO SPECIFIC DATA AVAILABLEncy","pruritus, rash, headache, dizziness, blurred vision"
gemcitabine,previously treated with 5-fu,inhibiting dNO SPECIFIC DATA AVAILABLE polymerase and ribonucleotide reductase,anticoagulant effect of warfarin,warfarin,"pregNO SPECIFIC DATA AVAILABLEncy, lactation; hypersensitivity",mild gi effects
gefitinib,limitation of use: safety and efficacy,atp)-binding site of the enzyme,cyp3a4 inducers,cyp3a4 inducers,hypersensitivity. lactation,elevations in blood creatinine
gatifloxacin + dexamethasone,sterile eye drops,inhibits bacterial dNO SPECIFIC DATA AVAILABLE gyrase and topoisomerase iv,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals hypersensitive,"mild burning, chemosis, redness may occur."
gatifloxacin (oral),infections,inhibition of both dNO SPECIFIC DATA AVAILABLE gyrase,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity of gatifloxacin,mild
gatifloxacin (ophthalmic),bacterial conjunctivitis,fluoroquinolones,specific drug interaction studies,eye drops,hypersensitivity to gatifloxacin,conjunctival irritation
ganciclovir (ophthalmic),acute herpetic keratitis,phosphorylation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"blurred vision (60%), eye irritation"
gadoversetamide,intravenous,paramagnetic agent,contrast agents,contrast agents,prior hypersensitivity reactions,NO SPECIFIC DATA AVAILABLEusea and paresthesia
gadodiamide,mri,does not cross the intact blood-brain barrier,drug,drug,"chronic, severe kidney disease","nephrogenic systemic fibrosis, hypersensitivity reactions"
gabapentin,partial seizure and secondary generalized seizure,activity of parent compound,oral contraceptive preparations,oral contraceptive preparations,patients who have known hypersensitivity to the drug,"fatigue, dizziness, ataxia, weight gain, peripheral edema"
fusidic acid + hydrocortisone,seborrhoeic dermatitis,anti-inflammatory &amp; anti-pruritic effects,hazardous drug interactions,hydrocortisone acetate,patients with hypersensitivity,generally local
fusidic acid + betamethasone,eczema and dermatitis with secondary infections,inhibition of bacterial protein synthesis,corticosteroids,skin-applied) medications,viral tuberculosis and fungal skin infections,allergic reactions
glycopyrronium bromide (oral solution),3 to 16 years,competitive inhibitor of acetylcholine receptors,dose reduction,digoxin tablets,patients with medical conditions that preclude anticholinergic therapy,"increased viscosity of bronchial secretion, NO SPECIFIC DATA AVAILABLEsal congestion"
glycopyrronium bromide (injection),anesthesia,quaterNO SPECIFIC DATA AVAILABLEry ammonium antimuscarinic with peripheral effects,failure to dissolve under the tongue owing to dry mouth,tricyclic antidepressants,NO SPECIFIC DATA AVAILABLE,rarely
glycopyrronium bromide (inhalation capsule),mainteNO SPECIFIC DATA AVAILABLEnce bronchodilator,inhibition of m3-receptors at the smooth muscle results in relaxation,without clinical evidence of drug interactions,inhaled steroids,hypersensitivity,"dehydration, dry mouth, constipation"
glycine,irrigating fluid of choice,amino acid and a non-electrolyte,do not store,"additives, use aseptic technique, mix thoroughly and do not store",patients with anuria,electrolyte loss
glycerol + liquid sugar,glycerol &amp; liquid sugar,osmosis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity or intolerance,allergic to the ingredients
glycerol + hypromellose + polyethylene glycol 400,keratoconjunctivitis sicca,greater muco-adhesive properties,an interval of at least 5 minutes between each application,medicines,patients with known hypersensitivity to any ingredient of the product,blurred vision after application
glycerol,latex condoms,NO SPECIFIC DATA AVAILABLE,drug,drug,persons with a known hypersensitivity,no common side effects have been reported
glycerin + hypromellose + polyethylene glycol + tetrahydrozoline + zinc sulfate,temporary relief of burning and irritation due to exposure to wind or sun,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,stop use and ask a doctor if you feel eye pain,"temporary stinging or burning; redness, itching and watering of the eye"
glycerin,occasioNO SPECIFIC DATA AVAILABLEl constipation,hyperosmotic laxative,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,constipated,rectal discomfort or a burning sensation
glucose 19% + vamin 18 novum + intralipid 20%,parenteral nutrition,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contra-indications to infusion therapy,transient increases in liver enzymes during intravenous nutrition
glucose 11% + vamin 18 novum + intralipid 20%,parenteral nutrition,NO SPECIFIC DATA AVAILABLE,soybean oil,soybean oil,contra-indications to infusion therapy,transient increases in liver enzymes during intravenous nutrition
glucosamine sulfate + diacerein,osteoarthritis rheumatoid arthritis,"aNO SPECIFIC DATA AVAILABLElgesic, antipyretic and anti-inflammatory activity",decrease absorption,aluminium,hypersensitivity,no serious adverse effect has been reported
glucosamine sulfate + chondroitin + camphor + peppermint oil,topically,chemically manufactured from turpentine oil,not known to interact significantly with other medicines,this medicine,NO SPECIFIC DATA AVAILABLE,there are no known systemic side effects
glucosamine sulfate + chondroitin,dietary supplement,synergistic effect,antibiotics,nitrates,allergic to shellfish or sulfur,amp
glucosamine hydrochloride,dietary supplement,prodrug for glucosamine,antibiotics,nitrates,proven hypersensitivity,rarely occurring side effects
glipizide + metformin hydrochloride,amp; metformin,sulfonylurea,alcohol,alcohol,"pregNO SPECIFIC DATA AVAILABLEncy, breast-feeding",amp; metformin
glipizide,certain patients who are receiving insulin,dependent upon functioning beta cells,hypoglycaemia,protein bound,patients who are hypersensitive,"dose related, transient, and responded to dose reduction or withdrawal of the medication"
glimepiride + metformin,replacement,metformin hydrochloride,alcohol and alcohol-containing medications iodiNO SPECIFIC DATA AVAILABLEted contrast agents,alcohol and alcohol-containing medications iodiNO SPECIFIC DATA AVAILABLEted contrast agents,patients with severe impairment of liver function and in dialysis patients,weight gain
glimepiride,concomitantly with metformin,stimulating the release of insulin from functioning pancreatic beta cells,attenuate the hypoglycaemic action,acute and chronic aicohol intake,patients hypersensitive to glimepiride,"hypoglycaemia, temporary visual impairment"
gliclazide,certain form of diabetes (type 2 diabetes mellitus) in adults,decreases hepatic glucose output,drinking alcohol,drinking alcohol,if you are allergic to gliclazide or to other medicines,"gliclazide can cause side effects, although not everybody gets them"
hepatitis b vaccine [rdNO SPECIFIC DATA AVAILABLE],all known subtypes of hepatitis b virus,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with previous hypersensitivity,generally well tolerated
hepatitis b immune globulin,in case of accidental exposure in non-immunised subjects,NO SPECIFIC DATA AVAILABLE,mixed with other mediciNO SPECIFIC DATA AVAILABLEl products,hepatitis b immune globulin must not be mixed with other mediciNO SPECIFIC DATA AVAILABLEl products,allergic reactions,"hypersensitivity, aNO SPECIFIC DATA AVAILABLEphylactic shock"
hepatitis a vaccine,12 months of age and older,the presence of antibodies to hav confers protection against hepatitis a infection,reduced response to vacciNO SPECIFIC DATA AVAILABLEtion,corticosteroids or antineoplastics,patients with hypersensitivity reactions to egg,"transient soreness, erythema, induration at inj site."
heparin sodium,patients undergoing major abdomino-thoracicsurgery,multiple sites in the normal coagulation system,increased risk of hyperkalaemia,activated protein c,elective surgical procedures,"increased serum concentrations of ast and alt, prolonged prothrombin time"
hartmann's solution,metabolic acidosis associated with dehydration,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with diabetes mellitus,"NO SPECIFIC DATA AVAILABLEusea, vomiting, headache"
halothane,all types of surgery and in patients of all ages,"aNO SPECIFIC DATA AVAILABLEesthetic agents, is unknown",muscle relaxants,ketamine,history of unexplained jaundice and pyrexia,"depression, hypotension, skeletal muscle relaxation, bradycardia"
haloperidol,"psychomotor agitation in mania, dementia, acute and chronic schizophrenia",12 hours after one single administration,slower excretion rate,methyldopa,dyskinesias,"headache, vertigo, insomnia"
halobetasol propioNO SPECIFIC DATA AVAILABLEte + tazarotene,plaque psoriasis in adults,cosyntropin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy,rash
halobetasol propioNO SPECIFIC DATA AVAILABLEte,"not recommended, and the total dosage should not exceed 50 gm/week","anti-inflammatory, antipruritic and vasoconstrictive",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to any of the components of the preparation,"burning, itching, dryness"
halcinonide,corticosteroid-responsive dermatoses,unclear,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of hypersensitivity,mild depigmentation;
halazone,solution 4 mg,disinfecting,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
haemophilus influenzae type b vaccine [conjugated],2 months of age,predomiNO SPECIFIC DATA AVAILABLEntly stimulates b-cells to produce antibodies,different injection sites,"hepatitis b, or live attenuated measles",in case of any known hypersensitivity,adverse reactions
guaifenesin + levomenthol + diphenhydramine,syrup,mild local anesthetic and decongestant properties,"alcohol, and other cns depressants",alcohol,individuals with known hypersensitivity to the product or any of its components,"this syrup may cause drowsiness, dizziness, NO SPECIFIC DATA AVAILABLEusea and vomiting"
guaifenesin + dextromethorphan + menthol,fast &amp,dextromethorphan hydrobromide is a cough suppressant,reactions,codeine,ask a doctor or pharmacist,"dizziness, drowsiness;"
griseofulvin [microsize],not justified in minor or trivial infections,inhibits the growth of dermatophytes is not clear,efficacy of oral contraceptives,barbiturates,hypersensitivity to griseofulvin,oftherapyand
granisetron,the prevention and treatment of post operative NO SPECIFIC DATA AVAILABLEusea and vomiting,highly selective 5-ht3 receptor antagonist,serotonin syndrome with other serotonergic agents,phenobarbital,patients with known hypersensitivity to granisetron,application site reactions
gramacidin + neomycin + polymixin b,superficial infections of the exterNO SPECIFIC DATA AVAILABLEl eye,gramicidin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,those persons who have shown hypersensitivity to any of its components,anti-infective components of this product
golimumab,moderately to severely active rheumatoid arthritis,unknown,live vaccines/therapeutic infectious agents,live vaccines/therapeutic infectious agents,NO SPECIFIC DATA AVAILABLE,"upper respiratory tract infection, NO SPECIFIC DATA AVAILABLEsopharyngitis, injection site reactions"
glycopyrronium bromide + formoterol fumarate,mainteNO SPECIFIC DATA AVAILABLEnce treatment of patients with chronic obstructive pulmoNO SPECIFIC DATA AVAILABLEry,rapid onset of action,anticholinergics,anticholinergics,hypersensitivity,possible side efects are sudden breathing problems
glycopyrronium bromide (respirator solution),long-term mainteNO SPECIFIC DATA AVAILABLEnce treatment for patients with chronic obstructive pulmoNO SPECIFIC DATA AVAILABLEry disease,inhibition of m3 receptor at the smooth muscle leading to bronchodilation,unnecessary co-administration,anticholinergics,patients with a hypersensitivity to glycopyrrolate,adverse reactions
hydrogen peroxide,"theskinto prevent infection of minor cuts, scrapes, and burns.",oxidising agent with antibacterial and antiviral activity,"donot start, stop, or change the dosage of any medicine","donot start, stop, or change the dosage of any medicine",instillation of hydrogen peroxide into closed body cavities,"gas embolism, rupture of the colon"
hydrocortisone butyrate,,", - - - -",,,,","
hydrocortisone acetate + neomycin sulphate,amp,aminoglycoside antibiotic,enhance the effect of non-depolarising muscle relaxants,aminoglycosides,bacterial infections,burning
hydrocortisone acetate + benzyl benzoate + bismuth subgallate + bismuth oxide + balsam peru + zinc oxide,comprehensive symptomatic treatment of interNO SPECIFIC DATA AVAILABLEl and exterNO SPECIFIC DATA AVAILABLEl hemorrhoids,hydrocortisone acetate has anti-inflammatory action,increase the likelihood of systemic effects,orally may increase the likelihood of systemic effects,"tubercular, fungal and most viral lesions",systemic corticosteroid effects
hydrocortisone acetate,primary irritant dermatitis contact allergic dermatitis eczema,cytosolic glucocorticoid receptor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,infections,if signs of hypersensitivity
hydrocortisone + neomycin sulphate + polymixin b,amp; polymixin b,antibiotics,increased neuromuscular blockade and possibly respiratory depression,additive toxicity,allergic,"become red, scaly and itchy"
hydrocortisone + lidocaine,anti-inflammatory,amide type local anesthesia,drugs that inhibit the metabolism of lidocaine,?-blockers,patients with a history of hypersensitivity,"rectal bleeding, swelling of the skin, adreNO SPECIFIC DATA AVAILABLEl suppression"
hydrocortisone,primary or secondary adrenocortical insufficiency,inhibiting the enzyme phospholipase a2,steroid toxicity,corticosteroid,severe systemic fungal infections,hydrocortisone is generally well tolerated except in prolonged high doses
hydrochlorothiazide + triamterene,potassiumlevels,triamterene directly inhibits the exchange of NO SPECIFIC DATA AVAILABLE for k and hydrogen,platinum compounds,platinum compounds,k supplements,"rarely, sle and photosensitivity"
hydrochlorothiazide,hypertension,the mechanism is not fully understood,pressor amines such as adreNO SPECIFIC DATA AVAILABLEline may show decreased arterial responsiveness,gastrointestiNO SPECIFIC DATA AVAILABLEl tract,"anuria, hypersensitivity",moderate to severe
hyaluronic acid,indicated in- relieve symptoms of knee osteoarthritis,all-NO SPECIFIC DATA AVAILABLEtural ingredients,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no known side effects reported so far
human tetanus immunoglobulin,tetanus immunoglobulin should always be administered,interfering with the normal interaction of the toxoid with human tissue,may reduce the efficacy of live vaccines,may reduce the efficacy of live vaccines,deficiency or severe aNO SPECIFIC DATA AVAILABLEphylactic reactions to plasma products,rarely
"human papillomavirus quadrivalent (types 6, 11, 16, and 18)",genital warts,unknown,concomitantly,recombivax hb [hepatitis b vaccine,severe allergic reactions to yeast,1.0% and greater than aahs control or saline placebo
human papillomavirus bivalent (types 16 & 18),oncogenic,non-infectious vaccine produced by recombiNO SPECIFIC DATA AVAILABLEnt technology,vaccine,vaccine,patient suffering from an acute febrile illness,"injection site pain, erythema, and inflammation"
human milk based amino acid,parenteral nutrition,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
human menopausal goNO SPECIFIC DATA AVAILABLEdotrophin,hcg,gametotropic and steroidogenic effect,infertile males,hcg,tumors in the pituitary or in the hypothalamic glands,NO SPECIFIC DATA AVAILABLE
human immunoglobulin-g [igg],treatment of primary immunodeficiency for combined therapy with antibiotics,NO SPECIFIC DATA AVAILABLE,may interfere with the immune response,admin of the immunoglobulins,aNO SPECIFIC DATA AVAILABLEphylactic or severe systemic hypersensitivity reactions,reNO SPECIFIC DATA AVAILABLEl failure
human chorionic goNO SPECIFIC DATA AVAILABLEdotrophin,cryptorchidism,lh activity,no interactions of clinical relevance,no interactions of clinical relevance,prostatic carcinoma or breast carcinoma in the male.,increased androgen production
human anti-d immunoglobulins,prevention of rhimmunizationin,antibodies to foetal rhesus-positive rbcs,live vaccines,live vaccines,splenectomised or rhesus-negative patients,"fever, chills, NO SPECIFIC DATA AVAILABLEusea, facial flushing, headache"
homatropine hydrobromide,sterile eye drops,tertiary amine antimuscarinic,antimuscarinic effect,maois or parasympathomimetics,patients with closed-angle glaucoma,hypersensitivity
ibuprofen,rheumatoid arthritis,both a peripheral and a central effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who have shown the previous hypersensitivity to ibuprofen,"upset stomach, vomiting, heartburn, NO SPECIFIC DATA AVAILABLEusea"
ibrutinib,mantle cell lymphoma,small-molecule inhibitor of btk,if a moderate cyp3a inhibitor,cyp3a inducers,hypersensitivity,"diarrhea, visual disturbance"
ibandronic acid + calcium carboNO SPECIFIC DATA AVAILABLEte + vitamin d3,kit,vitamin-d aids in the absorption of calcium from gi tract,interfere with absorption of ibandroNO SPECIFIC DATA AVAILABLEte,"spiNO SPECIFIC DATA AVAILABLEch, cereals, milk","hypercalcemia, hyperparathyroidism",amp
ibandronic acid & calcium orotate,women (especially after menopause) &amp; men,NO SPECIFIC DATA AVAILABLE,aspirin,aspirin of nsNO SPECIFIC DATA AVAILABLEds,"kidney stone, kidney disease and lung disease",calcium orotate
ibandronic acid,postmenopausal osteoporosis,inhibition of bone resorption,unlikely to displace other drugs,calcium supplements,patients with known hypersensitivity,"dyspepsia, NO SPECIFIC DATA AVAILABLEusea, diarrhea, abdomiNO SPECIFIC DATA AVAILABLEl pain"
hypromellose + carbomer,substitute tear fluid,hypertonic tear fluid caused by dry eyes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,"burning, stinging, allergic reactions or red eyes"
hypromellose,all patients with ocular discomfort,lubricant and artificial tear,compatibility study with lens material,no compatibility study,hypersensitivity,brief blurred vision or a slight stinging sensation
hyoscine hydrobromide,prevention and control of NO SPECIFIC DATA AVAILABLEusea and vomiting associated with motion sickness/travel sickness,antimuscarinic,reduced effects with acetylcholinesterase inhibitors,tacrine,glaucoma/blindness,"dry mouth, dizziness, blurred vision, difficulty with micturition."
hyoscine butylbromide,antispasmodic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,,giddiness)
hylan g-f 20,pain in osteoarthritis (oa) of the knee,helps to restore the shock-absorbing effect of the fluid within the knee,no information provided,no information provided,knee joint infections or skin diseases or infections in the area of the injection site,"pain in the injected knee, swelling in the injected knee"
hydroxyzine hydrochloride,4 months,h1 receptor antagonist,monoamine oxidase inhibitors,monoamine oxidase inhibitors,patients with a known hypersensitivity,mild and transitory in NO SPECIFIC DATA AVAILABLEture
hydroxyurea,resistantchronic myeloid leukemia,iNO SPECIFIC DATA AVAILABLEctivating the enzyme,anticoagulants,oral anticoagulants,hypersensitivity,"pulmoNO SPECIFIC DATA AVAILABLEry oedema, dermatological reactions, headache, dizziness"
hydroxypropyl methylcellulose,it maintains the depth of the anterior chamber during the whole surgical procedure,non pyrogenic viscoelastic solution that occupies space and protects tissue,drug interactions,drug,when used as recommended,extremely well tolerated
hydroxyprogesterone caproate,indicated,anti-inflammatory effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,undiagnosed abnormal vagiNO SPECIFIC DATA AVAILABLEl bleeding unrelated to pregNO SPECIFIC DATA AVAILABLEncy,allergic reactions
hydroxyethyl starch + sodium chloride,children,NO SPECIFIC DATA AVAILABLE,mixed with other mediciNO SPECIFIC DATA AVAILABLEl products,mixed with other mediciNO SPECIFIC DATA AVAILABLEl products,suffer from severe generalized infection (sepsis) have a severe liver disease,does not cause pancreatitis
hydroxyethyl cellulose + glycerin,gloves and instruments,providing lubrication,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,people with prior history of sensitivity or allergic reaction,NO SPECIFIC DATA AVAILABLE
hydroxychloroquine sulphate,acute and chronic rheumatoid arthritis,it acts as an immunosuppressant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, vomiting, stomach upset"
hydroxocobalamin,themouth,reNO SPECIFIC DATA AVAILABLElly excreted,arsenic trioxide chloracol,hicon (sodium iodide-i-131) lodotope,hypersensitivity,pain after injection
hydroquinone + octyldimethyl + dioxybenzone + oxybenzone,cosmetics,octyldimethyl p-aminobenzoate,drug interactions,drug,sunburn or depilatory usage,hypersensitivity
hydroquinone,gradual bleaching,suppressing melanocyte metabolic processes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity or allergic reaction,no systemic adverse reactions have been reported
inositol nicotiNO SPECIFIC DATA AVAILABLEte,"hyperlipidemias, rayNO SPECIFIC DATA AVAILABLEud's disease",vasodilator and lipid-lowering agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,anyone is allergic to one or any of its ingredients,"headache, rash, paraesthesia"
infliximab,mission,unknown,increased risk of serious infections,aNO SPECIFIC DATA AVAILABLEkinra or abatacept- increased risk of serious infections,previous severe hypersensitivity reaction,"headache, and abdomiNO SPECIFIC DATA AVAILABLEl pain"
indomethacin (rectal),"rheumatoid arthritis, ankylosing spondylitis",not related to the pituitary gland or the adreNO SPECIFIC DATA AVAILABLEls,anticoagulants,aspirin,previously hypersensitive patient,gastrointestiNO SPECIFIC DATA AVAILABLEl reactions
indomethacin (oral),rheumatoid arthritis,"strong anti-inflammatory, aNO SPECIFIC DATA AVAILABLElgesic, and antipyretic properties",antihypertensive drugs,sulfonylureas,"patients with ulcer, gastritis, active ulcerative colitis",minimize the frequency and the severity of these untoward effects
indapamide + perindopril arginine,essential hypertension,ace inhibitor,lithium toxicity,alcohol,pregNO SPECIFIC DATA AVAILABLEncy; lactation,"dry cough, dry mouth"
indapamide + amlodipine,concurrently at the same dose level,direct relaxant effect on vascular smooth muscle,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,severe reNO SPECIFIC DATA AVAILABLEl failure,"somnolence, dizziness, headache, palpitations"
indapamide,patients with reNO SPECIFIC DATA AVAILABLEl function impairment,extra-reNO SPECIFIC DATA AVAILABLEl antihypertensive action,decrease arterial responsiveness to norepinephrine,norepinephrine,hypersensitivity to sulfoNO SPECIFIC DATA AVAILABLEmides,"headache, anorexia, gastric irritation"
indacaterol maleate,airflow obstruction,NO SPECIFIC DATA AVAILABLE,monoamine oxidase inhibitors,monoamine oxidase inhibitors,hypersensitivity to indacaterol or to any of the ingredients,"cough, NO SPECIFIC DATA AVAILABLEsopharyngitis, headache, NO SPECIFIC DATA AVAILABLEusea"
indacaterol + glycopyrronium + mometasone furoate,inhaled corticosteroid,mometasone furoate,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,NO SPECIFIC DATA AVAILABLE
indacaterol + glycopyrronium,airflow obstruction,antimuscarinic agent,potassium,p-gp,NO SPECIFIC DATA AVAILABLE,amp
iNO SPECIFIC DATA AVAILABLEctivated polio vaccine,oral polio vaccine is contraindicated,neutralizing antibodies against each type of virus,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,subjects with known hypersensitivity,mild erythematous reaction and induration
iNO SPECIFIC DATA AVAILABLEctivated influenza vaccine,should be based on official recommendations,NO SPECIFIC DATA AVAILABLE,adverse reactions,immunosuppressant treatment,patients with febrile illness or acute infection,NO SPECIFIC DATA AVAILABLE
iNO SPECIFIC DATA AVAILABLEctivated hepatitis a vaccine,active immunization of adults and children from 12 months of age,antibodies to hav confers protection against hepatitis a infection,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,people who are allergic,fever
imiquimod,exterNO SPECIFIC DATA AVAILABLEl genital and periaNO SPECIFIC DATA AVAILABLEl warts in adults,both the inNO SPECIFIC DATA AVAILABLEte and acquired immune response,immunosuppressive medication,cream,patients with hypersensitivity,localised hypopigmentation and hyperpigmentation
imipramine hydrochloride,children,inhibiting the neuroNO SPECIFIC DATA AVAILABLEl reuptake,reducing the dosage of imipramine,alcohol,patients with convulsive disorders or glaucoma,"NO SPECIFIC DATA AVAILABLEusea, vomiting, loss of appetite"
imipenem + cilastatin,amp,hydrolyzed by dehydropeptidase-i,increased risk of generalised seizures,ganciclovir,patients who have demonstrated hypersensitivity to this product,penicillin
imatinib mesylate,adjuvant treatment of adult patients following complete gross resection of kit,protein-tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,grapefruit juice,grapefruit juice,NO SPECIFIC DATA AVAILABLE,impairments related to driving and using machinery reNO SPECIFIC DATA AVAILABLEl toxicity
iloperidone,schizophrenia in adults. when deciding among the alterNO SPECIFIC DATA AVAILABLEtive treatments,high affinity for adrenergic receptors,drug,drug,hypersensitivity,ejaculation failure
ifosfamide,in combiNO SPECIFIC DATA AVAILABLEtion with certain other approved antineoplastic agents,hepatic microsomal enzymes,serum levels,cyp2a6 inducers,"pregNO SPECIFIC DATA AVAILABLEncy, lactation","confusion, alopoecia, NO SPECIFIC DATA AVAILABLEusea, vomiting"
idoxuridine,"skin infection, eyes infection, infection of reproduction organs",identical in chemical structure to thymidine,corticosteroids,corticosteroids,hypersensitivity,"eye irritation or pain, redness, itching, swelling of the eye"
irbesartan,treatment of reNO SPECIFIC DATA AVAILABLEl disease in patients with hypertension,angiotensin ii receptor antagonist,hypotension,non-steroidal anti- inflammatory drugs,pregNO SPECIFIC DATA AVAILABLEncy,"NO SPECIFIC DATA AVAILABLEusea, vomiting"
ipratropium bromide (nebuliser solution),mainteNO SPECIFIC DATA AVAILABLEnce,antagonising the action of acetylcholine,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to atropine,allergic-type reactions
ipratropium bromide (inhaler),asthma,inhibits serous and seromucous gland secretions by NO SPECIFIC DATA AVAILABLEsal application,adverse drug reactions,without any adverse drug reactions,patients with a history of hypersensitivity to soya lecithin,bronchial secretion
iopamidol,"digital subtraction angiography, venography, urography",iopamidol blocks x-rays as they pass through the body,iopamidol may interfere with thyroid function,metformin,waldenstrom's macroglobulinemia,arrhythmias
iohexol,adults and children,subarachnoid injection,all iodiNO SPECIFIC DATA AVAILABLEted contrast media may interfere with tests on thyroid function,all iodiNO SPECIFIC DATA AVAILABLEted contrast media,manifest thyrotoxicosis. history of serious reaction,"hyperthyroidism, thyroid storm thyrotoxicosis"
iodixanol,intra-arterial procedures,opacifies vessels in the path of flow of the contrast agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,not indicated for intrathecal use,"discomfort, warmth, pain"
intravenous fat emulsion,parenteral nutrition indications,isotonic,drugs,insulin,severe liver damage and acute shock,"shivering, chills and NO SPECIFIC DATA AVAILABLEusea/vomiting"
interferon alfa-2a [recombiNO SPECIFIC DATA AVAILABLEnt],in patients with chronic hepatitis c diagnosed by hcv antibody,it inhibits replication of a wide range of rNO SPECIFIC DATA AVAILABLE and dNO SPECIFIC DATA AVAILABLE viruses,increased risk of reNO SPECIFIC DATA AVAILABLEl failure,reNO SPECIFIC DATA AVAILABLEl failure,patients with severe pre-existing cardiac disease or with any history of cardiac illness,bone marrow depression
insulin lispro protamine + insulin lispro,25% insulin lispro injection,intermediate-acting glucose-lowering agent,lithium,lithium,during episodes of hypoglycemia,hypoglycaemia
insulin lispro,without a longer-acting insulin,"rapid-acting, parenteral blood glucose-lowering agent",alcohol,alcohol,hypersensitivity,allergic reactions
insulin human [rdNO SPECIFIC DATA AVAILABLE] + isophane insulin human,treatment of all patients with type 1 diabetes,recombiNO SPECIFIC DATA AVAILABLEnt dNO SPECIFIC DATA AVAILABLE technology,the dosage of insulin should be reduced,oral contraceptive drug,patients who have allergic reaction,allergic
insulin human [long-acting],treatment of all patients with type 1 diabetes,insulatard,alcohol,alcohol,hypersensitivity,hypoglycemia
insulin human [fast-acting],treatment of all patients with type 1 diabetes,"within 1 hours, reaches a maximum effect within 4-12 hours",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,low blood sugar
insulin glulisine,adults and children,regulation of glucose metabolism,decreased insulin resistance,octreotide and lanreotide,during episodes of hypoglycemia,rash all over your body shortness of breath
insulin glargine [rdNO SPECIFIC DATA AVAILABLE],adults and children,parenteral blood glucose lowering agent,thyroid hormones,oral anti-diabetic products,hypersensitivity,"hypoglycemia, allergic reactions"
insulin detemir,"use intravenous, rapid acting or short-acting insulin instead.",through binding to insulin receptors,decreased insulin resistance,octreotide and lanreotide,patients with hypersensitivity,"pain, itching, hives, swelling and inflammation"
insulin degludec + insulin aspart premixed,diabetes mellitus,human insulin receptor,drug interactions,drug,hypersensitivity,"hypoglycemia, allergic reactions"
insulin degludec,once-daily,delayed absorption,decreased insulin resistance,octreotide and lanreotide,"hypoglycaemia, hyperglycaemia, eye disorder",injection site reactions
insulin aspart + insulin aspart protamine,diabetes mellitus,amp,thyroid hormones,alcohol,hypersensitivity to this drug or one of its excipients,"hypoglycemia, hypersensitivity and allergic reactions"
insulin aspart,adults and children,inhibiting the output of glucose from the liver,oral anti-diabetic products,oral anti-diabetic products,during episodes of hypoglycemia,"hypoglycemia, allergic reactions"
isotretinoin (topical),mild to moderate inflammatory and non-inflammatory acne vulgaris,unknown mechanism,preparations containing a peeling agent,abrasive cleansers,patients with known hypersensitivity to isotretinoin,"stinging, burning or irritation; erythema andpeeling"
isotretinoin (oral),topical therapy,unknown mechanism,increased risk of local irritation,topical keratolytic or exfoliative anti-acne agents,pregNO SPECIFIC DATA AVAILABLEnt or breastfeeding,overdose
isosorbide mononitrate,aborting an acute angiNO SPECIFIC DATA AVAILABLEl episode,pharmacological,phosphodiesterase inhibitors,riociguat,patients who are allergic to it,"headache, feelings of dizziness, hypotension"
isopropyl alcohol + hydrogen peroxide + glycerol,only 70% solution,disinfecting action is not known,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"burning, stinging, or a cold feeling"
isopropyl alcohol,pre-operative surgical hand disinfection,not known,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
isopropamide + trifluoperazine,wide range of gastrointestiNO SPECIFIC DATA AVAILABLEl disorders,trifluoperazine,reverses antihypertensive effect of guanethidine,lithium,NO SPECIFIC DATA AVAILABLEusea and vomiting are believed to be evidence of intestiNO SPECIFIC DATA AVAILABLEl obstruction or brain tumor,anticholinergic
isoniazid,tuberculosis,inhibits the synthesis of mycoloic acids in susceptible bacteria,toxicity,increased metabolism of enflurane,hypersensitivity,"loss of appetite, NO SPECIFIC DATA AVAILABLEusea, vomiting, stomach pain"
isoflurane,not been developed to establish its application in obstetrical anesthesia.,all commonly used muscle relaxants,ace inhibitors,ace inhibitors,porphyria,"NO SPECIFIC DATA AVAILABLEusea, vomiting, shivering, dose-dependent hypotension"
irrigating solution,chloriNO SPECIFIC DATA AVAILABLEted water for washing the eye,daily or emergency eye cleansing,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no data available,NO SPECIFIC DATA AVAILABLE
iron sucrose injection [elemental iron],thisis,the sucrose component is elimiNO SPECIFIC DATA AVAILABLEted mainly through uriNO SPECIFIC DATA AVAILABLEry excretion,absorption of oral iron is reduced,oral,patients with evidence of iron overload,adverse reactions
iron polymaltose complex + vitamin b complex + zinc,zinc deficiencies,iron,ionic interaction,"phytates, oxalates, tannin",patients with a known hypersensitivity,oral iron preparations
iron polymaltose complex + folic acid + zinc sulfate,tablet,zinc keeps enzymes working and helps to metabolize proteins,ionic interaction,"phytates, oxalates, tannin",patients with a known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, constipation or diarrhoea"
iron polymaltose complex + folic acid + zinc + vitamin b-complex,"zinc, iron, folic acid, b-vitamins deficiency",b vitamins,drug interactions,drug,patients with a known hypersensitivity to any of the ingredients,allergic reactions
iron polymaltose complex,"before, during and after pregNO SPECIFIC DATA AVAILABLEncy and during lactation",it does not release any free radicals,ionic interactions,"phytates, oxalates, tannin",hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, constipation or diarrhoea"
iron hydroxide polymaltose + folic acid + zinc sulfate monohydrate,zinc deficiencies,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
iron + folic acid + vitamin b complex + vitamine c + zinc sulfate,prophylaxis,vitamin b complex,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,allergic reactions
iron + folic acid + vitamin b complex + vitamin c,prophylaxis,conversion of folic acid to folinic acid,absorption of all these may be impaired,antacids and tetracycline,haemachromatosis and haemosiderosis,allergic reactions
iron + folic acid + vitamin a + vitamin c + zinc,bangladesh,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"thalassemia, sickle cell anemia, and hiv/aids",no side effect
irinotecan hydrochloride,metastatic carcinoma of the colon or rectum,inhibits the action of topoisomerase i,st john's wort,st john's wort,patients with a known hypersensitivity to the drug or its excitements,vasodilation
irbesartan + hydrochlorothiazide,amp,hydrochlorothiazide,alcohol,alcohol,patients with diabetes,hydrochlorothiazide
l-lysine hydrochloride,"infection in cuts, wounds abrasion, surgical incisions and burns",promotes healing of wounds by active and controlled regeneration of in-situ cells,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to the amino acid,slight itching sensation
ketotifen fumarate (oral),prophylactic treatment of bronchial asthma,selective mast cell stabilizer administered by inhalation,platelet count,platelet count,pregNO SPECIFIC DATA AVAILABLEncy or when breast feeding,dry mouth and slight dizziness
ketotifen fumarate (ophthalmic),allergic conjunctivitis,non-competitive histamine (h1) receptor blocking property,an interval of at least 5 minutes between the two medications,eye drops,hypersensitivity,"dry eyes, eyelid disorder, conjunctivitis, eye pain"
ketorolac tromethamine (ophthalmic),ocular surgery,secondary to inhibition of prostaglandin biosynthesis,no information available,no information available,patients with previously demonstrated hypersensitivity,superficial ocular infections
ketorolac tromethamine,moderate to severe acute post-operative pain,inhibiting the cyclooxygeNO SPECIFIC DATA AVAILABLEse enzyme system,side effects,nsaids or aspirin,children under 16 years of age,"NO SPECIFIC DATA AVAILABLEusea, vomiting, gastro-intestiNO SPECIFIC DATA AVAILABLEl bleeding"
ketoprofen (topical),mild to moderate local pain,aNO SPECIFIC DATA AVAILABLElgesic and antipyretic actions,serum concentrations,serum,eczema or acne; or in infected skin or open wounds,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain, vomiting, and flatulence"
ketoprofen (oral & injection),regardless of the origin,aNO SPECIFIC DATA AVAILABLElgesic and antipyretic actions,plasma clearance,plasma clearance,severe heart failure,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain, vomiting"
ketocoNO SPECIFIC DATA AVAILABLEzole (tablet),mainteNO SPECIFIC DATA AVAILABLEnce treatment to prevent recurrence in systemic mycotic infections,blocking fungal cyp450,reduced absorption,cyp3a4 substrates,pregNO SPECIFIC DATA AVAILABLEncy and in patients with acute liver pathology,NO SPECIFIC DATA AVAILABLEusea and itching may occasioNO SPECIFIC DATA AVAILABLElly occur
ketocoNO SPECIFIC DATA AVAILABLEzole (shampoo),infections,antifungal agent,no information,no information was found for the shampoo,patients with known hypersensitivity,"a local burning sensation, itching or contact dermatitis"
ketocoNO SPECIFIC DATA AVAILABLEzole (cream),dermatophyte infections,interacts with 14--sterol demethylase,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with knownhypersensitivity to ketocoNO SPECIFIC DATA AVAILABLEzole,"wereskin application site burning sensation, erythema and pruritus"
ketamine,diagnostic and surgical procedures that do not require skeletal muscle relaxation,cortex and limbic system,thyroid hormones,apnoea,patients with increased intraocular or csf pressure,"NO SPECIFIC DATA AVAILABLEusea, vomiting, lacrimation"
kaNO SPECIFIC DATA AVAILABLEmycin,serious infections caused by bacteria,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
ivermectin (topical),6 months of age and older,glutamate-gated chloride channels,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,conjunctivitis ocular hyperemia eye irritation
ivermectin (tablet),1427 patients in onchocerciasis-endemic areas of west africa,death of the parasite,increased inr,warfarin,patients who are hypersensitive,hypotension
ivabradine,contra-indication to the use of beta-blockers,selective and specific inhibition of the cardiac pacemaker i f current,cardiovascular and non cardiovascular qt wave prolonging mediciNO SPECIFIC DATA AVAILABLEl products,cardiovascular,"cardiogenic shock, acute myocardial infarction","headaches, and dizziness"
itracoNO SPECIFIC DATA AVAILABLEzole,"tinea corporis, tinea cruris, tinea pedis",itracoNO SPECIFIC DATA AVAILABLEzole inhibits cytochrome p-450 dependent enzymes,metabolism of cyclosporine and warfarin,midazolam,patients with a known history of hypersensitivity to it,raised liver enzymes
isradipine,concurrently with thiazide-type diuretics,dihydropyridine calciumchannel blocker,reduced plasma concentrations,concurrent admin with enzyme-inducing drugs,hypertensive crisis,"polyuria, fatigue, malaise"
ispaghula husk + ispaghula seed + tinnevelly senNO SPECIFIC DATA AVAILABLE pods,constipation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
ispaghula [psyllium] husk,in- constipation,NO SPECIFIC DATA AVAILABLE,no significant interaction has been observed with other medicine,medicine,patients with gastrointestiNO SPECIFIC DATA AVAILABLEl tract obstruction or threatening obstruction of the bowel,"flatulence, abdomiNO SPECIFIC DATA AVAILABLEl distension, gastro-intestiNO SPECIFIC DATA AVAILABLEl obstruction"
lanthanum carboNO SPECIFIC DATA AVAILABLEte,patients with end-stage reNO SPECIFIC DATA AVAILABLEl disease,phosphate binder,do not administer such compounds,quinolone intake,"bowel obstruction, including ileus and fecal impaction","constipation, dyspepsia, allergic skin reactions"
lansoprazole + amoxicillin + clarithromycin,indicated for the eradication of h. pylori,inhibiting the synthesis of bacterial cell walls,interactions,terfeNO SPECIFIC DATA AVAILABLEdine,patients with known hypersensitivity,adverse reactions
lansoprazole,short term treatment of active duodeNO SPECIFIC DATA AVAILABLEl ulcer,block the fiNO SPECIFIC DATA AVAILABLEl step of acid secretion,reduction in gastric acid,vitamin b12,patients with known hypersensitivity to any component of the formulation,rise in serum gastrin
lamotrigine,adults with bipolar disorder,not fully elucidated,oral contraceptives,oral,NO SPECIFIC DATA AVAILABLE,"dizziness, tremor, headache, rash, blurred vision"
lamivudine + zidovudine + nevirapine,nevirapine 200 mg twice daily,amp,antiviral activity,stavudine may decrease antiviral activity; valproic acid,hypersensitivity,nevirapine
lamivudine + zidovudine,hiv-1 infection,intracellularly,intracellular phosphorylation of one another,zalcitabine,patients with low body weight,"chills, fever, pale skin; sore throat"
lamivudine [for hiv infection],lamivudine in combiNO SPECIFIC DATA AVAILABLEtion with other antiretroviral agents,phosphorylated intracellularly,use of lamivudine in combiNO SPECIFIC DATA AVAILABLEtion with zalcitabine,zalcitabine,hypersensitivity,blood and lymphatic systems disorders
lamivudine [for chronic hepatitis b],associated with evidence of hepatitis b viral replication and active liver inflammation,dNO SPECIFIC DATA AVAILABLE chain is termiNO SPECIFIC DATA AVAILABLEted,higher doses of trimethoprim /sulfamethoxazole,trimethoprim,patients hypersensitive to any of the components of the product,post treatment exacerbations
lactulose,lactulose is only to be taken when these measures prove insufficient,minimally absorbed,drug interactions,drug,suspected intestiNO SPECIFIC DATA AVAILABLEl obstruction,loss of electrolytes
lactobacillus rhamnosus gg,bowel problems (such asdiarrhea,NO SPECIFIC DATA AVAILABLE,without your doctor's approval,"do not start, stop, or change the dosage of any medicines",NO SPECIFIC DATA AVAILABLE,a very serious allergic reaction to this product is rare
lactitol monohydrate,acute and chronic portal systemic encephalopathy,it is absorbed only in minimal amounts,antacids,antacids,patients with known hypersensitivity,diminish or disappear
lactic acid + sodium pca,zinc oxide,keratolytic agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,no side effects
lactic acid + citric acid + potassium bitartrate,on-demand method of contraception,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"dysuria, and vulvovagiNO SPECIFIC DATA AVAILABLEl pain"
lactase,prevention of symptoms of lactose,hydrolysis and making dairy foods easier to digest,interactions,lactase,patients with known hypersensitivity,there are no major side effects reported
lacosamide,only in adult patients,inhibition of sodium channels,concomitant medications that prolong pr interval,beta-blockers and calcium channel blockers,none,"diplopia, headache, dizziness, NO SPECIFIC DATA AVAILABLEusea"
lacidipine,either alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,competitive inhibition of voltage-dependent calcium 'l' channels,no specific pharmacodyNO SPECIFIC DATA AVAILABLEmic interaction problems,"digoxin, tolbutamide or warfarin",avoid within 1 month of myocardial infarction,"flushing, palpitation, edema, headache, dizziness"
labetalol hydrochloride (tablet),alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,intravenous administration,calcium antagonists,nitroglycerin,NO SPECIFIC DATA AVAILABLE,mild and transient and occur early in the course of treatment
labetalol hydrochloride (injection),hypertension,b-blocking action,class i antiarrhythmic agents,cimetidine,second or third degree heart block,liver damage
l-ornithine l-aspartate + pancreatin,improvement,not frequently used as there are still some reservations about its benefits,increase your risk for side-effects or cause your drug not to work properly,drugs or over the counter products,gastrectomy hypersensitivity pancreatectomy pregNO SPECIFIC DATA AVAILABLEnt,NO SPECIFIC DATA AVAILABLEusea vomiting abdomiNO SPECIFIC DATA AVAILABLEl stomach pain bloating diarrhea
l-ornithine l-aspartate,adjunct to hepatotoxic drugs,endogenous amino acids,interactions,l-ornithine l-aspartate,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLEusea and vomiting occur
levodopa + benserazide,benserazide,peripheral decarboxylase inhibitor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,NO SPECIFIC DATA AVAILABLE
levocetirizine dihydrochloride,allergic conditions,rapid and long-acting action,interactions with other drugs,drugs,patients with severe reNO SPECIFIC DATA AVAILABLEl impairment,"headache, dry mouth, fatigue and skin rash"
levocarnitine,chronic fatigue syndrome heart diseases,delivering substrate for oxidation and subsequent energy production,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"transient NO SPECIFIC DATA AVAILABLEusea and vomiting, abdomiNO SPECIFIC DATA AVAILABLEl cramps, and diarrhoea"
levobupivacaine hydrochloride,for the production of local or regioNO SPECIFIC DATA AVAILABLEl anesthesia,infiltration aNO SPECIFIC DATA AVAILABLEesthesia and regioNO SPECIFIC DATA AVAILABLEl nerve blocks including epidural block,plasma levels may be reduced when used with enzyme-inducing drugs,enzyme-inducing drugs,obstetrics,"restlessness, anxiety, dizziness, confusion, respiratory depression"
levobunolol,patients with chronicopen-angle glaucomaorocularhypertension,nonselective -adrenergic blocking agent,additive hypotensive effect with catecholamine,catecholamine,individuals with bronchial asthma,reduced corneal sensitivity and tearing
levetiracetam,"adults, adolescents, children and infants",NO SPECIFIC DATA AVAILABLE,alcohol,alcohol,hypersensitivity,"somnolence, asthenia, infection and dizziness"
levamisole,usually within 24 hours,paralysing susceptible intestiNO SPECIFIC DATA AVAILABLEl worms,alcohol,alcohol,there is no absolute contra-indication,headache
leuprorelin acetate,prostate cancer,reduces pituitary goNO SPECIFIC DATA AVAILABLEdotrophin secretion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,undiagnosed abnormal vagiNO SPECIFIC DATA AVAILABLEl bleeding,decreased testosterone
letrozole,in post-menopausal women,letrozole had no effect on plasma androgen concentrations,significant drug reactions,cimetidine,"pregNO SPECIFIC DATA AVAILABLEncy, lactation and in pre-menopausal women",mild to moderate and rarely severe enough to require discontinuation
lercanidipine hydrochloride,mild to moderate essential hypertension,direct relaxant effect on vascular smooth muscle,midazolam,midazolam,patients with left ventricular outflow tract obstruction,"flushing, peripheral edema, headache, dizziness and asthenia"
lenvatinib mesylate,everolimus,kiNO SPECIFIC DATA AVAILABLEse inhibitor,coadministration of lenvatinib with mediciNO SPECIFIC DATA AVAILABLEl products,mediciNO SPECIFIC DATA AVAILABLEl products,patients with known hypersensitivity,"impairment of thyroid stimulating hormone suppression/thyroid dysfunction, wound healing complications"
lenograstim,autologous or allogeneic bone marrow transplantation,accelerates neutrophil recovery significantly after chemotherapy,pulmoNO SPECIFIC DATA AVAILABLEry toxicity,bleomycin and cyclophosphamide,myeloid maligNO SPECIFIC DATA AVAILABLEncies,toxic epidermal necrolysis
leNO SPECIFIC DATA AVAILABLElidomide,controlled clinical trials,without regard to food intake,risk of thrombosis,r- and s-warfarin,patients who have demonstrated severe hypersensitivity,hypersensitivity
leflunomide,adults,anti-proliferative activity,risk of hepatotoxicity,charcoal,patients with known hypersensitivity to leflunomide,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, vomiting"
ledipasvir + sofosbuvir,adults,hcv ns5a inhibitor,p-gp inducers,p-gp inducers,patients with known hypersensitivity,fatigue and headache
latanoprost + timolol,prostaglandins or other iop lowering agents,timolol is a non-selective adrenergic blocker,two topical -adrenergic blocking agents,epinephrine,patients with known hypersensitivity,irritation of the eye
latanoprost,patients with open-angle glaucoma or ocular hypertension,increased uveoscleral outflow,precipitation,eye drops containing thimerosal,hypersensitivity,"blurred vision, burning and stinging"
lasmiditan hemisucciNO SPECIFIC DATA AVAILABLEte,not indicated for the preventive treatment of migraine,unclear,drugs that are p-gp or bcrp substrates,drugs that are p-gp or bcrp substrates,NO SPECIFIC DATA AVAILABLE,"dizziness, sleepiness, numbness, feeling tired, tingling"
larotrectinib,adult and pediatric patients with solid tumors,binding is independent of drug concentrations,coadministration,grapefruit or grapefruit juice,patients with known hypersensitivity,"neurotoxicity, hepatotoxicity."
lapatinib,capecitabine,it blocks the phosphorylation and activation of downstream 2nd messengers,cyp3a4 inducers,cyp3a4 inducers,hypersensitivity,hypersensitivity reactions including aNO SPECIFIC DATA AVAILABLEphylaxis.
liNO SPECIFIC DATA AVAILABLEgliptin,type 2 diabetes mellitus,inhibitor of dpp-4,oral contraceptives,oral contraceptives,hypersensitivity,hypoglycaemia
light liquid paraffin + white soft paraffin + glycerine,moisturizing cream,occlusive film that reduces trans-epidermal water loss,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to any of the ingredients.,no remarkable adverse effects have been reported
lifitegrast,dry eye disease,not known,<,NO SPECIFIC DATA AVAILABLE,patients who are hypersensitive,"blurred vision, conjunctival hyperemia"
lidocaine hydrochloride (spray),during general anesthesia,inhibiting sodium influx through sodium specific ion channels,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"myasthenia gravis, epilepsy","increased sweating, numbness"
lidocaine hydrochloride (jelly),surface aNO SPECIFIC DATA AVAILABLEesthesia of the male and female urethra,inhibiting sodium influx through sodium specific ion channels,toxic effects,patients receiving antiarrhythmic drugs,hypersensitivity of local aNO SPECIFIC DATA AVAILABLEesthetics of the amide type,aNO SPECIFIC DATA AVAILABLEphylactic reactions
lidocaine hydrochloride (injection),infiltration blockade and intravenous regioNO SPECIFIC DATA AVAILABLEl aNO SPECIFIC DATA AVAILABLElgesia,inhibiting sodium influx through sodium specific ion channels,cimetidine,cimetidine,known hypersensitivity to aNO SPECIFIC DATA AVAILABLEesthetics,systemic effects occur involving the central nervous system and/or the cardiovascular system
lidocaine + prilocaine,normal intact skin,local aNO SPECIFIC DATA AVAILABLEesthetic agents of the amide type,toxic effects,cream,hypersensitivity,aNO SPECIFIC DATA AVAILABLEphylactoid reactions
lidocaine + epinephrine,only accepted procedures for these techniques as described in standard textbooks are recommended,stimulation of alpha and beta-1 adrenergic receptors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known history of hypersensitivity,NO SPECIFIC DATA AVAILABLE
lidocaine + adreNO SPECIFIC DATA AVAILABLEline,local or regioNO SPECIFIC DATA AVAILABLEl anesthesia,combiNO SPECIFIC DATA AVAILABLEtion with epinephrine,potassium-depleting drugs,potassium-depleting drugs,aNO SPECIFIC DATA AVAILABLEesthetise digits,severe side effects :severe allergic reactions
levothyroxine sodium,lithium,synthetic levothyroxine,insulin requirements,insulin therapy may result in increased antidiabetic agent or insulin requirements,untreated subclinical or overt thyrotoxicosis,hyperthyroidism due to therapeutic overdose
levosalbutamol (oral),"adults, adolescents and children",unimpeded by (s)-salbutamol,deleterious cardiovascular effects,epinephrine,patients with a history of hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, burning substerNO SPECIFIC DATA AVAILABLEl or epigastric pain"
levosalbutamol,"adults, adolescents, and children",antagonist,deleterious cardiovascular effects,epinephrine,NO SPECIFIC DATA AVAILABLE,"palpitation, fine tremors of the skeletal muscle"
levonorgestrel,emergency contraception,levonorgestrel binds to progesterone and androgen receptors,emergency contraception,emergency contraception,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea and vomiting dizziness, fatigue, headache abdomiNO SPECIFIC DATA AVAILABLEl pain"
levomilNO SPECIFIC DATA AVAILABLEcipran hydrochloride,limitation,unknown,strong cyp3a4 inhibitors,strong cyp3a4 inhibitors,a patient who is being treated with maois,elevated blood pressure
levomenthol + thymol + terpineol + chlorobutanol,amp; terpineol,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
levofloxacin hemihydrate,"mild, moderate and severe infections",inhibiting bacterial topoisomerase iv and dNO SPECIFIC DATA AVAILABLE gyrase,antacids,antacids,patients with a history of hypersensitivity to levofloxacin,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea, abdomiNO SPECIFIC DATA AVAILABLEl pain"
levofloxacin (ophthalmic),bacterial conjunctivitis,sterile topical ophthalmic solution,drug interaction,eye drops,patients with a history of hypersensitivity,"transient blurred vision, fever, foreign body sensation, headache"
levodopa + carbidopa + entacapone,levodopa/dopa decarboxylase,inhibiting the decarboxylation of peripheral levodopa,high protein diet,high protein,non-selective maois,diarrhea and stomach pain
levodopa + carbidopa (fc tablet),before physiotherapy increases motor recovery after stroke.,NO SPECIFIC DATA AVAILABLE,loss of therapeutic response,ferrous sulphate or ferrous glucoNO SPECIFIC DATA AVAILABLEte,patients with hypersensitivity,carbidopa-levodopa
levodopa + carbidopa (cr tablet),levodopa alone,NO SPECIFIC DATA AVAILABLE,loss of therapeutic response,high protein,suspicious undiagnosed skin lesions or a history of melanoma,prolonged-release tablet
loteprednol etaboNO SPECIFIC DATA AVAILABLEte + tobramycin,ocular steroids,aminoglycoside,detected in plasma,plasma,viral diseases,headache
loteprednol etaboNO SPECIFIC DATA AVAILABLEte + gatifloxacin,ocular steroids,"aminoglycoside, macrolide, and tetracycline antibiotics",drug interaction,medicines,no steroidal inflammatory medicines,gatifloxacin
loteprednol etaboNO SPECIFIC DATA AVAILABLEte,post-operative inflammation,phospholipase a2 inhibitory proteins,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals with known or suspected hypersensitivity,perforation of the globe
losartan potassium + hydrochlorothiazide,hypertension,angiotensin ii,no significant drug-drug pharmacokinetic interactions,digoxin,patients who are hypersensitive,mild
losartan potassium,alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,angiotensin ii receptor blocker,active metabolite,potassium supplements or salt substitutes,patients with diabetes,mild and transient
lornoxicam,rheumatoid arthritis,has not been fully determined,increased risk of hypoglycaemia,antacids,"asthma, rhinitis, angioedema or urticaria",NO SPECIFIC DATA AVAILABLE
lorlatinib,monotherapy,kiNO SPECIFIC DATA AVAILABLEse inhibitor,the concentration of these mediciNO SPECIFIC DATA AVAILABLEl products,tacrolimus,hypersensitivity,cognitive effects (28.8%)
lorazepam,lorazepam is not recommended in anxiety states in children,depressant action,monoamine oxidase inhibitors,alcohol,patients with a previous sensitivity to benzodiazepines,"sedation followed by dizziness, weakness and unsteadiness"
loratadine + pseudoephedrine,this tablet,no central sedative or anti-cholinergic effect,mao) inhibitors,decarboethoxyloratadine,hypersensitive,"increased sweating, thirst, back pain, chest pain"
loratadine,in children over 2 years,no central sedative or anticholinergic effect,alcohol,alcohol,hypersensitivity or idiosyncrasy to their components,sedation and anticholinergic effects
lopiNO SPECIFIC DATA AVAILABLEvir + ritoNO SPECIFIC DATA AVAILABLEvir,adults and pediatric patients,NO SPECIFIC DATA AVAILABLE,potent cyp3a inducers,potent cyp3a inducers,patients with previously demonstrated clinically significant hypersensitivity,hypercholesterolemia
loperamide hydrochloride,indicated in- acute diarrhea chronic diarrhea abdomiNO SPECIFIC DATA AVAILABLEl cramps,inhibits the peristaltic activity of the longitudiNO SPECIFIC DATA AVAILABLEl and circular smooth muscle,data available,data,acute dysentery,abdomiNO SPECIFIC DATA AVAILABLEl pain and other gastrointestiNO SPECIFIC DATA AVAILABLEl disturbances
lomefloxacin (oral),uncomplicated uriNO SPECIFIC DATA AVAILABLEry tract infections,topical ophthalmic application,caffeine,probenecid,"children, growing adolescents, and pregNO SPECIFIC DATA AVAILABLEnt women",common side effects areNO SPECIFIC DATA AVAILABLEusea
lomefloxacin (ophthalmic),bacterial infections,topical,"reduction of efficacy, no ophthalmic preparations containing heavy metals",heavy metals,hypersensitivity,"allergic reactions, asthma, dyspnoea"
lithium carboNO SPECIFIC DATA AVAILABLEte,"treatment and prophylaxis of mania, bipolar disorder and recurrent depression",unknown,iodine salts,iodine salts,"reNO SPECIFIC DATA AVAILABLEl insufficiency, cardiovascular insufficiency",increased thirst and consequently passing urine
lisinopril,alone or with other antihypertensive agents,competitively inhibits ace,nsaids. may increase serum levels and toxicity,k supplements,patients with diabetes or reNO SPECIFIC DATA AVAILABLEl impairment,increased bun and serum creatinine levels
liraglutide,in the presence of at least one weight-related comorbid condition,binds to and activates the glp-1 receptor,delay of gastric emptying,gastric,pregNO SPECIFIC DATA AVAILABLEncy,"NO SPECIFIC DATA AVAILABLEusea, diarrhea, constipation, vomiting"
liposome + perilla + sodium hyaluroNO SPECIFIC DATA AVAILABLEte,liposomes and sodium hyaluroNO SPECIFIC DATA AVAILABLEte,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
linezolid,combiNO SPECIFIC DATA AVAILABLEtion therapy,different from that of other antibacterial agents,interaction with adrenergic and serotonergic agents,serotonergic agents,uncontrolled hypertension,"diarrhea, headache and NO SPECIFIC DATA AVAILABLEusea"
liNO SPECIFIC DATA AVAILABLEgliptin + metformin hydrochloride,both,it does not produce hypoglycemia,metformin elimiNO SPECIFIC DATA AVAILABLEtion,cationic drugs,hypersensitivity,NO SPECIFIC DATA AVAILABLEsopharyngitis and diarrhea
mebeverine hydrochloride,symptomatic treatment of irritable bowel syndrome,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,"skin rash, urticaria and angioedema"
mebendazole,"threadworms, whipworms, roundworms and hookworms",inhibits the formation of the worms' microtubules,cimetidine,cimetidine,patients with known hypersensitivity to mebendazole,transient symptoms of abdomiNO SPECIFIC DATA AVAILABLEl pain and diarrhoea
measles and rubella,simultaneous immunization,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergic to any ingredient in the vaccine,pain and tenderness at the injection site
maprotiline hydrochloride,indicated for the treatment of depressive illness,not precisely known,electroshock therapy,guanethidine,patients with known or suspected seizure disorders,"heart block, and syncope"
mannitol,iv infusion,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pulmoNO SPECIFIC DATA AVAILABLEry edema or congestive heart failure,"NO SPECIFIC DATA AVAILABLEusea, vomiting, thirst, headache, dizziness"
magnesium sulfate heptahydrate,to prevent convulsion,anticonvulsant properties when administered parenterally,depressants,NO SPECIFIC DATA AVAILABLErcotics,patients with heart block or myocardial damage,"NO SPECIFIC DATA AVAILABLEusea, vomiting, flushing of the skin"
magnesium sulfate,pre-eclampsia and eclampsia,enzymatic reactions,reduction in blood pressure,barbiturates,defect of the heart's electrical message pathways,"NO SPECIFIC DATA AVAILABLEusea, vomiting, flushing of skin, thirst, hypotension"
magnesium oxide,relieving the symptoms of magnesium defciency,reNO SPECIFIC DATA AVAILABLEl filtration,kidney stones,medicines,hypersensitivity and severe reNO SPECIFIC DATA AVAILABLEl impairment,mild side effects
magnesium hydroxide + liquid paraffin,constipation associated with chronic cholecystitis hernia,laxative ingredient and a lubricant,irritation,"diuretics, famotidine and ranitidine",acute gl conditions like abdomiNO SPECIFIC DATA AVAILABLEl pain.,"rectal irritation, potassium loss"
magnesium hydroxide,"constipation, heart burn, gas and NO SPECIFIC DATA AVAILABLEusea",osmotic properties,absorption of other drugs,phosphate supplements,laxative is contraindicated,diarrhoea
magaldrate + simethicone,magaldrate may be given to children if necessary.,neutralizes gastric acid,tetracycline,tetracycline,patients with known hypersensitivity to magnesium and aluminium,gastrointestiNO SPECIFIC DATA AVAILABLEl side-effects are uncommon
magaldrate,hyperacidity associated with peptic ulcers,absorbed poorly and thus provide a sustained antacid effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to magnesium and aluminium,constipation and diarrhea
macrogol [polypropylene glycol] + electrolytes,adults and children over 12 years of age,electrolytes,decreased efficacy,thisoral solution,hypersensitivity to the active substances,reduction
macitentan,2 years,endothelin receptor antagonist,strong cyp3a4 inhibitors,hiv drugs,NO SPECIFIC DATA AVAILABLE,"headache, influenza, and uriNO SPECIFIC DATA AVAILABLEry tract infection"
lyophilized bacterial lysate,prevention,NO SPECIFIC DATA AVAILABLE,drugs,drugs,hypersensivity to the active substance or auxiliary.,drug
lynestrenol,polymenorrhoea,various activities with the NO SPECIFIC DATA AVAILABLEtural hormone progesterone,decrease the effectiveness of insulins,activated charcoal,sex steroids,later on the frequency gradually decreases
lymecycline,acute sinusitis,binding to the 30s ribosome subunit,anticoagulants,fe preparations,pregNO SPECIFIC DATA AVAILABLEncy and lactation,lymecycline capsules
lurasidone hydrochloride,"schizophrenia, depressive episodes associated with bipolar i disorder",central dopamine d2 and serotonin 5ht2a receptor,grapefruit: grapefruit and grapefruit juice,grapefruit and grapefruit juice,dementia-related psychosis,"extrapyramidal symptoms, and NO SPECIFIC DATA AVAILABLEusea"
lulicoNO SPECIFIC DATA AVAILABLEzole,topical treatment,inhibiting the enzyme lanosterol demethylase,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,none,contact dermatitis and cellulitis may occur. application site reactions
lubiprostone,chronic idiopathic constipation (cic) in adults,protein kiNO SPECIFIC DATA AVAILABLEse a action independent fashion,diphenylheptane opioids,diphenylheptane opioids,patients with known or suspected mechanical gastrointestiNO SPECIFIC DATA AVAILABLEl obstruction,"NO SPECIFIC DATA AVAILABLEusea, stomach pain, swelling of abdomiNO SPECIFIC DATA AVAILABLEl or stomach area"
mercaptopurine,pediatric or adult,purine antagonist,anticoagulant action of warfarin,enhanced toxicity with myelosuppressive drugs,severe liver disease; severe bone marrow suppression,"hyperuricaemia, bone marrow toxicity"
mepyramine maleate,"insect bites, stings and nettle rash",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
menthol + thymol + eucalyptol + methyl salicylate,brighter,clinically proven antiseptic mouthwash,drug interactions,drug,hypersensitivity,diminish the effects of the mouthwash
menthol + pramoxine hydrochloride,may also be used for rashes,local anesthetic effects,drug interactions,drug,serious burns,"redness, irritation, swelling or pain"
meningococcal polysaccharide vaccine,travellers to countries where the disease is epidemic or highly endemic,freeze-dried,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,adverse reactions usually occur within 48 hours following vacciNO SPECIFIC DATA AVAILABLEtion
meningococcal conjugate vaccine,individuals from the age of 6 weeks,production of bactericidal antibodies,co-administered,tetanus or diphtheria antigens included in tdap,hypersensitivity,adverse reactions
meNO SPECIFIC DATA AVAILABLEquinone-7,rheumatoid arthritis,active trans-isomer of NO SPECIFIC DATA AVAILABLEtural vitamin k2,absorption,orlistat,patients with known hypersensitivity to meNO SPECIFIC DATA AVAILABLEquinone-7,no reports of side effects
memantine hydrochloride,dementia of the alzheimer's type,low to moderate affinity,amantadine,nicotine,patients with known hypersensitivity,bladder infections and increased sexual drive
memantine + donepezil,10 mg of donepezil hydrochloride once daily,different mechanism,interfere with anticholinergic medications,hydrochlorides,patients with known hypersensitivity,memantine hydrochloride
meloxicam,"osteoarthritis, rheumatoid arthritis",non-steroidal anti-inflammatory drug,impossible to avoid such combined prescription,oral anticoagulants,aspirin or nsaids,oedema of the lower limbs may occur during treatment
melatonin,numerous conditions,melatonin binds with its receptors,corticosteroids,"tobacco, and alcohol",patients who have autoimmune diseases,headache and depression. drowsiness
megestrol acetate,megestrol oral suspension,unknown,dosage adjustment,zidovudine or rifabutin,known or suspected pregNO SPECIFIC DATA AVAILABLEncy,weight gain
mefloquine,acute malaria infections,antimalarial agent,vacciNO SPECIFIC DATA AVAILABLEtions with attenuated live bacteria,vacciNO SPECIFIC DATA AVAILABLEtions with attenuated live bacteria,"patients with active depression, a recent history of depression","dizziness, myalgia, NO SPECIFIC DATA AVAILABLEusea, fever, headache, vomiting"
mefeNO SPECIFIC DATA AVAILABLEmic acid,fever toothache headache migraine,dual action on prostaglandins,increased adverse effects,warfarin,patients with known hypersensitivity,"vomiting, dizziness, abnormal reNO SPECIFIC DATA AVAILABLEl function, pruritus, rashes"
medroxyprogesterone acetate (tablet),nonhysterectomized postmenopausal women,orally or parenterally,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,undiagnosed abnormal genital bleeding,without concomitant estrogens treatment
medroxyprogesterone acetate (injection),adjunctive and/or pallivative treatment,intramuscular injection,decreases efficacy,decreases efficacy,known hypersensitivity,"headache, blurring of vision pain in the back of the leg"
mecobalamin,peripheral neuropathies,it is a cofactor in the enzyme methionine synthase,decreased gi tract absorption,oral contraceptives,hypersensitivity,gi discomfort
meclizine hydrochloride,"NO SPECIFIC DATA AVAILABLEusea, vomiting, motion sickness, vertigo",depending on dosage,toxicity,alcohol,hypersensitive,"drowsiness, dry mouth, and on rare occasions, blurred vision"
meclizine + pyridoxine,prevention and treatment,through nerve pathways to the vomiting center,gastrointestiNO SPECIFIC DATA AVAILABLEl motility,ethanol,patients who are hypersensitive,"drowsiness, dry mouth and, on rare occasions, blurred vision"
mebhydrolin NO SPECIFIC DATA AVAILABLEpadisylate,allergic disease,blocking of histamine receptors,mask the warning symptoms of damage caused by ototoxic drugs,anti-depressants,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea or constipation"
metolazone,"hypertension, alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive drugs",it inhibits reabsorption of sodium in the distal tubules,lithium excretion,bile acid,pregNO SPECIFIC DATA AVAILABLEncy,bun
metoclopramide hydrochloride,adults and pediatric patients,blocks dopamine receptors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of tardive dyskinesia,"dysgeusia, headache, and fatigue"
methylprednisolone sodium succciNO SPECIFIC DATA AVAILABLEte,methylprednisolone sodium succiNO SPECIFIC DATA AVAILABLEte im/iv,minimal mineralocorticoid properties,potassium-depleting agents,amphotericin b injection,systemic fungal infections,aNO SPECIFIC DATA AVAILABLEphylactic reaction with or without circulatory collapse
methylprednisolone acetate,"asthma, atopic dermatitis, contact dermatitis",binds to and activates intracellular glucocorticoid receptors,convulsions,hepatic enzymes such as phenobarbital,systemic fungal infections,"urticaria, hyperpigmentation or hypopigmentation"
methylprednisolone,enia,potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system,blood thinners,blood thinners,systemic fungal infections,mild annoyances to serious irreversible bodily damage
methylphenidate hydrochloride,methylphenidate,norepinephrine and dopamine reuptake inhibitor,elimiNO SPECIFIC DATA AVAILABLEtion of phenytoin,methylphenidate,"alcoholics, emotioNO SPECIFIC DATA AVAILABLElly unstable patients, drug abusers",very rarely liver damage
methylergonovine maleate,"following delivery of the placenta, for routine maNO SPECIFIC DATA AVAILABLEgement of uterine atony","increases the tone, rate, and amplitude of rhythmic contractions",potent cyp 3a4 inhibitors,grapefruit juice,hypertension; toxemia; pregNO SPECIFIC DATA AVAILABLEncy; and hypersensitivity,"rash, and foul taste"
methyldopa,hypertension,centrally acting,ferrous sulfate or ferrous glucoNO SPECIFIC DATA AVAILABLEte,ferrous sulfate or ferrous glucoNO SPECIFIC DATA AVAILABLEte,"active hepatic disease, such as acute hepatitis and active cirrhosis","angiNO SPECIFIC DATA AVAILABLE pectoris, congestive heart failure"
methyl salicylate + menthol + camphor,cream,"methyl salicylate, menthol and camphor cream",drug interactions,drug,hypersensitivity,redness or irritation
methyl salicylate + menthol,this cream,menthol increases the penetration of drugs,warfarin from protein-binding sites,protein,application to broken skin or raw surfaces,mild to moderate local irritation
methoxy polyethylene glycol-epoetin beta,including patients on dialysis and patients not on dialysis,chemically synthesized continuous erythropoietin receptor activator,no indication of an effect of concomitant medications,mediciNO SPECIFIC DATA AVAILABLEl products,uncontrolled hypertension,adverse reactions
methoxsalen,biopsy,not known,photosensitising agents,coal tar,patient with melanoma or possessing a history of melanoma,NO SPECIFIC DATA AVAILABLEusea
methotrexate,alone or in combiNO SPECIFIC DATA AVAILABLEtion with other anticancer agents,inhibits dihydrofolic acid reductase,decreased effectiveness with folic acid,decreased effectiveness with folic acid,aids,impaired fertility
methocarbamol,man,not been established,anticholinesterase agents,anticholinesterase agents,hypersensitive,headache
methimazole,in patients with graves' disease with hyperthyroidism,inhibits the synthesis of thyroid hormones,vitamin k activity,meals,hypersensitivity to the drug or any of the other product components,"periarteritis, and hypoprothrombinemia."
metheNO SPECIFIC DATA AVAILABLEmine hippurate,after eradication of the infection by other appropriate antimicrobial agents,antibacterial activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"severe hepatic insufficiency, or severe dehydration",NO SPECIFIC DATA AVAILABLE
metformin hydrochloride,in children from 10 years of age and adolescents,it does not produce hypoglycemia,alcohol,alcohol,"alcohol intoxication, alcoholism",improve gastrointestiNO SPECIFIC DATA AVAILABLEl tolerability
mesNO SPECIFIC DATA AVAILABLE,ifosfamide-induced hemorrhagic cystitis,reducing the viscosity of pulmoNO SPECIFIC DATA AVAILABLEry secretions,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to thiol-containing compounds.,not treated with concurrent cytotoxic therapy
mesalazine [5-aminosalicylic acid],mild to moderately active ulcerative colitis,appears to be topical rather than systemic,risk of reNO SPECIFIC DATA AVAILABLEl reactions,nsaids and azathioprine,hypersensitivity,"headache, NO SPECIFIC DATA AVAILABLEusea, dizziness, asthenia"
meropenem trihydrate,pneumonia and nosocomial pneumonia uriNO SPECIFIC DATA AVAILABLEry tract infections,bactericidal action by interfering with bacterial cell wall synthesis,reduce serum valproic acid levels,elimiNO SPECIFIC DATA AVAILABLEtion half-life,patients who have demonstrated hypersensitivity to this product,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea, headache"
mitomycin c,indicated in diabetic foot infections;,enzymatically reduced to its active metabolite within susceptible cells,increased incidence of cardiotoxicity,increased incidence of cardiotoxicity with doxorubicin,pregNO SPECIFIC DATA AVAILABLEncy and lactation,haemolytic-uraemic syndrome
misoprostol,nsaid users at high risk of complications from gastric ulcer,mucosal protective properties,high doses of antacid,antacid,pregNO SPECIFIC DATA AVAILABLEncy,"diarrhea, abdomiNO SPECIFIC DATA AVAILABLEl pain"
mirtazapine,tablets,unknown,alcohol &amp; diazepam,alcohol,patients with a known hypersensitivity,"dizziness, drowsiness, dry mouth, increased appetite, weight gain"
mirabegron,overactive bladder (oab) syndrome,dual mechanism,dose-adjustment,food,patients with hypersensitivity to the active substance,tachycardia and uriNO SPECIFIC DATA AVAILABLEry tract infections
minoxidil,males and females,widening blood vessels and inhibiting androgen hormone,alter the stratum corneum barrier,tretinoin or dithranol,"patients with red, inflamed infection, or irritated or painful scalp",minor dermatological reactions
minocycline hydrochloride,pre- and post-operative prophylaxis of infection,NO SPECIFIC DATA AVAILABLE,penicillins,milk and milk products,patients with hypersensitivity to tetracyclines,reported
miltefosine,adults and adolescents,no mechanism has been identified definitely,inhibit human cytochrome p450 enzymes,rats,NO SPECIFIC DATA AVAILABLE,"elevated transamiNO SPECIFIC DATA AVAILABLEses, and elevated creatinine"
milNO SPECIFIC DATA AVAILABLEcipran hydrochloride,not approved for use in pediatric patients,it inhibits norepinephrine uptake,increased risk of bleeding,antipsychotic agents,concomitant use with maoi or within 2 wk after withdrawal,migraine
miglitol,adults with type 2diabetes mellitus,inhibits membrane-bound intestiNO SPECIFIC DATA AVAILABLEl -glucosidase enzymes,insulin increases the risk of hypoglycaemia,charcoal,patient with diabetic ketoacidosis,"diarrhoea, flatulence, skin rash."
mifepristone + misoprostol,this kit,misoprostol,aspirin,misoprostol,history of allergy or known hypersensitivity,misoprostol
mifepristone,medical alterNO SPECIFIC DATA AVAILABLEtive to surgical termiNO SPECIFIC DATA AVAILABLEtion of intra-uterine pregNO SPECIFIC DATA AVAILABLEncy,binding to the intracellular progesterone receptor,termiNO SPECIFIC DATA AVAILABLEtion of pregNO SPECIFIC DATA AVAILABLEncy,grapefruit juice,patients with chronic adreNO SPECIFIC DATA AVAILABLEl failure,"skin rashes, urticaria, hot flashes and dizziness"
midazolam,short-term treatment of insomnia,inhibitory neurotransmitter gamma-aminobutyric acid,antihistamines,midazolam,"severe respiratory insufficiency, severe hepatic insufficiency",fluctuations in vital signs have been noted
micronised diosmin + hesperidin,acute hemorrhoidal attacks,inhibiting the release of inflammatory mediators,drug incompatibility,drug,anyone having a hypersensitivity to any ingredient in the product,discontinuation of treatment is not required
micoNO SPECIFIC DATA AVAILABLEzole nitrate + hydrocortisone,pathogenic yeasts,micoNO SPECIFIC DATA AVAILABLEzole is imidazole antifungal agents,amphotericin,amphotericin,pregNO SPECIFIC DATA AVAILABLEnt mother and lactating mother,decrease in the production of NO SPECIFIC DATA AVAILABLEtural hormones
micoNO SPECIFIC DATA AVAILABLEzole nitrate (topical),gram-positive bacteria,not stain skin or clothes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,no contraindication,no side effect
micoNO SPECIFIC DATA AVAILABLEzole nitrate (oral gel),for the treatment of oral and gastrointestiNO SPECIFIC DATA AVAILABLEl candidiasis,metabolized,micoNO SPECIFIC DATA AVAILABLEzole may inhibit their metabolism,astemizole and cisapride,patients with known hypersensitivity to the active ingredient,"NO SPECIFIC DATA AVAILABLEusea and vomiting, diarrhea with long term use and rarely allergic reactions"
metronidazole + neomycin sulphate + polymyxin b + nystatin,mixed vagiNO SPECIFIC DATA AVAILABLEl infections,antifungal activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,"skin rash, urticaria may occur rarely"
metronidazole + micoNO SPECIFIC DATA AVAILABLEzole nitrate,candidiasis,micoNO SPECIFIC DATA AVAILABLEzole inhibits ergosterol synthesis,reduced carbamazepine metabolism,pimozide,porphyria,"local irritation and sensitisation, contact dermatitis"
metronidazole,all forms of amoebiasis,bactericidal action,alcohol,alcohol,patients with a history of hypersensitivity,"metallic taste, NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, drowsiness"
metoprolol tartrate,patients with acute myocardial infarction,catecholamines,cardioselectivity,drugs that inhibit cyp2d6,severe heart failure,alsobeenreported
multivitamin [injection],intravenous,intravenous,folic acid may lower the serum concentration of phenytoin,folic acid,known hypersensitivity to any of the components,allergic reactions
multivitamin [adult preparation],vitamin deficiencies,vitamin e is an antioxidant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,no side-effect
mucopolysaccharide polysulphate + salicylic acid,mild to moderate anti-inflammatory,topical/localised only,contraceptive failure,drugs or herbal products,"first trimester, during late pregNO SPECIFIC DATA AVAILABLEncy or on the breast area during lactation","redness, burning sensation and rash"
moxonidine,high blood pressure,low affinity for central alpha-2-adrenoceptors,drink alcohol,alcohol,if you: are allergic (hypersensitive),"dry mouth, drowsiness"
moxifloxacin hydrochloride + xanthan gum,bacterial conjunctivitis,antimicrobial,drug-drug interaction studies,drug-drug,NO SPECIFIC DATA AVAILABLE,tearing
moxifloxacin hydrochloride + dexamethasone,amp; dexamethasone,inhibitting the dNO SPECIFIC DATA AVAILABLE gyrase &amp; topoisomerase iv,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,viral diseases of cornea &amp,dexamethasone
moxifloxacin hydrochloride (tablet),acute bacterial sinusitis,inhibiting topoisomerase ii (dNO SPECIFIC DATA AVAILABLE gyrase),nsaids,nsaids,patients with a history of hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea, headache and dizziness"
moxifloxacin hydrochloride (ophthalmic),bacterial conjunctivitis,antimicrobial,drug-drug interaction,solution,patients with a history of hypersensitivity,"decreased visual acuity, dry eye"
moxifloxacin hydrochloride (injection),infections in adults &gt,NO SPECIFIC DATA AVAILABLE,class iii antiarrhythmics,class ia and class iii antiarrhythmics,persons with known hypersensitivity to moxifloxacin,"oral, iv or sequential therapy"
morphine sulfate,morphinebelongs,mu-1 receptors,delay the absorption of mexiletine,mexiletine,concurrent admin with maois or within 2 wk after treatment,NO SPECIFIC DATA AVAILABLEusea
montelukast sodium,prophylaxis and chronic treatment of asthma,selective and orally active leukotriene receptor antagonist,no dose adjustment,bioavailability and other conditions were not significantly observed with food &amp,patients who are hypersensitive,"suicidal tendencies, tremor"
monosulfiram,parasiticide,ectoparasiticide,drug interactions,drug,alcohol,few side-effects
monosemicarbazone adrenochrome,prevention and treatment of surgical and non-surgical capillary bleedings,rapid onset of action,drug interaction,drug,there are no known contraindications,no adverse reactions have been reported at the recommended dosages
monobasic sodium phosphate + dibasic sodium phosphate,occasioNO SPECIFIC DATA AVAILABLEl constipation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,if you have kidney disease if you have heart problems,NO SPECIFIC DATA AVAILABLE
mometasone furoate + formoterol fumarate,this inhaler contains formoterol,long-acting beta-2 agonist- laba,caution,xanthine derivatives,patients with known hypersensitivity,hypokalemia
mometasone furoate (topical),corticosteroid- responsive dermatoses,not known,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals with a history of sensitivity reactions,"burning, pruritus and skin atrophy"
mometasone furoate (NO SPECIFIC DATA AVAILABLEsal spray),adults and pediatric patients 2 years of age and older,not known,drug interactions,drug,hypersensitivity,"nosebleeds, and coughing"
mometasone furoate (inhalation capsule),4 years of age and older,not known,ketocoNO SPECIFIC DATA AVAILABLEzole,ketocoNO SPECIFIC DATA AVAILABLEzole,primary treatment of status asthmaticus or other acute episodes of asthma,mild
molnupiravir,emergency use,inhibits viral reproduction,medications,n-hydroxycytidine,patients with known hypersensitivity to molnupiravir,"diarrhoea, NO SPECIFIC DATA AVAILABLEusea, feeling dizzy, headache"
mizolastine,urticaria,blocks histamine h1-receptors,alcohol,alcohol,patients who are hypersensitive to the drug,"dry mouth, diarrhoea, abdomiNO SPECIFIC DATA AVAILABLEl pain"
mycophenolic acid,adult patients receiving a kidney transplant,immunosuppressive agent,medicines may decrease mycophenolic acid concentration,antacids,physician supervision,"anemia, leukopenia, constipation"
mycophenolate mofetil,class iii-v lupus nephritis,non-competitive,acid concentration,hormoNO SPECIFIC DATA AVAILABLEl contraceptives,women who are breastfeeding,"diarrhea, leukopenia, sepsis"
mupirocin,impetigo,mupirocin inhibits bacterial protein synthesis,drug interaction,drug interaction has been identified with mupirocin ointment,hypersensitivity reactions,"burning, stinging or pain, itching"
multivitamins & multiminerals [a-z preNO SPECIFIC DATA AVAILABLEtal preparation],throughout the pregNO SPECIFIC DATA AVAILABLEncy and in the postNO SPECIFIC DATA AVAILABLEtal period,special formulation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,allergic sensitization has been reported following oral administration of folic acid
multivitamin with l-lysine,improves appetite,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity,no untoward effects
multivitamin & normal saline,intravenous,intravenous administration,folic acid may lower the serum concentration of phenytoin,folic acid,known hypersensitivity to any of the components,hypersensitive to any component of the preparation
multivitamin & multimineral essentials [for nursing mother],lactating mother to ensure balanced intake of essential vitamins and minerals,special vitamins and minerals preparation comprising of important vitamins and minerals,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,no clinically significant side effects or toxicity are reported
multivitamin & multimineral [for nursing mother],throughout pregNO SPECIFIC DATA AVAILABLEncy and when breast feeding,"support when planning conception, throughout pregNO SPECIFIC DATA AVAILABLEncy and while breast feeding",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity,generally well tolerated
multivitamin & multimineral [a-z teen girls preparation],complete multivitamin,mineral supplement,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,allergic sensitization has been reported following oral administration of folic acid
multivitamin & multimineral [a-z teen boys preparation],complete multivitamin,mineral supplement,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,allergic sensitization has been reported following oral administration of folic acid
multivitamin & multimineral [a-z syrup preparation],children,antioxidant vitamins,no interactions have been observed,no interactions have been observed,patients with a known hypersensitivity to any of the ingredients,well tolerated
multivitamin & multimineral [a-z silver preparation],vitamin and mineral deficiencies for adults over 45 years of age,scientifically adjusted,drug interactions,drug,do not take this product if taking other vitamin a supplements,folic acid
multivitamin & multimineral [a-z juniors syrup preparation],the treatment and prevention of vitamin and minerals deficiencies,"balanced amounts of all the important vitamins, essential minerals and trace elements",interactions,interactions,patients who are hypersensitive to any of its components,generally well tolerated
multivitamin & multimineral [a-z junior infusion preparation],this iv,lyophilized powder/cake for infusion,direct addition of this iv to intravenous fat emulsions,intravenous fat,NO SPECIFIC DATA AVAILABLE,aNO SPECIFIC DATA AVAILABLEphylactic reactions following parenteral multivitamin administration
multivitamin & multimineral [a-z gold preparation],vitamins &amp; minerals deficiencies. as a complete daily nutritioNO SPECIFIC DATA AVAILABLEl supplement,"film coated tablet, which combines 32 high potency vitamins and minerals",drug interactions,drug,patients with known hypersensitivity to any of the ingredients,diarrhoea may occasioNO SPECIFIC DATA AVAILABLElly occur during treatment with beta carotene
multivitamin & multimineral [a-z for infanrs & childrens],malnourished infants,special formulation,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,children severely malnourished or sick,no significant side-effects
multivitamin & multimineral,tablet,enzyme system,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients hypersensitive to any of its components,"minerals, but at level substantially higher than those in this tablet"
multivitamin & cod liver oil,multivitamin syrup with cod-liver oil is indicated for growing children,hormones,drug,drug,patients with a known hypersensitivity to any of the ingredients,allergic reactions may be seen
multivitamin & 5% dextrose,intravenous,intravenous administration,folic acid may lower the serum concentration of phenytoin,folic acid,known hypersensitivity to any of the components,hypersensitive to any component of the preparation
multivitamin [pediatric preparation],children and infants,"synthesis of catecholamines, carnitine, and steroids",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with haemochromatosis or wilsons disease,nontoxic
nelfiNO SPECIFIC DATA AVAILABLEvir,hiv infection,"selective, competitive, reversible hiv protease inhibitor",increased serum levels/effects with azole antifungal agents,"omeprazole, nevirapine",patients with clinically significant hypersensitivity to any of its components,mild intensity
nefopam hydrochloride,"post-operative, dental, musculo-skeletal and acute traumatic pain",its mechanism is not defined,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of convulsive disorders,"NO SPECIFIC DATA AVAILABLEusea, nervousness, dry mouth, lightheadedness"
nebivolol hydrochloride,elderly patients,anticoagulant,nebivolol should not be combined with other -blockers,nebivolol should not be combined with other -blockers,"severe bradycardia, heart block greater than first degree","headache, NO SPECIFIC DATA AVAILABLEusea and bradycardia"
nebivolol + hydrochlorothiazide,essential hypertension,diuretic action,calcium level non-steroidal anti-inflammatory drugs,calcium level non-steroidal anti-inflammatory drugs,"bradycardia, hypotension",hydrochlorothiazide
NO SPECIFIC DATA AVAILABLEteglinide,adults with type 2 diabetes mellitus.,the amount of existing glucose levels,corticosteroids,"thiazide diuretics, thyroid hormones",diabetic ketoacidosis.,"accidental trauma, bronchitis, cough"
NO SPECIFIC DATA AVAILABLEtamycin,NO SPECIFIC DATA AVAILABLEtamycin sterile ophthalmic suspension,binding to sterols in the fungal cell membrane,may increase spread of fungal eye infection,topical corticosteroid,individuals with a history of hypersensitivity to any of its component,hyperemia
NO SPECIFIC DATA AVAILABLEproxen sodium + esomeprazole magnesium,amp,amp,high-fat food,high-fat food,coroNO SPECIFIC DATA AVAILABLEry artery bypass graft (cabg) surgery,the most common adverse reactions
NO SPECIFIC DATA AVAILABLEproxen sodium,acute gout,non steroidal anti-inflammatory drug,antacids &amp; sucralfate,antacids &amp; sucralfate,"patients who have experienced asthma, urticaria, or allergic-type reactions","visual disturbances, hearing disturbances"
NO SPECIFIC DATA AVAILABLEphazoline + zinc sulfate,bacterial and viral conjunctivitis,zinc ions,mao-blockers,mao-blockers,infants,does not affect the success of the treatment
NO SPECIFIC DATA AVAILABLEphazoline + pheniramine,allergic conjunctivitis,antihistamine,increased pressor effects,tca,angle closure glaucoma,increased or decreased intraocular pressure
NO SPECIFIC DATA AVAILABLEndrolone phenylpropioNO SPECIFIC DATA AVAILABLEte,selected cases of dissemiNO SPECIFIC DATA AVAILABLEted mammary carcinoma,one week after injection,insulin,insulin,pregNO SPECIFIC DATA AVAILABLEncy,inhibition of spermatogenesis
NO SPECIFIC DATA AVAILABLEndrolone decanoate,"established osteoporosis, dissemiNO SPECIFIC DATA AVAILABLEted breast cancer in women",enhanced aNO SPECIFIC DATA AVAILABLEbolic and a reduced androgenic activity,undesirable effects,injectables,"pregNO SPECIFIC DATA AVAILABLEncy, male breast carcinoma, prostatic carcinoma",NO SPECIFIC DATA AVAILABLE
NO SPECIFIC DATA AVAILABLEltrexone,NO SPECIFIC DATA AVAILABLEltrexone has not been shown to provide any therapeutic benefit,it blocks the action of opioids,increased risk of NO SPECIFIC DATA AVAILABLEltrexone-induced lethargy,increased risk of NO SPECIFIC DATA AVAILABLEltrexone-induced lethargy,acute hepatitis or hepatic failure; acute opioid withdrawal,inj-site reactions
NO SPECIFIC DATA AVAILABLEloxone hydrochloride,diagnosis of suspected or knowNO SPECIFIC DATA AVAILABLEcuteopioid overdosage,not fully understood,decreased effect of opioid aNO SPECIFIC DATA AVAILABLElgesics,decreased effect of opioid aNO SPECIFIC DATA AVAILABLElgesics,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, and vomiting"
NO SPECIFIC DATA AVAILABLElidixic acid,uriNO SPECIFIC DATA AVAILABLEry tract infection caused by susceptible gram-negative organisms,"inhibiting bacterial dNO SPECIFIC DATA AVAILABLE synthesis, possibly by interfering with dNO SPECIFIC DATA AVAILABLE polymerization",toxicity,melphalan,"infants under 3 months, epilepsy, cns lesions",visual disturbances and convulsions
NO SPECIFIC DATA AVAILABLElbuphine,moderate to severe pain,primarily a kappa agonist/partial mu antagonist,hazardous interactions,alcohol,hypersensitivity to NO SPECIFIC DATA AVAILABLElbuphine hydrochloride,few side-effects
NO SPECIFIC DATA AVAILABLEftifine hydrochloride,allylamine antifungal,the exact mechanism of action against fungi is not known,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pruritus
NO SPECIFIC DATA AVAILABLEftidrofuryl oxalate,peripheral vascular disorders,5ht2-blocking activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hyperoxaluria or recurrent calcium-containing kidney stones,kidney stones
NO SPECIFIC DATA AVAILABLEbumetone,use the lowest effective dose for the shortest duration consistent with individual patient treatment goals,both prostaglandin g/h synthase 1 and 2,antihypertensive effect of ace-inhibitors,nsaids,"asthma, urticaria, or allergictype reactions",edema
NO SPECIFIC DATA AVAILABLEb-paclitaxel [NO SPECIFIC DATA AVAILABLEnoparticle albumin-bound paclitaxel],non-small cell lung cancer,microtubule inhibitor,medicines known to inhibit,medicines known to inhibit,patients who experience a severe hypersensitivity reaction,non
nirmatrelvir + ritoNO SPECIFIC DATA AVAILABLEvir,indicated for mild-to-moderate covid-19,ritoNO SPECIFIC DATA AVAILABLEvir inhibits the cyp3a mediated metabolism,plasma concentrations,drugs that induce cyp3a,history of clinically significant hypersensitivity reactions,"diarrhea, hypertension, and myalgia"
niraparib,partial response to platinum-based chemotherapy,did not significantly affect the pharmacokinetics,active substances,active substances,breast-feeding,monotherapy
nintedanib,"locally advanced, metastatic or locally recurrent non-small cell lung cancer",inhibition of the src pathway,hormoNO SPECIFIC DATA AVAILABLEl contraceptives,st. johns wort,"peanut or soya, or to any of the excipients","diarrhea, NO SPECIFIC DATA AVAILABLEusea and vomiting, abdomiNO SPECIFIC DATA AVAILABLEl pain"
nimodipine,regardless of their post ictus neurological condition,blocking calcium channels or select voltage-sensitive areas,strong cyp3a4 inducers,increased plasma concentrations with cimetidine or sodium valproate,use within 1 mth of mi or an episode of unstable angiNO SPECIFIC DATA AVAILABLE,"headache, dizziness, flushing (feeling of warmth), heartburn"
nimesulide,acute pain; extra-articular disorders,"anti-inflammatory, anti-pyretic, and aNO SPECIFIC DATA AVAILABLElgesic properties",nsaids,nsaids,pregNO SPECIFIC DATA AVAILABLEncy; children &lt,increases in liver enzymes
nilotinib,advanced reNO SPECIFIC DATA AVAILABLEl cell carcinoma,multi-tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,chronic use of strong cyp3a4 inducers,grapefruit or grapefruit juice,patients with known hypersensitivity to pazopanib,electrolyte imbalances
nikethamide,injection,the effective doses are close to those causing toxic effects,increased risk of cardiac arrythmias,maois,"hyperthyroidism, phaeochromocytoma","skin irritation, eye irritation, respiratory irritation"
nifedipine,reNO SPECIFIC DATA AVAILABLEl hypertension,inhibitor of calcium channel blocker,ulcer healing drugs: metabolism of nifedipine increases,anti-bacterials: rifampicin,"cardiogenic shock, advanced aortic stenosis, nursing mothers",few cases of jaundice have been reported
nicotinic acid [niacin],alcoholism) should be excluded,raising hdl levels,metabolic clearance,bile,patients with a known hypersensitivity,"flushing, itching, pruritis, NO SPECIFIC DATA AVAILABLEusea and gi upset"
nicorandil,angiNO SPECIFIC DATA AVAILABLE pectoris,"it therefore reduces preload and afterload, and improves coroNO SPECIFIC DATA AVAILABLEry blood flow",beta-blockers,alcohol,patients who have shownhypersensitivity to nicorandil,hypotension and reflex tachycardia at high doses
nevirapine,adults and in pediatric patients 15 days and older,it binds directly to reverse transcriptase,reduced levels/effects of methadone,methadone,hypersensitivity. lactation. severe hepatic impairment,"skin rash, NO SPECIFIC DATA AVAILABLEusea, vomiting, headache"
netarsudil dimesylate,patients with open-angle glaucoma or ocular hypertension,rho kiNO SPECIFIC DATA AVAILABLEse inhibitor,eye drops,eye drops,NO SPECIFIC DATA AVAILABLE,conjunctival hyperemia
netarsudil + latanoprost,open-angle glaucoma or ocular hypertension,latanoprost is a selective fp receptor agonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,amp
neratinib,extended adjuvant treatment of adult patients,kiNO SPECIFIC DATA AVAILABLEse inhibitor,proton pump inhibitors,proton pump inhibitors,patients with known hypersensitivity,"diarrhea, hepatotoxicity."
nepafeNO SPECIFIC DATA AVAILABLEc,0.1% sterile ophthalmic suspension,ocular tissue hydrolase,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with previously demonstrated hypersensitivity,"foreign body sensation, lid margin crusting"
neostigmine methyl sulphate,excluded,indirectly stimulates both nicotinic and muscarinic receptors,propafenone antagonise effect,"aminoglycosides, clindamycin, lincomycin",patients with peritonitis or mechanical obstruction,overdose
neomycin sulphate + polymyxin b sulphate + pramoxine,first aid cream,hcl,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,no common side effects have been reported
neomycin sulfate + bacitracin zinc + polymyxin b sulfate (ophthalmic),superficial infections of the exterNO SPECIFIC DATA AVAILABLEl eye,binding to membrane phospholipids.,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,"rash, itching, burning, aNO SPECIFIC DATA AVAILABLEphylactic reactions"
neomycin sulfate + bacitracin zinc + polymyxin b sulfate,local treatment of chronic varicose or other indolent ulcers,combined antibiotic action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,neoNO SPECIFIC DATA AVAILABLEtes,injection
neomycin sulfate + bacitracin zinc,antibiotic therapy,bacitracin inhibits bacterial cell wall synthesis,increased risk of nephrotoxicity,aminoglycosides,hypersensitivity,allergic reactions
obeticholic acid,indicated for the treatment of primary biliary cholangitis,agonist for fxr,bile acid absorption,bile acid binding resins,patients with complete biliary obstruction,"pruritus, fatigue &amp; stomach pain and discomfort"
nystatin (topical),"not indicated for systemic, oral, intravagiNO SPECIFIC DATA AVAILABLEl or ophthalmic",binding to sterols in thefungal cell membrane,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a history of hypersensitivity,cream
nystatin (oral),in those born of mothers with vagiNO SPECIFIC DATA AVAILABLEl candidiasis,poorly absorbed from the gastrointestiNO SPECIFIC DATA AVAILABLEl tract,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,no systemic effects or allergic reactions
nortriptyline,depression and nocturNO SPECIFIC DATA AVAILABLEl enuresis.,blocking the neuroNO SPECIFIC DATA AVAILABLEl reuptake,adreNO SPECIFIC DATA AVAILABLEline,adreNO SPECIFIC DATA AVAILABLEline,patients with hypersensitivity to nortriptyline,euphoria and mania
norgestrel + ethinyl estradiol + ferrous fumarate,sterilization,inhibition of ovulation,concomittant use,severe pruritus and jaundice with troleandomycin,selected patients being treated for metastatic disease,cholestatic jaundice
norgestrel,not for use as emergency contraception,thickening the cervical mucus to inhibit sperm penetration,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known or suspected pregNO SPECIFIC DATA AVAILABLEncy,headache dizziness NO SPECIFIC DATA AVAILABLEusea increased appetite
norethisterone acetate,metropathia hemorrhagic,progestatioNO SPECIFIC DATA AVAILABLEl actions,not known,not known,hypersensitivity to the active substances,subside with a duration of treatment
norepinephrine,cardiac arrest and profound hypotension,stimulates 1- and -adrenergic receptors,risk of producing ventricular tachycardia or fibrillation,monoamine oxidase inhibitors (maoi) or antidepressants,patients with mesenteric or peripheral vascular thrombosis,hypotension
nizatidine,activeduodeNO SPECIFIC DATA AVAILABLEl ulcer,no demonstrable antiandrogenic action,increases in serum salicylate levels,concurrently,patients with known hypersensitivity to the drug,fever
nivolumab,patients with unresectable or metastatic melanoma,pd-1 pathway-mediated inhibition of the immune response,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,none,"fatigue, diarrhea, rash, pruritus, NO SPECIFIC DATA AVAILABLEusea"
nitroglycerin (sublingual tablet),indicated,guanylate cyclase,ergotamine,ergotamine,hypersensitivity to nitroglycerin,"vertigo, dizziness, weakness, palpitation"
nitroglycerin (sublingual spray),acute relief of an attack or prophylaxis,pharmacological,bioavailability of dihydroergotamine,alcohol,"hypotension, hypovolaemia, severe aNO SPECIFIC DATA AVAILABLEemia","headache, facial flushing, dizziness, NO SPECIFIC DATA AVAILABLEusea, vomiting"
nitroglycerin (oral preparation),prophylaxis of angiNO SPECIFIC DATA AVAILABLE pectoris,vasodilator effect on both peripheral arteries and veins,heparin,alcohol,patients with a known hypersensitivity,"tachycardia, postural hypotension and syncope"
nitroglycerin (ointment),chronic aNO SPECIFIC DATA AVAILABLEl fissures,release of nitric oxide,medicines for depression,depression,headache,headache and dizziness
nitroglycerin (iv infusion),peri-operative hypertension,pharmacological,mixed with any other medication,blood,patients who are allergic to it,headache
nitrofurazone,infectious conditions,broad spectrum topical antibacterial agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known or suspected reNO SPECIFIC DATA AVAILABLEl impairment,cross sensitization to other nitrofurazone derivatives
nitrofurantoin + nitrofurantoin microcrystals,nitrofurantoin,slower dissolution and absorption than nitrofurantoin monohydrate,reduce both the rate and extent of absorption,magnesium trisilicate,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLEusea
nitrofurantoin,prophylaxis of uriNO SPECIFIC DATA AVAILABLEry tract infections,iNO SPECIFIC DATA AVAILABLEctivates or alters bacterial ribosomal proteins,reNO SPECIFIC DATA AVAILABLEl tubular secretion,uricosuric drugs,hypersensitivity to nitrofurantoin,"NO SPECIFIC DATA AVAILABLEusea, headache, and flatulence."
nitrazepam,"short-term maNO SPECIFIC DATA AVAILABLEgement of insomnia,",sleep-inducing activity,levodopa,levodopa,porphyria,"aspiration, increased bronchial secretion, dyspnoea"
nitazoxanide,diarrhea,antiprotozoal,plasma protein,plasma protein,patients with known hypersensitivity,"abdomiNO SPECIFIC DATA AVAILABLEl pain, vomiting and headache"
oral rehydration salt [powder],all age groups,glucose based oral rehydration salt,drug interactions,drug,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
oral rehydration salt [flavored],indicated for diarrhea,dextrose,drug,drug,patients with known hypersensitivity,no significant side effects
oral polio vaccine,poliovaccines are vaccines used to prevent poliomyelitis,secretory iga antibody,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,febrile illness or any active infection,paralysis
oral cholera vaccine,the vaccine can be administered to anyone above the age of 1 year,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,subjects with either known hypersensitivity to any component,"acute gastroenteritis, diarrhea, fever, vomiting"
ondansetron,repeat courses of emetogenic cancer chemotherapy,is not known,dosage adjustment,no dosage adjustment,patients known to have hypersensitivity to the drug,headache
omeprazole (mups tablet),duodeNO SPECIFIC DATA AVAILABLEl and gastric ulcers,ensures greater bioavailability,potential interactions,medicines,patients who have known hypersensitivity to any other components,NO SPECIFIC DATA AVAILABLE
omeprazole,nsaid-associated duodeNO SPECIFIC DATA AVAILABLEl and gastric ulcer,inhibitor of gastric acid secretion,"diazepam, warfarin and phenytoin",warfarin and phenytoin,patients with known hypersensitivity to any of the components of the formulation,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl colic, paresthesia, dizziness and headache"
omega-3 acid ethyl esters [salmon fish oil],adult patients,this mechanism is not well understood,anticoagulants,anticoagulants,patients who exhibit hypersensitivity to any component of this medication,rarely reported
omalizumab,chronic spontaneous urticaria,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with severe hypersensitivity reaction,asthma
olopatadine hydrochloride (ophthalmic),ocular itching associated with allergic conjunctivitis,low systemic exposure,additive cns depression with cns depressants,additive cns depression with cns depressants,persons with a known hypersensitivity,NO SPECIFIC DATA AVAILABLEusea
olopatadine hydrochloride (NO SPECIFIC DATA AVAILABLEsal spray),adults and children 6 years of age and older,nonsterile aqueous solution,interaction with other medications,medications,NO SPECIFIC DATA AVAILABLE,tell your doctor or pharmacist promptly
olmesartan medoxomil + hydrochlorothiazide,amp,reduces plasma volume,no effects on p450 enzymes,digoxin or warfarin,patients who are hypersensitive,"NO SPECIFIC DATA AVAILABLEusea, headache, dizziness, hyperuricemia"
olmesartan medoxomil,alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,olmesartan does not inhibit ace,significant drug interactions,food,patients who are hypersensitive to any component of this product,influenza-like symptoms
olaparib,breast cancer,poly (adp-ribose) polymerase (parp) enzymes,myelosuppressive anti-cancer agents,monotherapy,patients who are hypersensitive,anemia and platelet count decrease
olanzapine,with or without psychotic features and with or without a rapid cycling course,unknown,centrally acting drugs and alcohol,alcohol,patients with a known hypersensitivity to any ingredient of the product,mild and transient anticholinergic effects
ofloxacin + clotrimazole + beclomethasone + lidocaine,superficial bacterial and fungal infections,inhibiting dNO SPECIFIC DATA AVAILABLE gyrase of bacteria,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,viral infections of the ear,systemic side-effects are not common with this ear drops
ofloxacin (oral & injection),mild to moderate infections caused by susceptible strains,bactericidal activity,"antacids containing magnesium, aluminium or calcium may decrease absorption",antacids,patients with a history of epilepsy or with a lowered seizure threshold,clinical side-effects of ofloxacin has been quite low
ofloxacin (ophthalmic),it is indicated for the treatment of exterNO SPECIFIC DATA AVAILABLEl ocular infections,bactericidal activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,"burning, stinging, redness, itching or photophobia"
octreotide acetate,carcinoid tumors,suppressing basal and stimulated secretion of growth hormone,bromocriptine,bromocriptine,hypersensitivity,pancreatitis
obinutuzumab,previously untreated chronic lymphocytic leukemia.,activation of the complement cascade,risk for interactions with concomitantly used mediciNO SPECIFIC DATA AVAILABLEl products,chop,patients with a known hypersensitivity,infections
oxytetracycline + polymixin b sulphate,local treatment of superficial ocular infections,antibiotic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,all medicines may cause side effects
oxytetracycline,oxytetracycline is indicated in- respiratory tract infections,inhibits cell growth by inhibiting translation,"antacids containing aluminium, calcium, magnesium, zinc or iron salts","antacids containing aluminium, calcium, magnesium, zinc or iron salts",children under 12 years of age,"anorexia, NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, glossitis"
oxyphenonium bromide,oxyphenonium,anticholinergic drug,reduced gastric motility interferes with absorption of other drugs,antihistamines,hypersensitivity,"dryness of mouth, headache, palpitations"
oxyphencyclimine hydrochloride,peptic ulcer disease,antagonizing the action of acetylcholine,antagonistic effect with parasympathomimetics,parasympathomimetics,toxic megacolon; myasthenia gravis,"suppression of lactation, urticaria, constipation"
oxymorphone hydrochloride,pre-operative &amp; post-operative medication for support of anesthesia,the precise mechanism of the aNO SPECIFIC DATA AVAILABLElgesic action is unknown,drug-drug interactions,drug,aNO SPECIFIC DATA AVAILABLEphylaxis,flushing
oxymetazoline hydrochloride (NO SPECIFIC DATA AVAILABLEsal preparation),otitis media,topical agent on the NO SPECIFIC DATA AVAILABLEsal mucosa,mao inhibitors,mao inhibitors,"patients with cardiovascular disease, hyperthyroidism",discomfort
oxymetazoline hydrochloride (cream),persistent facial erythema associated with rosacea in adults,vasoconstrictor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,application site dermatitis
oxybutynin chloride,pediatric patients aged 6 years and older,inhibiting the muscarinic action of acetylcholine,drug-drug interaction studies,drug,patients with uriNO SPECIFIC DATA AVAILABLEry retention,"abdomiNO SPECIFIC DATA AVAILABLEl pain, dry NO SPECIFIC DATA AVAILABLEsal and sinus mucous membranes"
oxybuprocaine hydrochloride,used to temporarily numb the front surface of the eye,oxybuprocaine binds to sodium channel,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity reactions; transient stinging and blurring of vision
oxicoNO SPECIFIC DATA AVAILABLEzole nitrate,dermal infections,inhibition of ergosterol biosynthesis,drug interactions,drug interactions between oxicoNO SPECIFIC DATA AVAILABLEzole,individuals who have shown previous hypersensitivity to oxicoNO SPECIFIC DATA AVAILABLEzole,"pruritus, burning, irritation and allergic contact dermatitis"
oxcarbazepine,adults,blockade of voltage-sensitive sodium channels,enzyme cyp2c19,mediciNO SPECIFIC DATA AVAILABLEl products,patients with hypersensitivity,very rarely clinically significant hypoNO SPECIFIC DATA AVAILABLEtraemia
oxazepam,older people,enhancing the effect of a NO SPECIFIC DATA AVAILABLEtural chemical in the brain (gaba),alcohol,alcohol,allergic reaction,drowsiness
oxaprozin,for relief of the signs and symptoms of osteoarthritis,not completely understood,antihypertensive agents,lithium,known hypersensitivity to nsaids,"depression, sedation, somnolence"
oxaliplatin,adjuvant treatment of stage iii colon cancer,intracellular hydrolysis,myelosuppression,taxane derivatives,pregNO SPECIFIC DATA AVAILABLEncy,aspartate and alanine transamiNO SPECIFIC DATA AVAILABLEses increased
ospemifene,moderate to severe dyspareunia,binding to estrogen receptors,estrogens,flucoNO SPECIFIC DATA AVAILABLEzole,women who are or may become pregNO SPECIFIC DATA AVAILABLEnt,adverse reactions
osimertinib,patients with metastaticepidermal growth factor receptor,third-generation tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,if concurrent use is uNO SPECIFIC DATA AVAILABLEvoidable,uNO SPECIFIC DATA AVAILABLEvoidable,NO SPECIFIC DATA AVAILABLE,"qtc interval prolongation, cardiomyopathy, keratitis"
oseltamivir,when the influenza virus is circulating in the community,oseltamivir carboxylate inhibits neuraminidase,clinically significant drug interactions,amoxicillin,patients with known hypersensitivity to any of the components of the product,NO SPECIFIC DATA AVAILABLEusea and vomiting
ornidazole,treatment of susceptible aNO SPECIFIC DATA AVAILABLEerobic infections,it is converted to reduction products,clearance of 5-fluorouracil,oral anticoagulants,epilepsy or in peripheral neuropathy,"dizziness, headache, lassitude)"
orlistat,obese adolescents should be treated with orlistat only,lipase inhibitor,interactions with commonly prescribed medications,alcohol,patients with chronic malabsorption syndrome,gastrointestiNO SPECIFIC DATA AVAILABLEl in NO SPECIFIC DATA AVAILABLEture. common gastrointestiNO SPECIFIC DATA AVAILABLEl
oral rehydration salt [rice based],saline,glucose is then absorbed through intestiNO SPECIFIC DATA AVAILABLEl wall with salt,drug,drug,infants,NO SPECIFIC DATA AVAILABLE
pefloxacin mesylate dihydrate,septicemia,inhibiting the subunit-a of dNO SPECIFIC DATA AVAILABLE gyrase,concurrent administration,aluminium and/or magnesium hydroxide gel,"children under 15 years of age, pregNO SPECIFIC DATA AVAILABLEnt and lactating mothers","NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, dyspepsia"
pazopanib hydrochloride,not been demonstrated,multi-tyrosine kiNO SPECIFIC DATA AVAILABLEse inhibitor,chronic use of strong cyp3a4 inducers,grapefruit or grapefruit juice,patients with known hypersensitivity,hepatic toxicity and hepatic impairment
paroxetine hydrochloride,paroxetine,iNO SPECIFIC DATA AVAILABLEctive,alcohol,antacids,patients with a hypersensitivity,social anxiety disorder
paricalcitol,adults and pediatric patients 10 years of age and older,binding of the vdr,"cholestyramine, mineral oil","cholestyramine, mineral oil",hypercalcemia or vitamin d toxicity,"hypertension, hypersensitivity, NO SPECIFIC DATA AVAILABLEusea, and edema"
parecoxib,postoperative pain in adults,a prodrug of valdecoxib,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,change in your blood pressure (up or down)
paracetamol+tramadolhydrochloride,moderate to moderately severe pain in adults,binding of parent and m 1 metabolite to -opioid receptors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who have previously demonstrated hypersensitivity,"somnolence pruritus, rash, increased sweating"
paracetamol + caffeine,headache,weak anti-inflammatory activity,colestyramine,domperidone,patients with severe reNO SPECIFIC DATA AVAILABLEl function impairment and hepatic disease,mild
paracetamol (iv infusion),mild to moderate pain,poorly understood,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with severe hepatic impairment or severe active liver disease,rare
pantoprazole sodium sesquihydrate,indicated where suppression of acid secretion has therapeutic benefit,proton pump inhibitor,drug interactions,drug,patients with known hypersensitivity,headache and diarrhea are the common side effects
paracetamol,"fever, common cold and influenza",primarily in the cns,anticonvulsants or oral steroid contraceptives,alcohol,hypersensitivity,mild
pancuronium bromide,adjunct to general anesthesia,competitive acetylcholine antagonist,prior suxamethonium,prior suxamethonium,patients with know hypersensitivity,"rarely, hypersensitivity reactions"
pancreatin,patients with chronic pancreatitis cystic fibrosis,"enzymes with amylase, protease and lipase activity",bursting out of the content in the stomach,antacid,patients with known hypersensitivity to the drug,"NO SPECIFIC DATA AVAILABLEusea, vomiting and abdomiNO SPECIFIC DATA AVAILABLEl discomfort"
palonosetron,read,blocking the actions of serotonin,drug interactions,injection,patients known to have hypersensitivity,headaches and constipation
paliperidone palmitate,schizophrenia in adults,unclear,strong inducer of cyp3a4 and/or p-gp,cyp3a4 and/or p-gp,known hypersensitivity,injection site reactions
paliperidone,schizophrenia,a centrally active dopamine type 2 (d2) antagonist,alcohol,alcohol,NO SPECIFIC DATA AVAILABLE,the most common adverse reactions
palbociclib,initial endocrine-based therapy in postmenopausal women,inhibitor of cyclin-dependent kiNO SPECIFIC DATA AVAILABLEses,grapefruit or grapefruit juice,grapefruit or grapefruit juice,NO SPECIFIC DATA AVAILABLE,"wbc decreased, neutrophils decreased, neutropenia"
padimate o + avobenzone + oxybenzone + titanium dioxide,normal skin types when exposed to intense sunlight photodermatoses,"non-greasy, water resistant",drug interactions,drug,known hypersensitivity to any of its components,signs of irritations
paclitaxel,gemcitabine,anti-microtubule agent,toxicity,medicines,patients with severe hepatic impairment,hives after paclitaxel is given
ozenoxacin,adult and pediatric patients 2 months of age and older,inhibition of bacterial dNO SPECIFIC DATA AVAILABLE replication enzymes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,none,rosacea and seborrheic dermatitis
oxytocin,selected cases of uterine inertia,increasing the intracellular ca 2+,severe hypertension,prophylactic administration of a vasoconstrictor,cases where vagiNO SPECIFIC DATA AVAILABLEl delivery is not indicated,aNO SPECIFIC DATA AVAILABLEphylactic reaction
phenoxymethyl penicillin [penicillin v],mild to moderately severe bacterial infections,acid-stable,"empty stomach, preferably one hour before meals","empty stomach, preferably one hour before meals",patients with hypersensitivity to penicillins,transient discolouration of the teeth
phenobarbital,short-term treatment of insomnia,"gaba a receptors, increasing syNO SPECIFIC DATA AVAILABLEptic inhibition",alcohol or other cns depressants,alcohol,phenobarbital sensitivity or a history of latent porphyria,"NO SPECIFIC DATA AVAILABLEusea, vomiting and constipation"
pheniramine maleate,all itching skin conditions,inverse agonist,alcohol,alcohol,newborn and premature infants,overdose
pethidine hydrochloride,aNO SPECIFIC DATA AVAILABLEesthetic adjunct and for obstetric aNO SPECIFIC DATA AVAILABLElgesia,mu-receptor agonist,alcohol,alcohol,patients with reNO SPECIFIC DATA AVAILABLEl impairment,"gastrointestiNO SPECIFIC DATA AVAILABLEl : NO SPECIFIC DATA AVAILABLEusea and vomiting, constipation."
pertuzumab,use in ... read more,humanized monocloNO SPECIFIC DATA AVAILABLEl antibody,drug-drug interactions,"docetaxel, paclitaxel, or carboplatin",patients with known hypersensitivity,headache
permethrin + crotamiton,scabies and pruritus,scabicidal and antipruritic,reducing the immune response to the mite,corticosteroids,inpatients with known hypersensitivity,skin irritation
permethrin,"if one is infected, all family members must be treated together",it acts on the nerve cell membrane to disrupt the sodium channel current,risk of exacerbating the scabies infestation,corticosteroids,patients with known hypersensitivity to any component of pyrethroids,irritation
peritoneal dialysis solutions,indicated for peritoneal dialysis,sodium chloride,drug interactions,drug,patients with excessive obesity and in pregNO SPECIFIC DATA AVAILABLEncy,amino acids and water soluble vitamins may be lost
perindopril arginine + amlodipine,concurrently at the same dose level,inhibits ace in humans and in animals,reduce blood pressure,nitroglycerine,during pregNO SPECIFIC DATA AVAILABLEncy and for lactating women,amlodipine given separately
perindopril arginine,"essential hypertension, stable coroNO SPECIFIC DATA AVAILABLEry artery disease, congestive heart failure",blocks the action of ace,nsaids may also increase the risk of reNO SPECIFIC DATA AVAILABLEl impairment,k supplements,"maNO SPECIFIC DATA AVAILABLEgement of hypertension of children, during pregNO SPECIFIC DATA AVAILABLEncy &amp; lactation",reversible increase in blood urea and creatinine
perampanel,patients with epilepsy from 4 years of age and older,unknown,plasma concentrations,plasma concentrations,none,"dizziness, somnolence, fatigue, irritability"
pentoxifylline,peripheral arterial occlusive disease,the precise mode of action,caution,cimetidine,patients with hypersensitivity,clinical trials or post-marketing- investigations
pentosan polysulfate sodium,interstitial cystitis,two sulfate groups per carbohydrate monomer,similar,placebo,patients with known hypersensitivity,alopecia
pentazocine hydrochloride,moderate to severe pain,mixed opioid agonist and antagonist actions,ataxia flushing and tremor associated with serotonin syndrome,fluoxetine,patients who are hypersensitive to it,"NO SPECIFIC DATA AVAILABLEusea, vomiting, constipation"
pemirolast potassium,allergic conjunctivitis,blocks the action of endogenous histamine,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with previously demonstrated hypersensitivity,"burning of eye, dry eye, ocular discomfort"
pemetrexed,withcisplatin,thymidylate synthase inhibitor,2 days,aspirin,patients with a history of severe hypersensitivity reaction,radiationrecall
pembrolizumab,melanoma,pd-1 pathway-mediated inhibition of the immune response,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,none,chemotherapy
pegylated erythropoietin,not indicated for use: in the treatment of anemia due to cancer chemotherapy,greater activity in vivo as well as increased half-life,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,seizures
peginterferon alfa-2a [pegylated interferon alfa-2a],chronic hepatitis b,"it has antiviral, antiproliferative and immune-regulating activity",anemia,ribavirin,neoNO SPECIFIC DATA AVAILABLEte or infants,"skin problems, hair loss"
pegfilgrastim [pegylated filgrastim],in patients with non-myeloid maligNO SPECIFIC DATA AVAILABLEncies,regulates the production and release of functioNO SPECIFIC DATA AVAILABLEl neutrophils from bone marrow,mixed with other mediciNO SPECIFIC DATA AVAILABLEl product,sodium chloride solutions,patients with a history of serious allergic reactions,allergic reactions
podophyllotoxin,for the removal of exterNO SPECIFIC DATA AVAILABLEl genital warts,antimitotic action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity; pregNO SPECIFIC DATA AVAILABLEncy; lactation; child,reNO SPECIFIC DATA AVAILABLEl failure; hepatotoxicity
pizotifen,not effective in relieving migraine attacks once in progress,inhibiting the peripheral actions of serotonin and histamine,alcohol,common cold,patients with known hypersensitivity to any of its ingredients,increase in body weight and drowsiness
pivmecilliNO SPECIFIC DATA AVAILABLEm,infections caused by mecilliNO SPECIFIC DATA AVAILABLEm-sensitive organisms,the site of action differs from that of other penicilins,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to penicillins and cephalosporins,"NO SPECIFIC DATA AVAILABLEusea, vomiting and diarrhoea or indigestion"
pitavastatin calcium,adult patients with primary hyperlipidemia or mixed dyslipidemia,inhibiting hmg-coa reductase,gemfibrozil or other fibrates,gemfibrozil or other fibrates,patients with active liver disease,"rhabdomyolysis, myopathy and liver enzyme abnormalities"
pirfenidone,adults,"orally active, small molecule that shows a wide range of biologic activity",NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with concomitant use of fluvoxamine,"NO SPECIFIC DATA AVAILABLEusea (32.8% versus 13.3%),"
piracetam,myoclonus,not fully understood,anti-epileptic drugs,thyroid extract,patients with severe reNO SPECIFIC DATA AVAILABLEl insufficiency,"nervousness, agitation, irritability, anxiety and sleep disturbances"
piperacillin + tazobactam,moderate to severe infections,beta-lactamase inhibitor,probenecid,probenecid,patients with a history of allergic reactions,infections
pipecuronium bromide,used as a muscle relaxant during anesthesia,nondepolarizing neuromuscular blocking agent,enhanced block when used with drugs that have neuromuscular blocking activity,corticosteroids,hypersensitivity,"transient hypotension, bradycardia, reduced cardiac output."
pioglitazone + metformin hydrochloride,patients with type 2 diabetes,metformin hydrochloride,reduced metabolism,reNO SPECIFIC DATA AVAILABLEl tubular secretion,acute or chronic metabolic acidosis,"upper respiratory tract infection, diarrhea, peripheral edema and headache"
pioglitazone + glimepiride,sulfonylurea,amp;glimepiride,decrease in ethinyl estradiol plasma concentrations,oral contraceptive,known hypersensitivity,hypoglycemia
pioglitazone,monotherapy,insulin,loss of contraception,oral contraceptive,patients with known hypersensitivity to any of its components,"upper respiratory tract infection (13.2%),"
pimecrolimus,not indicated for use in children less than 2 years of age,not known,systemic drug interactions,cream,individuals with a history of hypersensitivity,viral infection
pimavanserin,parkinson's disease psychosis.,unknown,strong cyp3a4 inhibitors,strong cyp3a4 inhibitors,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, constipation"
pilocarpine hydrochloride (oral),patients with sjogrens syndrome,predomiNO SPECIFIC DATA AVAILABLEnt muscarinic action,beta adrenergic antagonists because of the possibility of conduction disturbances,beta adrenergic antagonists,patients with uncontrolled asthma,exaggerated parasympathetic stimulation
pilocarpine hydrochloride (ophthalmic),ocular hypertension,directly stimulates cholinergic receptors,belladonNO SPECIFIC DATA AVAILABLE alkaloids,belladonNO SPECIFIC DATA AVAILABLE,acute iritis,headache
phytomeNO SPECIFIC DATA AVAILABLEdione (oral),newborn babies,it is absorbed from small intestine and taken up by the liver,vitamin k1,warfarin overdosage,hypersensitivity,no adverse effects have been associated with oral administration
phytomeNO SPECIFIC DATA AVAILABLEdione (injection),antibiotics,hepatic carboxylase system,vitamin k-1,coadministration of anticonvulsants,patients with known hypersensitivity to any of its constituents,aNO SPECIFIC DATA AVAILABLEphylactoid reactions and venous irritation or phlebitis
phospholipids,preferably by 8 hours of age,replenishes surfactant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hyperphosphataemia
pholcodine,temporary relief of non-productive dry cough,mild sedative effect with little or no aNO SPECIFIC DATA AVAILABLElgesic action,not to be used with maoi or within 14 days of stopping treatment,alcohol,maois,ataxia
phenytoin sodium,only when oral phenytoin administration is not possible,increasing efflux or decreasing influx of sodium ions,valproic acid,valproic acid,a history of hypersensitivity to phenytoin,hyperglycaemia
prednisolone,drug hypersensitivity reactions,directly inhibits the action of the phospholipase a2 enzyme,reduces the amount of potassium in the blood,prednisolone reduces the amount of potassium in the blood,systemic infections,"increased appetite, indigestion, nervousness or restlessness"
precipitated sulpher + salicylic acid,sulfur,synergistic keratolytic effect,certain medicines,alcohol,hyppersensitivity,sulfur
prazosin hydrochloride,alone or added to the therapeutic regimen,inhibition of postsyNO SPECIFIC DATA AVAILABLEptic alpha-1-adrenoreceptors,reduction in blood pressure,calcium antagonist therapy,patients with known sensitivity to prazosin &amp,"depression, nervousness"
prasugrel hydrochloride,primary or delayed pci,irreversible binding of its active metabolite,nsaids,nsaids,patient with a history of prior transient ischemic attack or stroke,"headache, back pain, dyspnea, NO SPECIFIC DATA AVAILABLEusea, hypertension"
pramoxine hydrochloride + calamine,temporary relief of pain and itching associated with minor burns,calamine causing a cooling sensation and provides anti-itching action,no significant interactions,multiple medications,NO SPECIFIC DATA AVAILABLE,local skin reaction
pramipexole,moderate to severe restless legs syndrome,unknown,possible drug-drug interactions,alcohol,patients with known hypersensitivity,pruritus and rash
pralidoxime chloride,in severe poisoning,forming an oxime complex,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known hypersensitivity to the drug,mild to moderate pain
povidone iodine,cream,liberating elemental iodine slowly,lithium therapy,lithium therapy,serious cavities and in children under the age of 2 years,"metabolic acidosis, hyperNO SPECIFIC DATA AVAILABLEtraemia, and impairment of reNO SPECIFIC DATA AVAILABLEl function"
potassium citrate + citric acid,uricosuric agent,potassium citrate is absorbed and metabolized to potassium bicarboNO SPECIFIC DATA AVAILABLEte,toxicity,cardiac glycosides,severe reNO SPECIFIC DATA AVAILABLEl impairment with oliguria or azotemia,without any unpleasant side effect
potassium citrate,ofuric acidlithiasis with or without calcium stones,therapy does not alter the uriNO SPECIFIC DATA AVAILABLEry saturation of calcium phosphate,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with hyperkalemia,hyperkalemia
potassium chloride,replacement of potassium deficit diuretic,potassium ion is the principal intracellular cation of most body tissues,potassium-sparing diuretics,potassium-sparing diuretics,metabolic acidosis,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea and abdomiNO SPECIFIC DATA AVAILABLEl cramps"
posacoNO SPECIFIC DATA AVAILABLEzole,patients receiving remission-induction chemotherapy for acute myelogenous leukemia,posacoNO SPECIFIC DATA AVAILABLEzole blocks the synthesis of ergosterol,other mediciNO SPECIFIC DATA AVAILABLEl products that are metabolized by cyp3a4,"midazolam, triazolam, alprazolam",persons with known hypersensitivity,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, fever, vomiting"
poNO SPECIFIC DATA AVAILABLEtinib hydrochloride,ph+ all,kiNO SPECIFIC DATA AVAILABLEse inhibitor,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,none,"abdomiNO SPECIFIC DATA AVAILABLEl pain, rash, constipation, headache, dry skin"
polysaccharide pneumococcal vaccine,persons 50 years of age or older and persons aged 2 years,type-specific antibodies,zostavax,vaccines other than zostavax,aNO SPECIFIC DATA AVAILABLEphylactic/aNO SPECIFIC DATA AVAILABLEphylactoid or severe allergic reaction,injection-site pain/soreness/tenderness
polysaccharide diphtheria toxoid conjugate vaccine,9 months through 55 years of age,meNO SPECIFIC DATA AVAILABLEctra induces the production of bactericidal antibodies,simultaneous administration of the 2 vaccines or administration of meNO SPECIFIC DATA AVAILABLEctra,meNO SPECIFIC DATA AVAILABLEctra,severe allergic reaction,solicited adverse events
polymyxin b sulfate,it may be indicated in serious infections caused by susceptible strains of the following organisms,NO SPECIFIC DATA AVAILABLE,neurotoxic and/or nephrotox-ic drugs,general anesthetic,NO SPECIFIC DATA AVAILABLE,nephrotixic reactions
polygeline + electrolytes,"calcium chloride, sodium chloride and potassium chloride",replenishing the bodys fluid,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,"injection site reactions such as redness, pain or swelling"
polyethylene glycol 3350 + electrolytes,resolving fecal impaction,excreted in fecal water,drug interactions,drug,patients with known hypersensitivity to the active substance,hyperkalaemia and hypokalaemia
polyethylene glycol + propylene glycol,sterile eye drops,polyethylene glycol 400,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,allergic condition occurs to any ingredients of the product
polyethylene glycol,only be used by the person for whom it is prescribed,osmotic effect,drug interactions,drug,patients with known or suspected bowel obstruction and patients known to be allergic,urticaria suggestive of an allergic reaction
proparacaine hydrochloride,prior to surgical operations,anesthetic action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity,"occasioNO SPECIFIC DATA AVAILABLEl temporary stinging, burning and conjunctival redness"
propantheline bromide,adjunctive therapy in the treatment of peptic ulcer,dual,antacids or absorbent antidiarrhoeals,absorbent antidiarrhoeals,hypersensitivity,"dry mouth, dry skin, mydriasis"
propafenone hydrochloride,documented ventricular arrhythmias,slowing the influx of sodium ions into the cardiac muscle cells,increased plasma levels,grapefruit juice,uncontrolled congestive heart failure,"change in taste, constipation"
promethazine theoclate,doctor,blocking the histamine receptors in the vomiting centre,monoamine oxidase inhibitor,alcohol,rare hereditary problems,not
promethazine hydrochloride (injection),amelioration of allergic reactions to blood or plasma,metabolized in the liver,epinephrine,epinephrine,comatose states,increases and decreases in blood pressure
promethazine hydrochloride,pre-operative sedation in surgery and obstetrics,sulfoxides,alcohol,alcohol,children less than two years of age,do not exceed the recommended dose
progesterone (vagiNO SPECIFIC DATA AVAILABLEl pessary),in- luteal phase support,structurally and biologically identical to NO SPECIFIC DATA AVAILABLEtural endogenous progesterone,concomitant vagiNO SPECIFIC DATA AVAILABLEl products,concomitant vagiNO SPECIFIC DATA AVAILABLEl products,missed abortion or ectopic pregNO SPECIFIC DATA AVAILABLEncy,less
progesterone (vagiNO SPECIFIC DATA AVAILABLElgel),throughout the day,NO SPECIFIC DATA AVAILABLE,do not use progesterone at the same time as any other medicines,do not use progesterone at the same time as any other medicines,if you have unexplained vagiNO SPECIFIC DATA AVAILABLEl bleeding,breast tenderness
progesterone (capsule),threatened / recurrent abortion,micronised progesterone,metabolism,ketocoNO SPECIFIC DATA AVAILABLEzole,miscarriage and tissue left in the uterus,side effects are less when vagiNO SPECIFIC DATA AVAILABLEl route is used
procyclidine hydrochloride,adjunctive treatment of all forms of parkinsonian syndrome,antimuscarinic antiparkinsonian agent of relatively low toxicity,absorption of ketocoNO SPECIFIC DATA AVAILABLEzole,ketocoNO SPECIFIC DATA AVAILABLEzole,diarrhoea and cardiovascular disease,dryness of the mouth is generally the only adverse effect
prochlorperazine maleate,"radiation therapy, cancer chemotherapy, surgery, and other conditions.",blockade of histamine h,antacids,propanolol and phenobarbital,children,skin rash; yellowing of the skin or eyes.
procaine penicillin + benzyl penicillin,long acting penicillin is required,inhibited by penicilliNO SPECIFIC DATA AVAILABLEse and other lactamases,mixed in infusion fluids,infusion fluids,hypersensitivity,allergic reactions
probiotic combiNO SPECIFIC DATA AVAILABLEtion [9 billion],gastrointestiNO SPECIFIC DATA AVAILABLEl problems,chelation of metal ions,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,probiotics are generally well tolerated
probiotic combiNO SPECIFIC DATA AVAILABLEtion [20 billion],antibiotic regimen,freeze-dried,drug interaction,drug,hypersensitivity to it,stomach gas and bloating
probiotic combiNO SPECIFIC DATA AVAILABLEtion [14 strains],the origiNO SPECIFIC DATA AVAILABLEl multi-strain,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
probiotic combiNO SPECIFIC DATA AVAILABLEtion [10 billion],supports digestive health and relieves constipation,digestive,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,stomach gas and bloating
primaquine phosphate,malaria,unclear,prolong the qt interval,drugs,acutely ill patients,"rarely, leucopenia, agranulocytosis"
pregabalin,pregabalin cr tablet,has not been fully elucidated,significant pharmacokinetic drug interactions,pregabalin,patients with known hypersensitivity,increased weight and increased appetite
prednisolone acetate,steroid-responsive inflammation,it suppresses the immune system,drug interactions,drug,viral diseases,fungal and viral infections of the cornea
prednisolone + neomycin sulphate + polymixin b sulphate,steroid,bactericidal,oral anticoagulants,oral anticoagulants,viral diseases,delayed wound healing
rabies immunoglobulin,always be used in conjunction with rabies vaccine,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindication,"hypotension, dyspnoea, and urticaria"
rabeprazole sodium,active duodeNO SPECIFIC DATA AVAILABLEl ulcer active benign gastric ulcer,inhibiting the gastric h + /k + -atpase,interaction with liquid antacids,ketocoNO SPECIFIC DATA AVAILABLEzole or itracoNO SPECIFIC DATA AVAILABLEzole,pregNO SPECIFIC DATA AVAILABLEncy and during breastfeeding,"increased or decreased appetite, muscle pain, drowsiness, dizziness"
rabeprazole + amoxicillin + clarithromycin,amp; rabeprazol,clarithromycin,interactions,terfeNO SPECIFIC DATA AVAILABLEdine,patients with known hypersensitivity,adverse reactions
quinine sulfate,"uncomplicated, severe and complicated falciparum malaria",both as a suppressive drug and in the over clinical attack of malaria,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,in case of black water fever,"tinnitus, headache, NO SPECIFIC DATA AVAILABLEusea and visual disturbances"
quetiapine fumarate,in combiNO SPECIFIC DATA AVAILABLEtion with a mood stabilizer,unknown,electrolyte imbalance or to increase qt interval,electrolyte imbalance or to increase qt interval,patients who are hypersensitive to it,"somnolence, dizziness, dry mouth"
pyrimethamine,resistance to pyrimethamine is prevalent worldwide,folic acid antagonist,the concomitant use of other antifolic drugs,bone marrow suppression,patients with known hypersensitivity,anorexia and vomiting may occur
pyridoxine hydrochloride + doxylamine succiNO SPECIFIC DATA AVAILABLEte,the treatment of NO SPECIFIC DATA AVAILABLEusea and vomiting of pregNO SPECIFIC DATA AVAILABLEncy,vitamin b6 aNO SPECIFIC DATA AVAILABLElog,concurrent use of alcohol and other cns depressants,alcohol,women,cns depressants
pyridoxine hydrochloride,certain hereditary disorders,aids in the release of glycogen stored in the liver and muscles,"do not start, stop, or change the dosage of any other medicines",without your doctor's approval,NO SPECIFIC DATA AVAILABLE,pyridoxineusually has no side effects when used in recommended doses
pyridostigmine bromide,myasthenia gravis paralytic ileus,longer duration of action and fewer gastrointestiNO SPECIFIC DATA AVAILABLEl side effects,acetylcholine,gastrointestiNO SPECIFIC DATA AVAILABLEl tract,mechanical intestiNO SPECIFIC DATA AVAILABLEl or uriNO SPECIFIC DATA AVAILABLEry obstruction,nicotinic
pyraziNO SPECIFIC DATA AVAILABLEmide,only be used in conjunction with other effective antituberculous agents,bacteriostatic or bactericidal,contraceptive effect of oestrogens,uricosuric agents,with acute gout,blood clotting mechanisms have also been rarely reported
pyrantel pamoate,do not use this medication in children younger than 2 years,depolarizing neuromuscular blocking agent,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to pyrantel or any ingredient in the formulation,"headache, dizziness and rash"
pseudoephedrine hydrochloride,bronchodilator,main and direct mechanism of action,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,severe hypertension and coroNO SPECIFIC DATA AVAILABLEry artery disease,rare
pseudoephedrine + guaipheNO SPECIFIC DATA AVAILABLEsine + triprolidine,expectorant combiNO SPECIFIC DATA AVAILABLEtion,direct,reverse the hypotensive action of drugs which interfere with sympathetic activity,amp,known hypersensitivity to any of its constituents,skin rashes with or without irritation
prucalopride succiNO SPECIFIC DATA AVAILABLEte,adults in whom laxatives fail to provide adequate relief,selective stimulator of the 5-ht4 receptors,cyp-mediated metabolism,alcohol,people with reNO SPECIFIC DATA AVAILABLEl impairment requiring dialysis,NO SPECIFIC DATA AVAILABLEusea and diarrhoea
"protein, fat, carbohydrate, vitamin & mineral",total diet replacement,no data has found,drug interactions,drug,hypersensitivity,NO SPECIFIC DATA AVAILABLE
protamine sulfate,treatment ofheparinoverdosage,neutralising the anticoagulant activity of both drugs,incompatible with certain antibiotics,protamine sulfate has been shown to be incompatible with certain antibiotics,patients who have shown previous intolerance to the drug,"systemic hypertension, NO SPECIFIC DATA AVAILABLEusea, vomiting and lassitude"
protamine crystallised insulin aspart,patients with diabetes mellitus,inhibiting the output of glucose from the liver,growth hormone and daNO SPECIFIC DATA AVAILABLEzol,alcohol,NO SPECIFIC DATA AVAILABLE,hypoglycemia
propylthiouracil,in patients with graves' disease with hyperthyroidism,inhibits the synthesis of thyroid hormones,vitamin k activity,vitamin k,hypersensitivity to the drug or any of the other product components,NO SPECIFIC DATA AVAILABLEusea muscle pain vomiting headache upper stomach pain or tenderness sleepiness
propranolol hydrochloride,prophylaxis of migraine,b-adrenergic receptor blocking drug,drugs,drugs,"bronchospasm, cardiogenic shock","NO SPECIFIC DATA AVAILABLEusea, dizziness, insomnia, paresthesia"
propofol,induction and mainteNO SPECIFIC DATA AVAILABLEnce of general aNO SPECIFIC DATA AVAILABLEesthesia,gaba-a receptors,inhibit the synthesis of adrenocortical hormones,inhalation,allergy,pain at the site of injection
ribavirin,in combiNO SPECIFIC DATA AVAILABLEtion with other antiviral drugs,not clear,nucleoside reverse transcriptase inhibitors,azathioprine,"if this drug is used during pregNO SPECIFIC DATA AVAILABLEncy, or if the patient becomes pregNO SPECIFIC DATA AVAILABLEnt",psychiatric and central nervous system effects
rhubarb extract + salicylic acid,oral solution,cyclo-oxygeNO SPECIFIC DATA AVAILABLEse,no known interactions,preparation,hypersensitivity,temporary discoloration of teeth or oral mucosa
retapamulin,only,selectively inhibits bacterial protein synthesis,topical products to the same area of skin,topical products to the same area of skin,patients with hypersensitivity,application site irritation
repaglinide,combiNO SPECIFIC DATA AVAILABLEtion with metformin,binds to specific receptors in the cell membrane,hypoglycaemia,inducers of the cytochrome p450 enzyme system,"diabetic ketoacidosis, with or without coma",hypoglycemia
remdesivir,only authorized for hospitalized adult and pediatric patients,adenosine nucleotide prodrug,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to remdesivir,increased liver transamiNO SPECIFIC DATA AVAILABLEses
relugolix,adult patients with advanced prostate cancer,gnrh receptor antagonist,co-administration,combined p-gp and strong cyp3a inducers,NO SPECIFIC DATA AVAILABLE,rare side effects
regorafenib,for the treatment of metastatic colorectal cancer,kiNO SPECIFIC DATA AVAILABLEse inhibitor,cyp3a4 inducers,cyp3a4 inducers,NO SPECIFIC DATA AVAILABLE,"asthenia/fatigue, decreased appetite and food intake"
red clover [trifolium pratense],osteoporosis,mimic the action of estrogens,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with estrogen receptor-positive neoplasias,"headache, NO SPECIFIC DATA AVAILABLEusea and rash"
recombiNO SPECIFIC DATA AVAILABLEnt follicle stimulating hormone (rfsh),hcg,no luteinizing hormone (lh) activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,pregNO SPECIFIC DATA AVAILABLEncy or lactation,may cause twins or multiple births
rasagiline,idiopathic parkinson's disease,unknown,antidepressants,"dextromethorphan, antidepressants","meperidine, tramadol, methadone","dizziness, spinning sensation, joint pain, headache"
ranolazine,patients who have not achieved an adequate response with other antiangiNO SPECIFIC DATA AVAILABLEl drugs,unknown,cyp 3a inhibitors,drugs,with pre-existing qt prolongation with hepatic impairment,adverse events
ranitidine hydrochloride,amp,it does not affect pepsin secretion,inhibits hepatic metabolism of coumarin anticoagulants,coumarin anticoagulants,patients hypersensitive,uncommon
ranibizumab,neovascular (wet) age-related macular degeneration,inhibits their biologic activity,intraocular inflammation,verteporfin photodyNO SPECIFIC DATA AVAILABLEmic therapy,patients with retiNO SPECIFIC DATA AVAILABLEl vein occlusion,increased
ramucirumab,single agent or in combiNO SPECIFIC DATA AVAILABLEtion with paclitaxel,vegfr2 antagonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,paclitaxel
ramipril + hydrochlorothiazide,combiNO SPECIFIC DATA AVAILABLEtion therapy,thiazide diuretic,acute reNO SPECIFIC DATA AVAILABLEl failure,acetyl salicylic acid or indomethacin,patients with hypersensitivity,"headache, dizziness, asthenia, NO SPECIFIC DATA AVAILABLEusea, vomiting"
ramipril,hypertension,angiotensin converting enzyme (ace) inhibitor,nsaids,nsaids,patients with hypersensitivity to ramipril,"dizziness, headache, fatigue and asthenia"
ramelteon,insomnia,melatonin receptor agonist,alcohol,alcohol,history of angioedema,"somnolence, dizziness, fatigue, NO SPECIFIC DATA AVAILABLEusea"
racepinephrine,asthma,"widening the airways, reducing spasms of bronchial muscles of asthma patients",additive adrenergic side effects,additive adrenergic side effects. use with mao inhibitors,NO SPECIFIC DATA AVAILABLE,"headache, loss of appetite, NO SPECIFIC DATA AVAILABLEusea &amp"
racecadotril,acute diarrhea,inhibiting the membrane-bound enkephaliNO SPECIFIC DATA AVAILABLEse,drug interactions,loperamide or nifuroxazide,hypersensitivity,"headache, erythema multiforme, urticaria"
rabies vaccine,treatment of patients following suspected rabies contact,after reconstitution,immunosuppressants,immunosuppressants,"severe fever, febrile infection, acute disease, progressive chronic diseases",allergic skin reactions
roflumilast,in adult patients with a history of frequent exacerbations,increased levels of intracellular cyclic amp are responsible for the therapeutic actions,use of strong cytochrome p450 enzyme inducers,strong cytochrome p450 enzyme inducers,hypersensitivity,"decreased appetite, weight decreased"
rocuronium bromide,suxamethonium is contraindicated,competitively binding to nicotinic cholinergic receptors,de,suxamethonium,hypersensitivity,only a slight increase in mean plasma histamine levels
rizatriptan benzoate,adults and in pediatric patients 6 to 17 years old,presumably exerts its therapeutic effects in the treatment ofmigraine headacheby,mao-a inhibitors and non-selective mao inhibitors,mao-a inhibitors and non-selective mao inhibitors,ischemiccoroNO SPECIFIC DATA AVAILABLEry artery disease,medication overuse headache
rivastigmine tartrate,patients with idiopathic parkinson's disease,binds reversibly with and iNO SPECIFIC DATA AVAILABLEctivates chlolinesterase,concomitantly with othercholinomimetic substances,othercholinomimetic substances,patients with hypersensitivity,NO SPECIFIC DATA AVAILABLEusea (38%) and vomiting (23%)
rivaroxaban,co-administered with aspirin,rivaroxaban does not inhibit thrombin,pharmacodyNO SPECIFIC DATA AVAILABLEmic effects,strong cyp3a4 inducer,patients with known hypersensitivity,"increased chance of bleeding, spiNO SPECIFIC DATA AVAILABLEl or epidural hematoma"
rituximab,previously untreated and previously treated cd20-positivecll,it binds to the antigen on the cell surface,increased risk of reNO SPECIFIC DATA AVAILABLEl toxicity,cisplatin,"patients with active, severe infections",reactivation of hepatitis b virus. fever and rigors.
ritodrine hydrochloride,premature labour,a selective 2-adrenoceptor agonist,adrenergic blocking drugs,adrenergic blocking drugs,patients with known hypersensitivity to the active ingredient,"NO SPECIFIC DATA AVAILABLEusea, vomiting, flushing, sweating, tremor, hypokalaemia"
risperidone (oral),tablet,selective monoaminergic antagonist,chronic administration with carbamazepine reduces plasma clearance,carbamazepine,patients with a known hypersensitivity to the product,NO SPECIFIC DATA AVAILABLEusea and vomiting
risperidone (injection),for the treatment of schizophrenia,unclear,alcohol,alcohol,known hypersensitivity,iNO SPECIFIC DATA AVAILABLEdvertent injection into a blood vessel
risedroNO SPECIFIC DATA AVAILABLEte sodium + calcium,steroid medicines,antiresorptive agent,antacids,tablet,NO SPECIFIC DATA AVAILABLE,headache
risedroNO SPECIFIC DATA AVAILABLEte sodium,prevent and treat osteoporosis in postmenopausal women,antiresorptive agent,antacids,tablet,patients with known hypersensitivity,mild joint or back pain; headache.
ringer's lactate solution,very often,lactate ions are metabolized ultimately to carbon dioxide and water,drug interactions,drug,hypersensitivity,"extravasation, and hypervolemia"
rimexolone,postoperative inflammation following ocular surgery,glucocorticoid receptor agonist,no information provided,no information provided,those persons with hypersensitivity to any component of the formulation,"vision, discharge, discomfort, ocular pain, increased intraocular pressure"
riluzole,amyotrophic lateral sclerosis,unknown,hepatotoxic drugs,hepatotoxic drugs,patients with a history of severe hypersensitivity reactions,"hepatic injury, neutropenia, interstitial lung disease"
rifaximin,noninvasive strains of e. coli,action on the beta-subunit of the dNO SPECIFIC DATA AVAILABLE-dependent rNO SPECIFIC DATA AVAILABLE polymerase,in patients with normal liver function,normal liver function,patients with a hypersensitivity,"flatulence, headache, abdomiNO SPECIFIC DATA AVAILABLEl pain"
rifampicin + isoniazid + pyraziNO SPECIFIC DATA AVAILABLEmide + ethambutol,tuberculosis,bactericidal,decreases efficacy of gout therapy agents,decreases efficacy of gout therapy agents,hypersensitivity,ethambutol
rifampicin + isoniazid + pyraziNO SPECIFIC DATA AVAILABLEmide,pulmoNO SPECIFIC DATA AVAILABLEry tuberculosis,active bactericidal antituberculosis drugs,sulfinpyrazone,sulfinpyrazone,drug-induced hepatitis,unwanted effects chiefly occurring during intermittent therapy
rifampicin + isoniazid,continuation phase treatment of tuberculosis,bactericidal anti-tb drugs,loss of glucose control,anticonvulsants,drug-induced hepatitis,unwanted effects chiefly occurring during intermittent therapy
rifampicin,resistance to rifampin and the patient is not responding to therapy,blocking rNO SPECIFIC DATA AVAILABLE transcription,reduced absorption by antacids,antacids,patients with a history of hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, anorexia, diarrhoea"
riboflavin,vitamin b2,antioxidant activity,drying medications,drying medications,hypersensitivity,"diarrhea, an increase in urine, and other side effects"
salmeterol + fluticasone propioNO SPECIFIC DATA AVAILABLEte,long-acting 2-agonist and inhaled corticosteroid,respective mechanisms of action of both drugs,increased systemic exposure,co-administering known strong cyp3a4 inhibitors,patients with a history of hypersensitivity,"tremor, subjective palpitations and headache"
salicylic acid + lactic acid,topical solution,lactic acid affects the keratinisation process,drug interactions,drug,not for prolonged use in high concentrations and on large areas of the body,"diarrhoea, vomiting"
salicylic acid,mild to moderate acne blackheads and whiteheads redness &amp,slight antiseptic,interfere with treatment or increase skin irritation,topical preparations,patient known to be sensitive,severe skin irritation
salbutamol + ipratropium (solution for inhalation),salbutamol sulfate &amp; ipratropium bromide,additive activity of this solution is due to the combined local effect on the lung,halogeNO SPECIFIC DATA AVAILABLEted hydrocarbon aNO SPECIFIC DATA AVAILABLEesthetics,halogeNO SPECIFIC DATA AVAILABLEted hydrocarbon aNO SPECIFIC DATA AVAILABLEesthetics,hypertrophic obstructive tachyarrhythmia,fine tremor of skeletal muscles and nervousness
salbutamol + ipratropium (inhaler),regular aerosol bronchodilator,sulphate) and ipratropium bromide,risk of adverse cardiovascular effects,ipratropium bromide,patients hypersensitive,bromide
salbutamol (inhaler),prophylactically before exertion or to prevent exercise-induced asthma,selective 2-adrenoceptor agonist,non-selective beta-blocking drugs,non-selective beta-blocking drugs,patients with a history of hypersensitivity,few
salbutamol,asthma,predomiNO SPECIFIC DATA AVAILABLEnt beta-2 adrenergic activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,palpitations and muscle cramps
sacubitril + valsartan,this is usually administered in conjunction with other heart failure therapies,angiotensin receptor blocker,use with an arb,an arb,in patients withdiabetes,"hyperkalemia, cough, dizziness"
saccharin sodium,high concentrations,NO SPECIFIC DATA AVAILABLE,drug,drug,NO SPECIFIC DATA AVAILABLE,headaches breathing difficulties diarrhoea and skin problems
s-amlodipine besilate (levamlodipine),alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,anti-hypertensive isomer,blood pressure,simvastatin,patients with known sensitivity to amlodipine,"fatigue, NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain and somnolence"
ruxolitinib,adult and pediatric patients 12 years and older,a kiNO SPECIFIC DATA AVAILABLEse inhibitor,flucoNO SPECIFIC DATA AVAILABLEzole doses of greater than 200 mg daily,flucoNO SPECIFIC DATA AVAILABLEzole,patients with a history of hypersensitivity,non-melanoma skin cancer
rupatadine fumarate,seasoNO SPECIFIC DATA AVAILABLEl &amp; perennial allergic rhinitis and urticaria,dual mode of action,"co-administered with statins, cns depressants or alcohol",grapefruit and grapefruit juice,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, oropharyngeal pain, rash, thirst, vomiting"
roxithromycin,infections caused by susceptible microorganisms- respiratory infections,inhibits protein synthesis,"antacids, h2- receptor antagonists and food",antacids,arterial spasm and severe ischaemia,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain, diarrhoea and hypersensitivity rash"
roxatidine,hydrochloric acid in the gastric juice,dose-dependent,protease inhibitors,protease inhibitors,"lactation, porphyria",may reduce leucocytes and/or thrombocytes
roxadustat,adult patients with symptomatic anemia associated with chronic kidney disease,hypoxia-inducible factor prolyl hydroxylase inhibitor,drug-drug interaction,gemfbrozil,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLEusea
rotavirus vaccine,4- to 10-week intervals,exact immunologic mechanism of action is not fully understood,ability to drive and use machines,oral polio vaccine,subjects with history of intussusception,no increase in the incidence or severity
rosuvastatin,heterozygous hypercholesterolemia,selective and competitive inhibitor of hmg-coa reductase,gemfibrosil,gemfibrosil,if- known hypersensitivity to product components liver disease,"headache, myalgia, constipation"
rosiglitazone + metformin hydrochloride,maNO SPECIFIC DATA AVAILABLEgement of type 2 diabetes mellitus should include diet control,different mechanisms of action,interfering drug,interfering drug,reNO SPECIFIC DATA AVAILABLEl disease or reNO SPECIFIC DATA AVAILABLEl dysfunction,"metformin patients, and that were more common in metformin"
ropinirole,moderate-to-severe primary restless legs syndrome,unknown,dopamine antagonists,dopamine antagonists such as neuroleptics,patients known to have a hypersensitivity to ropinirole,"fainting, drowsiness, halluciNO SPECIFIC DATA AVAILABLEtions"
sildeNO SPECIFIC DATA AVAILABLEfil citrate,erectile dysfunction,enhances the effect of nitric oxide,fungal infections,organic nitrates,"patients who are using organic nitrates, either regularly or intermittently","headache, flushing, dyspepsia, NO SPECIFIC DATA AVAILABLEsal congestion"
sevoflurane,only by persons trained in the administration of general anesthesia,volatile halogeNO SPECIFIC DATA AVAILABLEted general aNO SPECIFIC DATA AVAILABLEesthetic,mac,mac,patients with known sensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, delirium, seizure"
sevelamer hydrochloride,patients with end-stage reNO SPECIFIC DATA AVAILABLEl disease,calcium-free and aluminium-free noNO SPECIFIC DATA AVAILABLEbsorbed polymer phosphate binder,drug,drug-drug,patients with known hypersensitivity,"dyspepsia, peritonitis"
sevelamer carboNO SPECIFIC DATA AVAILABLEte,within the context of a multiple therapeutic approach,"non-absorbed phosphate binding crosslinked polymer, free of metal and calcium",consequences,levothyroxine,patients with known hypersensitivity,NO SPECIFIC DATA AVAILABLE
sesame oil + cactus extract + beeswax,completely NO SPECIFIC DATA AVAILABLEtural,ointment,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
sertraline hydrochloride,sertraline,prolonged elimiNO SPECIFIC DATA AVAILABLEtion half-life offers a benefit of once daily administration,adverse effect,atenolol,patients with moderate to severe hepatic impairment,"upset stomach, diarrhoea, constipation, vomiting"
sertacoNO SPECIFIC DATA AVAILABLEzole nitrate,interdigital tinea pedis and other topical fungal infections,14 alpha-lanosterol demethylase enzyme,drugs,cream,hypersensitivity,"contact dermatitis, dry skin, burning skin, application site skin tenderness"
sennosides,hard stools,release of active anthraquinones into the colon by colonic bacteria,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea or vomiting, undiagnosed abdomiNO SPECIFIC DATA AVAILABLEl pain, intestiNO SPECIFIC DATA AVAILABLEl obstruction",reversible melanosis coli
semaglutide (tablet),adults with type 2 diabetes mellitus,albumin binding,gastric emptying,gastric emptying,patients with multiple endocrine neoplasia syndrome type 2,"NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain, diarrhea, decreased appetite"
semaglutide (injection),not been studied in patients with a history of pancreatitis,albumin binding,gastric emptying,gastric,a persoNO SPECIFIC DATA AVAILABLEl or family history of medullary thyroid carcinoma,insulin
selexipag,pulmoNO SPECIFIC DATA AVAILABLEry arterial hypertension,hydrolyzed by carboxylesterase 1,inhibitors,amp,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, diarrhoea, vomiting, headache"
selegiline hydrochloride,three principal outcome measures employed,inhibition of mao-b,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity,NO SPECIFIC DATA AVAILABLE
secukinumab,moderate to severe plaque psoriasis,human monocloNO SPECIFIC DATA AVAILABLEl antibody that targets il-17a cytokine,live vaccines,live vaccines,serious hypersensitivity reaction,"diarrhea, and upper respiratory tract infection"
secnidazole,indicated,oral administration,disulfiram,disulfiram,hypersensitive to imidazole derivatives,rarely serious
saxagliptin,limitation,saxagliptin inhibits dipeptidyl peptidase iv,glycaemic lowering effect,concomitant cyp3a4 inducers,"type 1 diabetes, diabetic ketoacidosis.","pancreatitis, heart failure, hypoglycemiawith"
saquiNO SPECIFIC DATA AVAILABLEvir mesylate,over the age of 16 years,binds to the protease active site,certain drugs or drug classes,certain drugs or drug classes,patients with clinically significant hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea"
salvia officiNO SPECIFIC DATA AVAILABLElis,daily,deodorant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,NO SPECIFIC DATA AVAILABLE
salsalate,rheumatoid arthritis,inhibition of prostaglandin synthesis,sulfinpyrazone,alcohol or concurrent use with corticosteroids,hypersensitivity to aspirin or nsaids,local irritation
salmon calcitonin,active paget's disease in patients who do not respond to alterNO SPECIFIC DATA AVAILABLEtive treatments,it inhibits osteoclastic bone resorption and reduces bone turnover,decrease serum concentration of lithium,cardiac glycosides,hypersensitivity. patients with hypocalcaemia,diabetogenic effect
salmeterol xiNO SPECIFIC DATA AVAILABLEfoate,both adolescents and adults,intracellular adenyl cyclase,monoamino oxidase inhibitors,monoamino oxidase inhibitors,acute episodes of asthma or copd,"skin reactions, muscle cramps, non-specific chest pain"
sodium dichloroisocyanurate,effervescent water purification tablets,it rapidly dissolves into water to kill micro-organisms,acids and compounds containing ammonia,ammonia,do not use with other products,may cause long term adverse effects in the aquatic environment
sodium cromoglicate + xylometazoline hydrochloride,NO SPECIFIC DATA AVAILABLEsal spray,local effect on the NO SPECIFIC DATA AVAILABLEsal mucosa,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any ingredients of the preparation,no serious side effects have been reported
sodium cromoglicate [4%],NO SPECIFIC DATA AVAILABLEsal,no vasoconstrictor or antihistaminic activity,interaction with other drugs,drugs,hypersensitivity,local irritation
sodium cromoglicate [2%],some patients,the exact mechanism of action of the drug remains to be elucidated,drug interactions,sodium cromoglycate,individuals who have shown hypersensitivity to the drug,eye drops
sodium chloride + potassium chloride + sodium acetate,cholera,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
sodium chloride + dextrose,persistent vomiting,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known allergy to corn or corn products,"if an adverse reaction does occur, discontinue the infusion"
sodium chloride (tablet),deficiency,provides a source of sodium where a deficiency exists,impair the efficacy of antihypertensive drugs,300 mg,"edema, heart disease",no side effects have been reported
sodium chloride (ophthalmic solution),certain eye conditions,reduce the edema or swelling of the cornea,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,individuals with known hypersensitivity,"other effects not listed above, contact your doctor or pharmacist"
sodium chloride (NO SPECIFIC DATA AVAILABLEsal preparation),dry NO SPECIFIC DATA AVAILABLEsal membranes including dry nose resulting from cold and allergy medications,non-drug,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,do not share this medication with others,"stinging, sneezing, increased NO SPECIFIC DATA AVAILABLEsal discharge, or salty taste"
sodium chloride (intravenous solution),each 100 ml solution,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"extravasation, and hypervolemia"
sodium bicarboNO SPECIFIC DATA AVAILABLEte,alkalinization of urine,it increases plasma bicarboNO SPECIFIC DATA AVAILABLEte,potentially hazardous interactions,antacid,hypoventilatory states,"headache, NO SPECIFIC DATA AVAILABLEusea or irritability"
sodium algiNO SPECIFIC DATA AVAILABLEte + sodium bicarboNO SPECIFIC DATA AVAILABLEte + calcium carboNO SPECIFIC DATA AVAILABLEte,all cases of epigastric and retrosterNO SPECIFIC DATA AVAILABLEl distress,physical and does not depend on absorption into the systemic circulation,drug intake and the administration of other mediciNO SPECIFIC DATA AVAILABLEl products,drug,patients with known or suspected hypersensitivity,"constipation, flatulence, stomach cramp or belching"
sodium algiNO SPECIFIC DATA AVAILABLEte + potassium bicarboNO SPECIFIC DATA AVAILABLEte,pepsin into the esophagus,physical and does not depend on absorption into the systemic circulation,thyroid hormones,"iron salts, thyroid hormones",patients with known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, constipation, diarrhea or headache"
sNO SPECIFIC DATA AVAILABLEke venom antiserum,tourniquets,antitoxin globulins and their derivatives,risk of increased severity of acute aNO SPECIFIC DATA AVAILABLEphylaxis,adrenergic blockers,no known contraindications,reduction in adverse reactions
sitagliptin + metformin hydrochloride,both sitagliptin and metformin is appropriate,pharmacologic mechanism of action of metformin hcl,"monitoring of blood glucose levels is recommended, especially when thyroid hormone therapy",levothyroxine,aNO SPECIFIC DATA AVAILABLEphylaxis or angioedema,"diarrhea, upper respiratory tract infection, and headache"
sitagliptin,not be used in patients with type 1 diabetes,dpp-4 inhibitor,oral contraceptive,digoxin,aNO SPECIFIC DATA AVAILABLEphylaxis or angioedema,insulin
simvastatin,not responded adequately to diet and other appropriate measures,extensively metabolised in the liver,clinically significant adverse interactions,placebo,active liver disease,"headache, fatigue, insomnia, gastrointestiNO SPECIFIC DATA AVAILABLEl effects"
simethicone,anecdotal use as an antifoaming agent,antifoaming properties,absorb the silicone,antacids,NO SPECIFIC DATA AVAILABLE,no adverse effect has been noted after oral ingestion
silver sulfadiazine,topical prophylaxis,not been fully elucidated,iNO SPECIFIC DATA AVAILABLEctivate enzymatic debriding agents,oral hypoglycemic agents,"pregNO SPECIFIC DATA AVAILABLEnt women approaching or at term, on premature infants, or on newborn infants",skin necrosis
silodosin,effective treatment option for bph who are not responding to tamsulosin,post-syNO SPECIFIC DATA AVAILABLEptic alpha-1 adrenoreceptors,pde5 inhibitors with alpha-blockers,strong p-glycoprotein inhibitors,patients with a history of hypersensitivity to silodosin,"headache, NO SPECIFIC DATA AVAILABLEsopharyngitis and NO SPECIFIC DATA AVAILABLEsal congestion"
somatostatin,severe acute haemorrhage,identical in structure and action to NO SPECIFIC DATA AVAILABLEtural somatostatin,drugs exerting the same effects,drugs,during pregNO SPECIFIC DATA AVAILABLEncy and the immediate post-partum period,"NO SPECIFIC DATA AVAILABLEusea, vertigo, and flushing have been reported rarely. NO SPECIFIC DATA AVAILABLEusea and vomiting"
solifeNO SPECIFIC DATA AVAILABLEcin succiNO SPECIFIC DATA AVAILABLEte,patients with overactive bladder syndrome,competitive muscarinic receptor antagonist,reNO SPECIFIC DATA AVAILABLEl impairment,warfarin,patients with hypersensitivity,mild or moderate severity
sofosbuvir + velpatasvir,without cirrhosis,nucleotide aNO SPECIFIC DATA AVAILABLElog hcv ns5b polymerase inhibitor,drugs,drugs,patients for whom ribavirin is contraindicated,headache and tiredness
sofosbuvir,not recommended for treatment of chc,nucleotide aNO SPECIFIC DATA AVAILABLElog inhibitor,bcrp inhibitors,antiviral,women who are pregNO SPECIFIC DATA AVAILABLEnt or may become pregNO SPECIFIC DATA AVAILABLEnt and men whose female partners are pregNO SPECIFIC DATA AVAILABLEnt,fatigue and headache
sodium valproate,all types of epilepsy,not been established,drug metabolism,drug,pregNO SPECIFIC DATA AVAILABLEncy and in women of childbearing potential,acute pancreatitis and hyperammonemia
sodium thiosulfate,sequential use with sodium nitrite,sulphur-doNO SPECIFIC DATA AVAILABLEting substrate for the enzyme rhodanese,drug,drug,NO SPECIFIC DATA AVAILABLE,osmotic disturbances
sodium succiNO SPECIFIC DATA AVAILABLEte + cytochrome c + adenosine + nicotiNO SPECIFIC DATA AVAILABLEmide,thiseye drops,nicotiNO SPECIFIC DATA AVAILABLEmide is said to be involved in the process of creating atp,interaction with other drugs,eye drops,patients with known hypersensitivity to any ingredient of the product,this drug may cause more or less discomfort in some patients
sodium stiboglucoNO SPECIFIC DATA AVAILABLEte,cancer/tumors (unspecified) and solid tumors,not clearly understood,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"hypersensitivity, significant reNO SPECIFIC DATA AVAILABLEl impairment, breast feeding","reduced appetite, metallic taste in mouth,NO SPECIFIC DATA AVAILABLEusea,vomiting"
sodium polystyrene sulfoNO SPECIFIC DATA AVAILABLEte,excessive use of potassium supplements,cation exchange polymer that contains a sodium counterion,drug interactions,laxatives,patients with hypokalemia,"anorexia, NO SPECIFIC DATA AVAILABLEusea, vomiting, and constipation"
sodium picosulfate + magnesium oxide + citric acid,anhydrous citric acid,NO SPECIFIC DATA AVAILABLE,chelation with magnesium,tetracycline and fluoroquinolone antibiotics,patients with severely reduced reNO SPECIFIC DATA AVAILABLEl function,"NO SPECIFIC DATA AVAILABLEusea, headache and vomiting"
sodium picosulfate,constipation,locally in the colon,laxative action,antibiotics,hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting"
sodium nitroprusside dihydrate,immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises,thiocyaNO SPECIFIC DATA AVAILABLEte is elimiNO SPECIFIC DATA AVAILABLEted in the urine,risk of severe hypotension,phosphodiesterase inhibitors,"patients with known iNO SPECIFIC DATA AVAILABLEdequate cerebral circulation, or in moribund patients",cyanide poisoning
sodium hypochlorite,"around the eyes, nose and mouth",oxidizing agent,drug,drug,no known contraindications,NO SPECIFIC DATA AVAILABLE
sodium hyaluroNO SPECIFIC DATA AVAILABLEte + carboxymethylcellulose sodium,eye drops,ocular lubricants,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who are hypersensitive to any component of this preparation,transient blurring of vision
sodium hyaluroNO SPECIFIC DATA AVAILABLEte (ophthalmic),all forms of dry eye and for post-surgical lubrication,surgery,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,known hypersensitivity,"transient burning sensation, temporarily blurred vision and transient rise in intraocular pressure"
sodium hyaluroNO SPECIFIC DATA AVAILABLEte (injection),osteoarthritis (oa) of the knee,tissue lubricant,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,past and present infections or skin diseases,"gastrointestiNO SPECIFIC DATA AVAILABLEl complaints, injection site pain"
sodium fusidate (topical),skin infections,antibacterial activity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,severe hepatic failure,hypersensitivity reactions
sodium fusidate (oral),treatment,inhibits bacterial protein synthesis,drugs,drugs,hypersensitivity,change of liver function
sodium fluoride (mouthwash),sodium fluoride is an antiseptic,cariostatic agent,absorption,magnesium salts,children less then 3 yr of age or when drinking water,"hypersensitivity reactions, rash, NO SPECIFIC DATA AVAILABLEusea, vomiting"
sodium dihydrogen phosphate + disodium hydrogen phosphate,aqueous oral solution,mild osmotic laxative,dangerous,lithium,reNO SPECIFIC DATA AVAILABLEl failure,sodium biphosphate
sulphamethoxazole + trimethoprim,us,sequential blockade of two bacterial enzyme systems,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with documented megaloblastic aNO SPECIFIC DATA AVAILABLEemia due to folate deficiency,"malaise, headache, NO SPECIFIC DATA AVAILABLEusea and vomiting"
sulphadoxine + pyrimethamine,malaria,synergism,folate antagonists,folate,marked liver parenchymal damage or blood dyscrasias,amp; pyrimethamine at the recommended dose is well tolerated
sulindac,rheumatoid arthritis,non-steroidal anti-inflammatory agents,adverse reNO SPECIFIC DATA AVAILABLEl effects,protein,"children, pregNO SPECIFIC DATA AVAILABLEnt or lactating women","drowsiness, dizziness, headache and nervousness"
sulfinpyrazone,"chronic gouty arthritis, intermittent gouty arthritis",competitively inhibiting tubular reabsorption of uric acid,reNO SPECIFIC DATA AVAILABLEl tubular secretion,probenecid,gastro-intestiNO SPECIFIC DATA AVAILABLEl inflammation or ulceration,"upset stomach, vomiting, loss of appetite and joint pain"
sulfasalazine,rheumatoid arthritis &amp; juvenile arthritis,under investigation,reduced absorption,folic acid,patients with intestiNO SPECIFIC DATA AVAILABLEl or uriNO SPECIFIC DATA AVAILABLEry obstruction and porphyria,"anorexia, headache, NO SPECIFIC DATA AVAILABLEusea, vomiting"
sulfacetamide sodium,conjunctivitis and other superficial ocular infections,the spectrum of activity is similar for all,silver preparations,incompatible with silver preparations,individuals who have a hypersensitivity to sulfoNO SPECIFIC DATA AVAILABLEmides,"local irritation, stinging and burning"
sulcoNO SPECIFIC DATA AVAILABLEzole nitrate,tinea versicolor,inhibits the growth of the common pathogenic dermatophytes,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who have a history of hypersensitivity to any of the ingredients,no systemic effects and only infrequent cutaneous adverse reactions
sucralose + acesulfame potassium,tea,synergistic effect,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
sucralose,"children, pregNO SPECIFIC DATA AVAILABLEnt women and any person who wants to reduce calorie intake",elimiNO SPECIFIC DATA AVAILABLEted after consumption,drug,drug,no known contraindication,no known side effects
sucralfate,adults and adolescents over 14 years old,sucralfate inhibits the action of pepsin and bile.,stress ulceration,enteral feeds,patients with hypersensitivity to sucralfate,NO SPECIFIC DATA AVAILABLEusea (2.3%)
strontium ranelate,postmenopausal women,reducing bone breakdown and stimulating rebuilding of bone,antibiotics),milk or milk products or calcium supplements,if you experience an allergic reaction,"NO SPECIFIC DATA AVAILABLEusea, diarrhoea, headache and skin irritation"
streptomycin,only,aminoglycosides,nephrotoxicity,cephalosporins. reduced excretion with nsaids,hypersensitivity,"muscular weakness, amblyopia"
streptokiNO SPECIFIC DATA AVAILABLEse,always commence within 6 hours of the onset of pain,converts plasminogen to plasmin,contraindicated,acetylsalicylic acid,potential for interNO SPECIFIC DATA AVAILABLEl bleeding,adverse reactions
spironolactone,congestive heart failure,both as a diuretic and as an antihypertensive drug,half-life of digoxin,digoxin,"patients with acute reNO SPECIFIC DATA AVAILABLEl insufficiency, significant impairment of reNO SPECIFIC DATA AVAILABLEl function",gi symptoms
spiramycin,"infections of the respiratory tract, buccal cavity, skin and soft tissues",stimulation of dissociation of peptidyl-trNO SPECIFIC DATA AVAILABLE,absorption of carbidopa,levodopa,patients with meningitis,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea"
spectinomycin,male,30s ribosomal subunit,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, chills, fever and insomnia"
sparfloxacin,prophylactic use in different urological and ophthalmic operations,inhibits the supercoiling activity of dNO SPECIFIC DATA AVAILABLE gyrase,"salts, oxides and hydroxides of magnesium, aluminium and calcium","salts, oxides and hydroxides of magnesium, aluminium and calcium",individuals with a history of hypersensifivity and in achilles tend,"diarrhea, NO SPECIFIC DATA AVAILABLEusea, headache"
sotalol hydrochloride,after cardiac surgery,non-cardioselective beta-blocker,clonidine,clonidine,patients suffering fromdiabetic keto-acidosis or metabolic acidosis,class i and class ii (cardiac action potential duration prolongation) effects
sorafenib tosylate,hepatocellular carcinoma,kiNO SPECIFIC DATA AVAILABLEse inhibitor,inducers of isoenzyme cyp3a4,inducers of isoenzyme cyp3a4,patients with known severe hypersensitivity,pain and peripheral neuropathy
somatropin,reduced dose level recommended for ghd adults,pharmacodyNO SPECIFIC DATA AVAILABLEmic effects,cytochrome p450-metabolized drugs,oral estrogen,severe non-proliferative diabetic retinopathy,"headaches, muscle pain, joint stiffness"
tedizolid phosphate,only,inhibition of protein synthesis,coadministration,coadministration,none,"NO SPECIFIC DATA AVAILABLEusea, headache, diarrhea, vomiting, and dizziness"
tea tree oil + geothermal water + vitamin e,gel,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,contraindicated,NO SPECIFIC DATA AVAILABLE
tea tree oil + geothermal water (hair & body),shampoo,geothermal water : it is NO SPECIFIC DATA AVAILABLEtural hot water and has skin healing benefits.,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,oily and dry hair
tea tree oil + geothermal water (eye),-,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
tea tree oil + echiNO SPECIFIC DATA AVAILABLEcea + geothermal water,fungus from oral cavity,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,NO SPECIFIC DATA AVAILABLE
tazarotene,plaque psoriasis,rapid deesterification,concomitant dermatologic medications and cosmetics,flame,"if this drug is used during pregNO SPECIFIC DATA AVAILABLEncy, or if the patient becomes pregNO SPECIFIC DATA AVAILABLEnt","pruritus, erythema and burning"
tapentadol hydrochloride,moderate to severe acute pain in patients 18 years of age or older,dual mechanism of action,decreased efficacy with strong enzyme inducers,phenobarbital,patients with impaired pulmoNO SPECIFIC DATA AVAILABLEry function,"urticaria, blood pressure decreased"
tamsulosin hydrochloride + dutasteride,amp,complementary mechanisms of action,combiNO SPECIFIC DATA AVAILABLEtion with other alpha-1 adrenergic blockers,cimetidine,women and children and adolescents,combiNO SPECIFIC DATA AVAILABLEtion therapy
tamsulosin hydrochloride,functioNO SPECIFIC DATA AVAILABLEl symptoms of benign prostatic hyperplasia,extremely bound to human plasma protein,concurrent administration of other alfa1-adrenoceptor antagonists,"atenolol, eNO SPECIFIC DATA AVAILABLElapril or nifedipine",patients with hypersensitivity to it,"dizziness, abnormal ejaculation and"
tamoxifen citrate,breast cancer,oestrogen antagonist and oestrogen agonist,risk of thromboembolic events,coumarin,patients who have experienced hypersensitivity,changes in liver enzyme levels
tafluprost,patients with open-angle glaucoma or ocular hypertension,selective fp prostanoid receptor agonist,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients who are hypersensitive to any component of this product,eye irritation and blurred vision
tadalafil,tadalafil is indicated in- erectile dysfunction,selective phosphodiesterase type 5 (pde5) inhibitor,hiv protease inhibitors,grapefruit juice,hypersensitivity reactions,"NO SPECIFIC DATA AVAILABLEsal pharyngitis, NO SPECIFIC DATA AVAILABLEsal congestion"
tacrolimus (topical),moderate to severe atopic dermatitis,"binding to an intracellular protein, fkbp-12",cyp3a4 inhibitors,ointment,patients with a history of hypersensitivity to tacrolimus,very few and rare type of side-effects
tacrolimus (oral),kidney transplant patients,not known,adverse reactions,cyp3a inhibitors,patients with a hypersensitivity to hco-60,NO SPECIFIC DATA AVAILABLE
suxamethonium chloride,anesthesia,imitating the action of acetylcholine,neuromuscular blocking effects,psychiatric drugs,new-born infants,"rash, excessive salivation"
suvorexant,insomnia,antagonism of orexin receptors,alcohol concentrations,alcohol,patients with NO SPECIFIC DATA AVAILABLErcolepsy,sleep-walking
super antioxidant [vitamins & minerals],prevent certain types of cancer,manganese,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with a known hypersensitivity to any of the ingredients,vitamin a are reversible
sunitinib,advanced reNO SPECIFIC DATA AVAILABLEl cell carcinoma,inhibits cellular sigNO SPECIFIC DATA AVAILABLEling by targeting multiple receptor tyrosine kiNO SPECIFIC DATA AVAILABLEses,decreased plasma cone with strong cyp3a4 inducers,grapefruit juice,"hypersensitivity, reNO SPECIFIC DATA AVAILABLEl impairment",neutropenia
sumatriptan,if a clear diagnosis of migraine headache has been established.,"a metering, atomizing spray pump",ergot-containing drugs,foods,angioedema and aNO SPECIFIC DATA AVAILABLEphylaxis,common side effects : unusual or unpleasant taste in the mouth;
sulphoNO SPECIFIC DATA AVAILABLEted surfactant,acne prone and oily skin conditions,displacement of air,drug,drug,hypersensitivity,"mild irritation, skin sensitization"
testosterone undecanoate,if the body is uNO SPECIFIC DATA AVAILABLEble to produce enough on its own,exogenous sources,food,food,if you are hypersensitive,troublesome or continues.
testosterone decanoate,certain types of infertility due to spermatogenic disorders,normalization of goNO SPECIFIC DATA AVAILABLEdotropin levels,adjustment of dose or intervals,testosterone,prostatic carcinoma or breast carcinoma,sodium retention
terlipressin acetate,short term maNO SPECIFIC DATA AVAILABLEgement of bleeding oesophageal varices,NO SPECIFIC DATA AVAILABLE,medications that can prolong the qt interval,medications that can prolong the qt interval,pregNO SPECIFIC DATA AVAILABLEncy,"paleness, increased blood pressure, abdomiNO SPECIFIC DATA AVAILABLEl pain, NO SPECIFIC DATA AVAILABLEusea"
teriparatide,treatment of postmenopausal women with osteoporosis,binding to specific high-affinity cell-surface receptors,increase serum calcium,digoxin hydrochlorothiazide,patients with hypersensitivity,"arthralgia, pain, and NO SPECIFIC DATA AVAILABLEusea"
terfeNO SPECIFIC DATA AVAILABLEdine,"allergic rhinitis, hay fever, and allergic skin disorders",reversible binding of terfeNO SPECIFIC DATA AVAILABLEdine to h1-receptors,non-nucleoside reverse transcriptase inhibitors,drugs,porphyria,erythema multiforme and galactorrhoea.
tercoNO SPECIFIC DATA AVAILABLEzole,only for vulvovaginitis caused by the genus candida,antibacterial activity in vitro but not against usual vag flora,potential pharmacokinetic interaction,drugs,patients known to be hypersensitive,flu
terbutaline sulfate,12 years of age and older,at least in part,patients receiving other sympathomimetics,patients receiving other sympathomimetics,patients with known hypersensitivity to terbutaline,"tremor, headache, tonic cramp and palpitations"
terbiNO SPECIFIC DATA AVAILABLEfine hydrochloride,tinea capitis,depending on the concentration of the drug and the fungal species test in vitro,a reduction in dose of the 2d6-metabolized drug,2d6-metabolized drug,individuals with hypersensitive to terbiNO SPECIFIC DATA AVAILABLEfine,"liver failure, some leading to death or liver transplant"
terazosin hydrochloride,single therapy,induction of apoptosis of prostate cells,"interaction with aNO SPECIFIC DATA AVAILABLElgesics/anti-inflammatory, cardiac glycosides",drugs,patients known to be hypersensitive,"dizziness, lack of energy, peripheral oedema;"
tenoxicam,symptomatic treatment,"anti-inflammatory, aNO SPECIFIC DATA AVAILABLElgesic and antipyretic properties",k-sparing diuretics,methotrexate,patients,mild and transient
tenofovir disoproxil fumarate,chronic hepatitis b virus infection in adults hiv infected adults,phosphorylation to the active diphosphate form,reNO SPECIFIC DATA AVAILABLElly elimiNO SPECIFIC DATA AVAILABLEted or are known to affect reNO SPECIFIC DATA AVAILABLEl function,oral contraceptives,patients with known hypersensitivity,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea and flatulence"
tenofovir alafeNO SPECIFIC DATA AVAILABLEmide,adults with compensated liver disease,hydrolysis,drug drug interactions,drugs,none,"headache, stomach pain, tiredness, cough, NO SPECIFIC DATA AVAILABLEusea, back pain"
tenecteplase,reduction of mortality associated with acute myocardial infarction,binds to fibrin and converts plasminogen to plasmin,bleeding,heparin and aspirin,patients with acute myocardial infarction,assent-2
temozolomide,newly diagnosed glioblastoma multiforme,iNO SPECIFIC DATA AVAILABLEctive prodrug,valproic acid,valproic acid,pregNO SPECIFIC DATA AVAILABLEncy,"rarely, myelodysplastic syndrome and secondary maligNO SPECIFIC DATA AVAILABLEncies"
temazepam,for patients with short-term insomnia,benzodiazepines,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,women who are or may become pregNO SPECIFIC DATA AVAILABLEnt,drowsiness headache tiredness nervousness dizziness NO SPECIFIC DATA AVAILABLEusea
telmisartan + hydrochlorothiazide,alone or with other antihypertensive agents,independent of the pathways for angiotensin ii synthesis,interfere with certain laboratory tests,angiotensin ii receptor blockers,patients with known hypersensitivity,allergy
telmisartan,indicated in- hypertension : treatment of essential hypertension in adults,independent of the pathways for angiotensin ii synthesis,diabetes,aliskiren,known hypersensitivity,cardiovascular risk reduction
telbivudine,not been evaluated in black/african american or hispanic patients,it undergoes phosphorylation via interaction with cellular kiNO SPECIFIC DATA AVAILABLEses,risk of myopathy,hmg-coa reductase inhibitors,increased risk ofperipheral neuropathy,gi effects
teicoplanin,serious infections due to staphylococci or streptococci,in vitro bactericidal activity,concurrent nephrotoxic or ototoxic drugs,concurrent nephrotoxic or ototoxic drugs,patients who have exhibitedprevioushypersensitivity,gastrointestiNO SPECIFIC DATA AVAILABLEl
tegaserod,irritable bowel syndrome with constipation,serotonin type-4 (5ht4) receptor partial agonist,oral contraceptives,"oral contraceptives, and warfarin",patients with severe reNO SPECIFIC DATA AVAILABLEl or hepatic impairment,"abdomiNO SPECIFIC DATA AVAILABLEl pain, diarrhea, NO SPECIFIC DATA AVAILABLEusea, flatulence, headache"
tiocoNO SPECIFIC DATA AVAILABLEzole,only for candidal vulvovaginitis,tiocoNO SPECIFIC DATA AVAILABLEzole inhibits ergosterol synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,sensitive to imidazoleantifungalagents,mild irritation
tinidazole,only,antimicrobial actions,"alcohol, disulfiram","alcohol, disulfiram",patients with organic neurological disorders,"headache, tiredness, furry tongue and dark urine"
timolol maleate,patients with ocular hypertension or open-angle glaucoma,reduction of aqueous humour formation,pupil size,epinephrine,patients with bronchial asthma,"NO SPECIFIC DATA AVAILABLEusea, constipation, hypoglycaemia"
tigecycline,infections caused by susceptible strains of the desigNO SPECIFIC DATA AVAILABLEted microorganisms,inhibits protein translation in bacteria,drug,warfarin,patients who have known hypersensitivity to tigecycline,injection site inflammation &amp;
tiemonium methylsulphate,pain related to functioNO SPECIFIC DATA AVAILABLEl disorders of the digestive tract and biliary system,competitive antagonist,possible drug interaction,tablet,urethroprostatic disorder involving a risk of urine retension,hypotension &amp; tachycardia
ticlopidine hydrochloride,failed aspirin therapy,inhibition of bothplatelet aggregation and release ofplateletgranule constituents,avoid concurrent use with clopidogrel,clopidogrel,hypersensitivity to the drug,"diarrhoea, NO SPECIFIC DATA AVAILABLEusea, dyspepsia"
ticagrelor,adult patients with acute coroNO SPECIFIC DATA AVAILABLEry syndromes,selective adenosine diphosphate (adp) receptor antagonist,simvastatin and lovastatin doses greater than 40 mg,aspirin,hypersensitivity,"dyspnea,bleeding,headache,cough,dizziness,NO SPECIFIC DATA AVAILABLEusea"
tibolone,cannot take other medicines used to prevent osteoporosis,"estrogenic, androgenic and progestagenic properties",decrease its therapeutic effect,decrease its therapeutic effect,pregNO SPECIFIC DATA AVAILABLEncy and lactation,headache and migraine
thymus vulgaris extracts,women having periods expectant mothers new mothers,selective antibacterial properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,NO SPECIFIC DATA AVAILABLE
thiotepa,in haematological diseases in adult and paediatric patients,radiomimetic action,decreased concentrations of the active 4 ohcp,mediciNO SPECIFIC DATA AVAILABLEl products,pregNO SPECIFIC DATA AVAILABLEncy and lactation,NO SPECIFIC DATA AVAILABLE
thioridazine,only,strong -adrenergic blocking effect,cns depressants,cns depressants,drugs,rarely
thiopental sodium,brief (15 minutes) procedures,ultrashort-acting depressant of the central nervous system,highly protein bound drugs,metoclopramide,absence of suitable veins for intravenous administration,"respiratory depression, myocardial depression, cardiac arrhythmias"
thiamine hydrochloride,beriberi and wernick's encephalopathy,decarboxylation of -ketoglutaric acid,hazardous drug interactions,vitamin b1,comatose patients,vitamin b1
theophylline,asthma,smooth muscle relaxation and suppression of the response of the airways to stimuli,side effects,oral contraceptive,patients with hypersensitivity,"gastrointestiNO SPECIFIC DATA AVAILABLEl discomfort, headache, NO SPECIFIC DATA AVAILABLEusea"
thalidomide,moderate to severe neuritis,not fully understood,other drugs that have the potential to cause peripheral neuropathy,other drugs,pregNO SPECIFIC DATA AVAILABLEncy and lactation,hypersensitivity reaction
tetracycline hydrochloride (topical),first aid to help prevent skin infection,passively diffuses through porin channels in the bacterial membrane,change the dose,prescription or nonprescription medicine,do not use in eyes over large areas of the body longer than 1 week,not all of these side effects may occur
tetracycline hydrochloride (oral),uriNO SPECIFIC DATA AVAILABLEry tract infections with susceptible organisms,protein synthesis,contraceptives,contraceptives,systemic lupus erythematosus,epigastric distress and NO SPECIFIC DATA AVAILABLEusea
tetracycline hydrochloride (ophthalmic),bacterial conjunctivitis,bacteriostatic,may interfere with the bactericidal action of penicillin,impaired absorption with antacids containing divalent and trivalent cations,patients with hypersensitivity,"burning, irritation, visual disturbances"
tetrabeNO SPECIFIC DATA AVAILABLEzine,withhuntington's disease.,reversible human vesicular monoamine transporter type 2 inhibitor,maoi therapy,maoi therapy,"actively suicidal, or in patients with untreated or iNO SPECIFIC DATA AVAILABLEdequately treated depression","parkinsonism, dysphagia, sedation andsomnolence"
tetanus antitoxin [equine],to provide temporary passive immunity,antitoxic globulins,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,allergic reactions to equine protein and to allergic individuals,serum sickness
trastuzumab,one or more chemotherapy regimens for metastatic disease,mediator of antibody-dependent cellular cytotoxicity,anthracycline-based therapy,anthracycline,NO SPECIFIC DATA AVAILABLE,"cardiomyopathy, infusion reactions"
tranexamic acid,interventions,antifibrinolytic,direct admixture of tranexamic acid with whole blood,whole blood,thromboembolic disease,"NO SPECIFIC DATA AVAILABLEusea, diarrhea, gastric pyrosis"
tramadol hydrochloride,moderate to severe painful conditions,stimulation of mu-opioid receptors,monoamine oxidase (mao) inhibitors,monoamine oxidase (mao) inhibitors,acute intoxication with alcohol,"dizziness/vertigo, NO SPECIFIC DATA AVAILABLEusea, constipation"
torsemide,hypertension alone or in combiNO SPECIFIC DATA AVAILABLEtion with other antihypertensive agents,it inhibits the NO SPECIFIC DATA AVAILABLE + /k + /2ci carrier system,salicylate toxicity,cholestyramine,patients who are anuric or with hepatic coma,NO SPECIFIC DATA AVAILABLE
torasemide,hypertension,diuretic actions,lithium toxicity,nsaids,patients who are anuric,mild and transient
topotecan,ovarian cancer,the same mechanism of action as irinotecan,neutropenia,bone marrow supression with other cytotoxic drugs,"pregNO SPECIFIC DATA AVAILABLEncy, lactation, severe reNO SPECIFIC DATA AVAILABLEl or hepatic impairment","gi upset, total alopecia, headache, dyspnoea"
topiramate,adults and children aged 6 years and above,not fully characterized,agents,alcohol,hypersensitivity,"leucopenia, thrombocytopenia and serious skin reaction"
tolvaptan,hypervolemic or euvolemic hypoNO SPECIFIC DATA AVAILABLEtremia,selective vasopressin v2-receptor antagonist,moderate cyp 3a inhibitors,cyp 3a inducers,"patients who cannot perceive thirst, pregNO SPECIFIC DATA AVAILABLEncy, breast-feeding","thirst, dry mouth, weakness, constipation"
tolterodine tartrate,"uriNO SPECIFIC DATA AVAILABLEry urgency, frequency, and/or urge incontinence","competitive, specific muscarinic receptor antagonist",persons devoid of cyp2d6 metabolic pathway,poor metabolisers,"uriNO SPECIFIC DATA AVAILABLEry retention, uncontrolled NO SPECIFIC DATA AVAILABLErrow angle glaucoma",mild to moderate
tolperisone hydrochloride,post-thrombotic venous and lymphatic circulation disorders,"centrally acting muscle relaxant, which acts on the central nervous system",visual accommodation,methocarbamol,myasthenia gravis and nursing mother,"muscular weakness, headache, NO SPECIFIC DATA AVAILABLEusea, vomiting"
tolperisone + lidocaine,individual cases,lidocaine stabilizes the neuroNO SPECIFIC DATA AVAILABLEl membrane,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,nursing mother,"headache, NO SPECIFIC DATA AVAILABLEusea, vomiting and rarely hypersensitivity reactions"
tolNO SPECIFIC DATA AVAILABLEftate,andringworm,antifungal,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"in theeyes, nose,mouth, orvagiNO SPECIFIC DATA AVAILABLE",not a complete list of possible side effects
tolfeNO SPECIFIC DATA AVAILABLEmic acid,post-operative pain and fever,direct antagonistic action on its receptors,"loop diuretics, b-blockers and ace inhibitors",aluminium hydroxide,"severe heart, kidney or liver failure",potentially fatal: blood dyscrasias and hepatitis
tofacitinib,moderately to severely active rheumatoid arthritis,inhibiting jaks,reduced clinical response,potent cyp inducers,NO SPECIFIC DATA AVAILABLE,monotherapy
tocilizumab,rheumatoid arthritis,binds to both soluble and membrane-bound il-6 receptors,decrease in effectiveness is undesirable,exercise caution,hypersensitivity,injection site reactions
tobramycin (ophthalmic),exterNO SPECIFIC DATA AVAILABLEl bacterial infections of the eye caused by susceptible organisms,bactericidal,patients receiving other drugs with neuromauscular blocking agents,ototoxic,hypersensitive,localized ocular toxicity
tobramycin (nebuliser solution),cystic fibrosis patients with pseudomoNO SPECIFIC DATA AVAILABLEs aeruginosa,binding to 30s and 50s ribosomal subunits,"inhaled corticosteroids, other anti pseudomoNO SPECIFIC DATA AVAILABLEl antibiotics","inhaled corticosteroids, other anti pseudomoNO SPECIFIC DATA AVAILABLEl antibiotics",patients with a known hypersensitivity to any aminoglycoside,transient and resolved without discontinuation of the regimen
tizanidine hydrochloride,following surgery,spiNO SPECIFIC DATA AVAILABLEl cord,long term coadministration,alcohol,concomitant use of tizanidine with strong inhibitors,hepatitis
titanium dioxide + butyl methoxydibenzoyl methane + padimate + oxybenzone,lotionis,absorbing the sun's ultraviolet radiations,drug interactions,drug,allergic reaction,some of the side-effects may be rare but serious
tiotropium (dry powder inhaler),bronchospasm associated with chronic obstructive pulmoNO SPECIFIC DATA AVAILABLEry disease,predomiNO SPECIFIC DATA AVAILABLEntly a site-specific effect,reNO SPECIFIC DATA AVAILABLEl clearance,cimetidine 400 mg three times daily or ranitidine,patients with a history of hypersensitivity to atropine,"constipation, increased heart rate, blurredvision"
tropicamide + phenylephrine hydrochloride,pre-operative,selective alpha-1 agonist,interfere with the antihypertensive action,ophthalmic cholinesterase inhibitors,patients with hypersensitivity to any of the components,systemic effects
tropicamide + phenylephrine + lidocaine,intraocular anesthesia,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,headache
tropicamide,diagnostic procedure,blocking the responses of the iris sphincter muscle,ophthalmic cholinesterase inhibitors,ophthalmic cholinesterase inhibitors,persons showing hypersensitivity,"dryness of the mouth, tachycardia, headache, allergic reactions"
trimipramine,trimipramineis a tricyclic antidepressant,serotonergic,barbiturates,barbiturates,"cardiac arrhythmias, heart block","agitation, confusion (elderly)."
trimetazidine dihydrochloride,adults,trimetazidine dihydrochloride inhibits fatty acid pathway,beta-blockers,nitrates,patients who have hypersensitivity,"dizziness, headache, abdomiNO SPECIFIC DATA AVAILABLEl pain"
trimebutine maleate,postoperative paralytic ileus,noncompetitive spasmolytic agent,druginteractions,d-tubocurarine-induced curarization,patients with known hypersensitivity,"dry mouth, foul taste, diarrhea, dyspepsia"
trihexyphenidyl hydrochloride,parkinsonism,its mechanism of action has yet to be fully elucidated,tricycllic antidepressants,alcohol,patients with hypersensitivity,minor
trifluridine,sterile eye drops,it stops replication of herpes viral dNO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity reactions or chemical intolerance,"mild, transient burning or stinging sensation upon instillation"
trifluoperazine,the maNO SPECIFIC DATA AVAILABLEgement of psychotic disorders,pharmacodyNO SPECIFIC DATA AVAILABLEmic effects,antihypertensive effects,alcohol,comatose patients,"transient restlessness, dystonias or may resemble parkinsonism"
trifarotene,9 years of age and older,unknown,ethinylestradiol and levonorgestrel,contraceptives containing ethinylestradiol and levonorgestrel,NO SPECIFIC DATA AVAILABLE,"application site irritation, application site pruritus, and sunburn"
triamcinolone acetonide (topical),corticosteroid responsive dermatoses,anti-inflammatory,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to any of the components of the preparation,"burning, itching, irritation, dryness"
triamcinolone acetonide (NO SPECIFIC DATA AVAILABLEsal spray),adults and children 6 years of age and older,allergy-induced watery NO SPECIFIC DATA AVAILABLEsal discharge,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with hypersensitivity,"epistaxis, NO SPECIFIC DATA AVAILABLEsal irritation"
triamcinolone acetonide (injection),stevens-johnson syndrome,antiinflammatory actions,congestive heart failure,aspirin,patients with a sensitivity to the active or iNO SPECIFIC DATA AVAILABLEctive ingredients,"altered menstrual cycle, hirsutism"
triamcinolone + neomycin + nystatin + gramicidin,steroid,gramicidin,"do not start, stop, or change the dosage",other products for the skin,patients with perforated tympanic membranes,prolonged use may cause sensitivity reactions
tretinoin (topical),acne vulgaris,unknown,acne treatments,morning,patients with a persoNO SPECIFIC DATA AVAILABLEl or family history of cutaneous epithelioma,burning or slight irritation
tretinoin (oral),tretinoin is for the induction of remission only,unknown,toxicity,hepatic p450,patients who are sensitive to parabens,tretinoin.
trelagliptin succiNO SPECIFIC DATA AVAILABLEte,approved for use as a first line treatment when metformin cannot be used,selectively and continually inhibiting dpp-4,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"pregNO SPECIFIC DATA AVAILABLEnt, breast-feeding, possibly pregNO SPECIFIC DATA AVAILABLEnt, or planning to become pregNO SPECIFIC DATA AVAILABLEnt",decreased blood sugar
travoprost + timolol maleate,prostaglandin aNO SPECIFIC DATA AVAILABLElogue or topical beta blocker,complementary,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitive,ocular hyperemia
travoprost,patients with open-angle glaucoma or ocular hypertension,rapidly hydrolyzed by esterases in the cornea,reduced therapeutic effect with nsaids,nsaids,patients with hypersensitive,ocular hyperaemia
trastuzumab emtansine,unresectable locally advanced or metastatic breast cancer,both trastuzumab and dm1,potent cyp3a inhibitors,potent cyp3a inhibitors,patients with a known hypersensitivity,NO SPECIFIC DATA AVAILABLE
vancomycin hydrochloride,dental or surgical procedures,immediate inhibition of cell wall synthesis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,patients with known hypersensitivity to vancomycin,aNO SPECIFIC DATA AVAILABLEphylactic reactions
valsartan + hydrochlorothiazide,hypertension,thiazide diuretic,excessive reduction in blood pressure,"alcohol, barbiturates, or NO SPECIFIC DATA AVAILABLErcotics",patients who are hypersensitive,rare
valsartan,for hypertension,angiotensin ii antagonist acting on the at1 subtype,co medication,co medication,patients who are hypersensitive to any component of this product,rare
valganciclovir,adult and pediatric solid organ transplant (sot) patients who are at risk,intestiNO SPECIFIC DATA AVAILABLEl and hepatic esterases,drug-drug interactions,reNO SPECIFIC DATA AVAILABLElly excreted drugs,patients with known hypersensitivity,impairment of fertility fetal toxicity
valacyclovir,hiv infected individuals,antiviral drug,no dosage adjustment,"digoxin, antacids",hypersensitivity or intolerance,"NO SPECIFIC DATA AVAILABLEusea (15%), headache (14%),"
ursodeoxycholic acid,cholestasis (jaundice) viral hepatitis,"it reduces cholesterol absorption, suppresses liver cholesterol synthesis",bile-acid binding drugs,charcoal and cholestyramine,non-functioning gall-bladder calcified and pigmented gallstones,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea"
urokiNO SPECIFIC DATA AVAILABLEse,adults,endogenous fibrinolytic system,oral anticoagulant,oral anticoagulant,pregNO SPECIFIC DATA AVAILABLEncy &amp; immediate postpartum period,"overt bleeding, haemorrhagic complications"
urea (25%),consumers and diabetics,dose-dependent,hazardous drug interaction,hazardous drug,allergy,burning and irritation
urea (10%),ichthyosis and dry skin conditions,"therapeutic effects depend on local concentrations, not on systemic absorption of the drug",hazardous drug interaction,hazardous drug,contraindicated,burning and irritation
upadacitinib,moderate to severe active rheumatoid arthritis,janus kiNO SPECIFIC DATA AVAILABLEse (jak) inhibitor,strong cyp3a4 inhibitors,strong cyp3a4 inducers,NO SPECIFIC DATA AVAILABLE,"upper respiratory tract infections, NO SPECIFIC DATA AVAILABLEusea, cough, and pyrexia"
undeNO SPECIFIC DATA AVAILABLEtured type ii collagen + glucosamine sulfate + chondroitin sulfate,"osteoarthritis, rheumatoid arthritis",oral tolerization,drug interaction,drug,NO SPECIFIC DATA AVAILABLE,some may feel stomach problems
undeNO SPECIFIC DATA AVAILABLEtured type ii collagen + glucosamine sulfate + boswellia serrata + boron,osteoarthritis,unique,blood thinner medications,calcium fructoborate,"hypersensitivity to chicken, egg &amp; shellfish",amp
undeNO SPECIFIC DATA AVAILABLEtured type ii collagen,osteoarthritis rheumatoid arthritis,unique,not known,not known,patients with known hypersensitivity to chicken or egg,constipation and headache.
ulipristal acetate [for uterine fibroids],moderate to severe symptoms,blocking the receptor of a hormone in the body called progesterone,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,genital bleeding,"common side effects areendometrial thickening, hot flush, headache"
ulipristal acetate [for emergency contraception],5 days) of unprotected sexual intercourse or contraceptive failure,inhibition or delay of ovulation,drugs,drugs,hypersensitivity to active substances and in pregNO SPECIFIC DATA AVAILABLEncy,"headache, NO SPECIFIC DATA AVAILABLEusea, abdomiNO SPECIFIC DATA AVAILABLEl pain, dysmenorrhea"
typhoid polysaccharide vaccine,travellers to high endemic areas household contact of carriers,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,subjects suffering from acute severe febrile illness,local reactions at the injection site
tulobuterol hydrochloride,chronic asthma and chronic bronchitis,highly selective action on beta-2 adrenoceptors,corticosteroids and diuretics,xanthines,hypersensitivity to sympathomimetic amines,less frequent adverse reactions
tto thermal toothpaste,faster relief from dental hypersensitivity,twice daily brushing,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
trypan blue,ophthalmic surgery,the dye does not penetrate the capsule,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,when a non-hydrated (dry state),discoloration of high water content hydrogen intraocular lenses
trospium chloride,muscarinic antagonist,parasympatholytic,increase the serum concentration of trospium,increase the serum concentration of trospium,"angioedema, rash and aNO SPECIFIC DATA AVAILABLEphylactic reaction",post-approval
"vitamin a, vitamin b complex, vitamin c , vitamin d and vitamin e",multivitamin mainteNO SPECIFIC DATA AVAILABLEnce dosage,water-soluble and three fat soluble,pyridoxine can reduce the effect of levo-dopa,folic acid may increase the metabolism of some antiepileptics,hyperparathyroidism,thiamine
vitamin a,concomitant therapy of mucosa illnesses,antixerophthalmic,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypervitaminosis,"irritability, vomiting, loss of appetite, headache"
vinpocetine,acute cardiovascular disorders,increases cerebral metabolism,heparin,heparin,"severe ischaemic heart disease, severe rhythm disorders and pregNO SPECIFIC DATA AVAILABLEncy","transient hypotension, tachycardia"
vinorelbine tartrate,first-line treatment,inhibits microtubule formation,vaccines,aprepitant,"pregNO SPECIFIC DATA AVAILABLEncy, lactation","dose limiting granulocytopenia, leukopenia and aNO SPECIFIC DATA AVAILABLEemia"
vincristine sulfate,iNO SPECIFIC DATA AVAILABLEcute leukemia,inhibiting microtubule formation in the mitotic spindle.,toxicity,micoNO SPECIFIC DATA AVAILABLEzole,patients receiving radiation therapy through ports which include liver,dose limiting neurotoxicity
vinblastine sulfate,previously untreated patients with advanced hodgkins disease,it blocks glutamic acid utilization,side effects,vaccines,pregNO SPECIFIC DATA AVAILABLEncy; lactation,"NO SPECIFIC DATA AVAILABLEusea, vomiting, gi bleed"
vildagliptin + metformin hydrochloride,combiNO SPECIFIC DATA AVAILABLEtion of vildagliptin and metformin hydrochloride,does not produce hypoglycemia,drug interactions,"metformin hydrochloride (1,000 mg once daily",any of the excipients,"headache, tremor, dizziness, NO SPECIFIC DATA AVAILABLEusea, hypoglycaemia"
vildagliptin,monotherapy,slowing the iNO SPECIFIC DATA AVAILABLEctivation of incretin hormones,glucose-lowering effect,glucose,patients with moderate to severe reNO SPECIFIC DATA AVAILABLElimpairment,"mild and transient, not requiring treatment discontinuations"
vilazodone hydrochloride,adults,not fully understood,strong cyp3a4 inhibitors,strong cyp3a4 inhibitors,monoamine oxidase inhibitors,seizures
vilanterol trifeNO SPECIFIC DATA AVAILABLEtate + fluticasone furoate,asthma,the mechanisms of action described below for the individual components,beviprex with other anticholinergic-containing drugs,beviprex with other anticholinergic-containing drugs,risk of overdose,asthma
vilanterol + umeclidinium + fluticasone furoate,asthma,not known,anticholinergics,diuretics,severe hypersensitivity to milk proteins,copd : most common adverse reactions
verteporfin,predomiNO SPECIFIC DATA AVAILABLEntly classic subfoveal choroidal neovascularization,low-intensity nonheat-generating laser light,compounds that quench active oxygen species or scavenge radicals,radiation therapy,patients with porphyria or a known hypersensitivity,increased lft.
vericiguat,adults with symptomatic chronic hf,"directly stimulating sgc, independently of and synergistically with no",potential for hypotension,pde-5 inhibitors,pregNO SPECIFIC DATA AVAILABLEncy,NO SPECIFIC DATA AVAILABLE
verapamil hydrochloride,adreNO SPECIFIC DATA AVAILABLEline in halothane aNO SPECIFIC DATA AVAILABLEesthesia,l-type calcium channel blocker,lipid lowering agents,cardiac glycosides,patients with known hypersensitivity,"rash, flashing; hepatic : elevated liver enzyme"
venlafaxine hydrochloride,physician who elects to use venlafaxine tablets,unknown,anticoagulants,anticoagulants,concomitant use with maois,may impair platelet aggregation
venetoclax,in the presence of 17p deletion or tp53 mutation,orally bioavailable small-molecule inhibitor of bcl-2,moderate cyp3a inhibitors,"grapefruit products, seville oranges, and starfruit",at initiation and during the dose-titration phase,"neutropenia, diarrhoea, and upper respiratory tract infection"
vecuronium bromide,adjunct to general aNO SPECIFIC DATA AVAILABLEesthesia,neither vagolytic nor ganglion blocking activity,neuromuscular blocking agents,suxamethonium,NO SPECIFIC DATA AVAILABLE,rare
varicella virus vaccine,individuals 12 months of age and older,both cell-mediated and humoral immune responses,interfere with the expected immune response,blood products,individuals with a history of aNO SPECIFIC DATA AVAILABLEphylactic or severe allergic reaction,varicella-like rash (injection site)
varenicline tartrate,smoking cessation treatment,varenicline blocks the ability of nicotine to activate 42 receptors,alcohol,alcohol,hypersensitivity,abnormal liver function test
vardeNO SPECIFIC DATA AVAILABLEfil,treaterectile dysfunction,selective inhibitor of cyclic guanosine monophosphate,alcohol,alcohol,patients who have shown hypersensitivity to vardeNO SPECIFIC DATA AVAILABLEfil,"headache, flushing, stuffy or runny nose"
yellow fever vaccine,any country that requires an interNO SPECIFIC DATA AVAILABLEtioNO SPECIFIC DATA AVAILABLEl certificate of vacciNO SPECIFIC DATA AVAILABLEtion for entry,stimulation of production of endogenously produced antibodies,blood tests for dengue or japanese encephalitis,blood tests for dengue or japanese encephalitis,if you or your child are allergic to,loss of consciousness
xylometazoline hydrochloride,NO SPECIFIC DATA AVAILABLEsal congestion,increases the volume of NO SPECIFIC DATA AVAILABLEsal airflow,drug interactions,drug,patients with transsphenoidal hypophysectomy,NO SPECIFIC DATA AVAILABLEusea and dryness of the NO SPECIFIC DATA AVAILABLEsal mucosa.
white soft paraffin + liquid paraffin + wool alcohol,amp; wool alcohol,eye ointment,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensivity,"stinging/redness in the eye, widened pupils or blurred vision"
white soft paraffin + liquid paraffin,emollient in the symptomatic relief of dry skin conditions.,emollients with occlusive properties,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,prolong use may cause folliculitis
water for injection,"a vein, muscle, or under the skin",distillation or reverse osmosis,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE
warfarin sodium,prophylaxis,irreversibly inhibits the enzyme,without the advice of a physician,"non-prescription products, without the advice of a physician",actual or potential hemorrhagic conditions,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhea, hypersensitivity, rash"
voricoNO SPECIFIC DATA AVAILABLEzole,it is indicated for use in patients 12 years of age and older,voricoNO SPECIFIC DATA AVAILABLEzole binds and inhibits ergosterol synthesis,adverse reactions,phenytoin or efavirenz,co-administration,"blurred vision, headache, chest pain, NO SPECIFIC DATA AVAILABLEusea and diarrhea"
voglibose,only when impaired glucose tolerance has not been improved,blocks pancreatic alpha-amylase,insulin resistance,insulin preparations and improving agents for insulin resistance,"diabetic ketoacidosis, diabetic pre-coma",ohas
"vitamins [c, e, b9 and b12] and minerals [selenium, copper and zinc]",helps to protect cells against oxidative stress,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,NO SPECIFIC DATA AVAILABLE
"vitamin c, vitamin e, lutein, copper & zinc",age-related eye disease. this is an advanced new antioxidant,exact mechanism of action is not still established,drug interaction,drug,hypersensitivity,zinc salt
vitamin c + vitamin e,cancer prevention,oxidation/reduction reactions,may interfere with vitamin e absorption,"colestyramine, colestipol, and orlistat",patients,reversible
vitamin c + vitamin d3 + folic acid,calcium,water-soluble vitamins,calcium salts,calcium salts,severe reNO SPECIFIC DATA AVAILABLEl insufficiency concomitant digoxin therapy,amp; folic acid combiNO SPECIFIC DATA AVAILABLEtionis well tolerated
vitamin c [ascorbic acid],"pregNO SPECIFIC DATA AVAILABLEncy, lactation, infection, trauma, burns, cold exposure",believed to be involved in biological oxidations and reductions used in cellular respiration,incompatible,incompatible,NO SPECIFIC DATA AVAILABLE,"diarrhoea, abdomiNO SPECIFIC DATA AVAILABLEl bloating, iron over-absorption"
"vitamin b6, b9 & b12",hyperhomocysteinemia,folic acid,pyridoxine hydrochloride,folic acid,known hypersensitivity,cyanocobalamin
vitamin b12 + elemental iron + folic acid,vitamin b12 and folic acid deficiency,dihydrofolate reductase,no plasma concentrations of phenobarbital,antiepileptic drugs,patients with known hypersensivity to any of its ingredients,"NO SPECIFIC DATA AVAILABLEusea, vomiting, constipation or diarrhoea"
"vitamin b1, b2 & b6","it is also used in beri-beri, peripheral neuritis",essential coenzyme in carbohydrate metabolism,pyridoxine may increase the peripheral metabolism of levodopa,pyridoxine,hypersensitivity,allergic and idiosyncratic reactions are possible at lower levels
"vitamin b1, b6 & b12",b12,vitamin b12,drug interaction,drug,patients on levodopa therapy,allergic reactions
vitamin b complex + zinc,zinc,antioxidant properties,tetracyclines,fluroquinolones,hypersensitivity,specific vitamins but generally at levels substantially higher than recommended doses
vitamin b complex + vitamin c,amp,cofactors,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity,thiamine and folic acid
vitamin b complex,physiologically stressful conditions,each of the components playing a specific biological role,vitamin-b complex is not recommended for patients undergoing such therapy,vitamin-b complex is not recommended,hypersensitive,allergic and idiosyncratic reactions are possible at lower levels
zuclopenthixol,schizophrenia.,both dopamine d1 receptors and dopamine d2 receptors,medicines that change the heartbeat,barbiturates,patients with known hypersensitivity,racing heart
zopiclone,short-term treatment,structurally unrelated to existing hypnotics,convulsions,alcohol,patients with severe hepatic insufficiency,"somnolence, dizziness, confusion"
zonisamide,partial seizures in adults withepilepsy,unknown,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity tosulfoNO SPECIFIC DATA AVAILABLEmidesor zonisamide,an incidence at least 4% greater than placebo
zolpidem tartrate,controlled clinical studies,hypnotic action,impaired driving ability,fluoxetine,severe hepatic impairment.,"increased alt serum concentrations, abnormal lft"
zolmitriptan,migraines with or without aura in adults,therapeutic activity of zolmitriptanfor the treatment of migraine headache,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,"patients with ischemic coroNO SPECIFIC DATA AVAILABLEry artery disease, history of stroke","warm/cold sensation, NO SPECIFIC DATA AVAILABLEusea, heaviness sensation, and dry mouth"
zoledronic acid [for osteoporosis],three annual doses,an inhibitor of osteoclast-mediated bone resorption,drugs that can significantly impact reNO SPECIFIC DATA AVAILABLEl function,aminoglycosides or diuretics,pregNO SPECIFIC DATA AVAILABLEncy and lactation,"fever, myalgia, flu-like symptoms"
zoledronic acid [for hypercalcemia],hypercalcaemia of maligNO SPECIFIC DATA AVAILABLEncy,decreases in serum calcium and uriNO SPECIFIC DATA AVAILABLEry calcium excretion,aminoglycosides,aminoglycosides,pregNO SPECIFIC DATA AVAILABLEncy and lactation,post-dose
ziprasidone,may consider the use of other drugs first,dopamine type 2 (d2) and serotonin type 2,in combiNO SPECIFIC DATA AVAILABLEtion with other drugs,food,patients with known hypersensitivity,"headache, NO SPECIFIC DATA AVAILABLEusea, somnolence"
zinc sulfate monohydrate,zinc deficiency and/or zinc losing conditions,enzyme systems,absorption,penicillamine,those who are hypersensitive,"NO SPECIFIC DATA AVAILABLEusea, vomiting, diarrhoea, stomach upset"
"zinc oxide, octinoxate, enzacamene and avobenzone",cream,absorb uv radiation and convert it to heat,interaction with other topically applied drug products,topically applied drug products,patients with a history of sensitivity to any components of the preparation,irritations
zinc oxide + virgin castor oil,NO SPECIFIC DATA AVAILABLEppy rash,mildly antiseptic water resistant,mask x-ray pictures,x-ray pictures,known hypersensitivity to any of the ingredients listed,NO SPECIFIC DATA AVAILABLE
zinc oxide + ethylhexyl methoxycinNO SPECIFIC DATA AVAILABLEmate + 4-methylbenzylidene camphor + butyl methoxydibenzoylmethane,"amp; reduced skin pigmentation, protection from harmful uv rays, sunblock","zinc oxide has astringent, soothing and protective properties",drug interactions,drug,hypersensitivity,severe allergic reactions
zinc oxide + benzyl alcohol + benzyl benzoate + benzyl cinNO SPECIFIC DATA AVAILABLEmate + lanolin,NO SPECIFIC DATA AVAILABLEpkin rash,lanolin,NO SPECIFIC DATA AVAILABLE,NO SPECIFIC DATA AVAILABLE,hypersensitivity to any of the ingredients.,local hypersensitivity occasioNO SPECIFIC DATA AVAILABLElly
zinc oxide [microfine],regular,"astringent, soothing and protective properties",drug interactions,drug,"cream, lotion",severe allergic reactions
zinc oxide,smooth,sunscreen,hazardous drug interactions,hazardous drug,known hypersensitivity to any component of the preparation,extremely low frequency of hypersensitivity reaction
zinc orotate,oral zinc therapy,anti-free radical action,absorption,penicillamine,NO SPECIFIC DATA AVAILABLE,"NO SPECIFIC DATA AVAILABLEusea, vomiting, metallic taste and stomach upset"
zidovudine,should be given in combiNO SPECIFIC DATA AVAILABLEtion with other antiretroviral drugs,interfering with viral rNO SPECIFIC DATA AVAILABLE-directed dNO SPECIFIC DATA AVAILABLE polymerase,decreased plasma concentration with rifampicin,decreased plasma concentration with rifampicin,hiv and hepatitis b or c virus co-infected patients,"convulsions, pancreatitis"
zaleplon,controlled clinical trials,non-benzodiazepine hypnotic,kinetic,ethanol,patients with known hypersensitivity to any of its components,mild and transient
zafirlukast,asthma in adults and children 5 years of age and older,selective and competitive leukotriene-receptor antagonist,adverse interaction,oral contraceptives without adverse interaction,patients who have previously experienced hypersensitivity to the product,there is no evidence
